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ABSTRACT 
 
Research in the field of exhaled breath analysis is developing rapidly and is 
currently focussed on disease diagnosis and prognosis. The ability to identify early 
onset of life-threatening diseases, by a subtle change in exhaled profile that is 
picked up through a non-invasive measure, is of clinical interest. However, 
implementation of exhaled breath analysis can extend further beyond disease 
diagnosis and/or management. Using a non-invasive and rapid sample collection 
with high sensitivity, breath analysis may be seen to have potential benefit to the 
wider community. This research describes preliminary investigations into exhaled 
breath in exercise-based scenarios that aims to translate current breath analysis 
methodologies into a sport and exercise medicine context. 
 An adaptive absorbent-based breath sampling methodology was used to 
collect a total of 220 breath samples from 54 participants over 3 studies. Breath 
volatiles were analysed using thermal desorption-gas chromatography-mass 
spectrometry. Data were analysed with targeted, and multivariate metabolomics-
based approaches. 
 Potential health impacts to high performance and recreational swimmers 
exposed to chlorinated water was studied. Following preliminary and scoping 
studies, 19 participants were sampled before a 30 min swim, and a further 5 times 
for 10 hrs after swimming. Environmental and control samples were also collected. 
Concentrations of chlorine-based disinfection by-products were observed to 
increase by up to a median of 121-fold, and take up to 8.5 hrs to return to pre-
swimming levels. Metabolomic profiling identified the monoterpene geranylacetone 
to be a discriminant variable in samples taken 10 hrs after swimming. 
Geranylacetone is associated with membranes and extracellular fluids and an 
upregulated trend was observed across the five sampling time points post-
swimming. Further research with an appropriately stratified and powered cohort 
(n=38) was recommended. 
The effects of intense exercise on breath profiles was explored for the 
possible use of breath analysis for exercise science with elite performance-based 
medicine. Twenty-nine participants provided exhaled breath samples before 
  
undergoing a maximal oxygen uptake (fitness) test and then provided 2 additional 
samples over the following 1 hr period. High and low fitness groupings, deemed by 
oxygen uptake values, were compared for exhaled metabolites. Lower exhaled 
acetone and isoprene were observed in participants with greater absolute oxygen 
uptake leading to a hypothesis for a non-invasive breath based fitness test.  
 Finally, an interface for breath-by-breath analysis using a transportable mass 
spectrometer was developed. A controlled change in exhaled profiles was achieved 
through the ingestion of a peppermint oil capsule. Menthone was measured on-line 
and monitored for up to 10 hrs post-administration. Sixteen participants enabled 
the system to be demonstrated as exhaled menthone was at elevated 
concentrations for at least 6 hrs. Validation against thermal desorption-gas 
chromatography-mass spectrometry confirmed the system to be detecting 
metabolites at the sub-µg L-1 range.  
 
One journal article has been published for the work detailed from Chapter 6 in this 
thesis: 
 
Heaney LM, Ruszkiewicz DM, Arthur KL, Hajithekli A, Aldcroft C, Lindley MR,  
Thomas CLP, Turner MA, Reynolds JC. Real-time monitoring of exhaled breath 
volatiles using atmospheric pressure chemical ionization on a compact mass 
spectrometer. Bioanalysis 2016;doi: 10.4155/bio-2016-0045 
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If— by Rudyard Kipling 
 
If you can keep your head when all about you  
Are losing theirs and blaming it on you, 
If you can trust yourself when all men doubt you, 
But make allowance for their doubting too; 
If you can wait and not be tired by waiting, 
Or being lied about, don't deal in lies, 
Or being hated, don't give way to hating, 
And yet don't look too good, nor talk too wise: 
 
If you can dream - and not make dreams your master; 
If you can think - and not make thoughts your aim; 
If you can meet with Triumph and Disaster 
And treat those two impostors just the same; 
If you can bear to hear the truth you've spoken 
Twisted by knaves to make a trap for fools, 
Or watch the things you gave your life to, broken, 
And stoop and build 'em up with worn-out tools:  
 
If you can make one heap of all your winnings  
And risk it on one turn of pitch-and-toss, 
And lose, and start again at your beginnings 
And never breathe a word about your loss; 
If you can force your heart and nerve and sinew 
To serve your turn long after they are gone, 
And so hold on when there is nothing in you 
Except the Will which says to them: 'Hold on!' 
 
If you can talk with crowds and keep your virtue, 
'Or walk with Kings - nor lose the common touch, 
If neither foes nor loving friends can hurt you, 
If all men count with you, but none too much; 
If you can fill the unforgiving minute 
With sixty seconds' worth of distance run, 
Yours is the Earth and everything that's in it, 
And - which is more - you'll be a Man, my son! 
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CHAPTER ONE: GENERAL INTRODUCTION AND THESIS 
DIRECTION 
 
1.1 Scope of doctoral thesis 
This research sought to explore the potential of the analysis of exhaled volatile 
organic compounds (VOCs) as a research methodology in sport and exercise 
science. The studies undertaken highlight the potential uses for exhaled breath 
analysis with athletes to assess their health and current performance capabilities, 
with the view to possible use of assays for personalised and/or stratified training 
protocols. A central aim of this research was to reflect on the prospects for breath 
analysis to improve health and performance monitoring as part of an exercise 
science routine. In addition, any beneficial advances for elite sport could translate 
into a wider remit of public health and treatments involving exercise. Therapy and 
training associated with managing chronic disease, maintaining good health and 
preparing elite athletes for competition is generally time constrained and so a focus 
on rapid analysis is required. These works aim to potentiate the development and 
introduction of exhaled breath analyses into exercise and health. 
 
1.2 The premise of exhaled breath analysis 
Exhaled breath is predominantly comprised of mixture of nitrogen (N2), oxygen (O2)), 
carbon dioxide (CO2), inert gases and water vapour. However, trace amounts of 
volatile compounds have been observed at parts per million (> 0.1 g m-3(g), ppm(v/v)), 
parts per billion (1 μg m-3(g) to 0.1 g m-3(g), ppb(v/v)) and parts per trillion (< 1 μg m-3(g), 
ppt(v/v)) concentrations [1,2]. Endogenous VOCs are produced during metabolic 
processes, transported in the circulatory system and enter the air in the lungs 
across the alveolar membrane. Various diseases result in disrupted metabolic 
pathways and it has been suggested that such changes would be apparent in the 
concentration of VOCs in exhaled breath. It has been proposed that, through further 
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research, exhaled breath analysis can be used as a non-invasive clinical diagnostic 
method to help assess health status [3]. 
The notion of exhaled breath investigation has been evident across two 
millennia. In circa 400 BC Hippocrates used the aroma of exhaled breath to 
diagnose illness in his patients, before it was known that specific volatile 
compounds are associated with certain diseases. For example, diabetic patients 
have an increased level of acetone in their breath, which holds a characteristic 
sweet smell [4,5]. Insulin deficiency means they are unable to metabolise glucose 
efficiently, so metabolism shifts toward the oxidation of fat. This action increases 
ketoacidosis, and acetone is formed by hepatocytes in the decarboxylation of 
acetoacetate (a derivative of lipolysis) under conditions of excess Acetyl-CoA [1]. 
These blood-borne VOCs equilibrate with the gases in the small airways of the lung, 
diffusing across the blood-alveoli barrier, causing them to be detectable in exhaled 
air. 
The continuous development and enhancement of analytical technologies 
has allowed the capture and detection of a variety of exhaled compounds to be 
achieved routinely. Consequently, the use of exhaled breath analysis is being 
adopted by an increasing number of researchers, and the prospect of breath 
analysis providing the early-onset diagnosis of health conditions is one of 
widespread interest. The premise is that disrupted metabolism, resulting from the 
deterioration of cells or the growth of tumours, alters the types and concentrations 
of volatile compounds that can ultimately pass into the alveoli and be exhaled. The 
focus of this research was not to use exhaled breath for diagnostic purposes, but 
instead to begin the exploration of possible uses of exhaled VOC analysis in sport- 
and/or exercise-based situations. The underlying premise of this work is that 
exhaled breath analyses, with extensive development, could show utility for the 
monitoring of elite athletes and provide valuable information on rehabilitation from 
illness and/or injury for both athletes and the general population alike. Although the 
use of exhaled breath is common in exercise testing, with the measurement of 
inhaled/exhaled O2 and CO2 to estimate O2 utilisation, little has been done to study 
exhaled VOCs; only 14 research articles that assess exhaled VOCs in an exercise 
environment have been published [6-19].  
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1.3  Exhaled breath in sport and exercise 
 
1.3.1 The importance of sport and exercise science 
It has long been established that exercise generates adaptions within the biological 
system, with significant increases in exercise output ability following periods of 
repeated exercise training. Understanding of how these adaptations occur, and the 
underlying mechanisms that result in improved performance characteristics, such 
as strength and endurance, is continually increasing as the field of sport and 
exercise science/medicine grows. Better characterisation of the preferential 
adaptations that occur as a result of different exercise interventions, i.e. training 
regimes, results in more sophisticated and better targeted programmes. This could 
benefit individuals of different phenotypes, who may fall into disparate groups of 
exercise capability. For elite sports people it is important to focus on sport-specific 
training and to push the adaptations that confer the greatest competitive advantage 
for each individual. Such training regimes may be focussed toward strength, for 
example weightlifters and power sports such as rugby, or more toward endurance, 
for long distance runners and cyclists. The research conducted in these areas 
allows these athletes, and their coaches, to adopt strategies that match the results 
of their exercise adaptations to the requirements of their sport or event. Such 
advances go beyond competitive benefits to the prevention of injury and illness and 
accelerated recovery from sporting injuries.  
Sports science yields many benefits to public health that go beyond the 
sphere of elite exercise and sport. Exercise is beneficial to everyone, and the 
American College of Sports Medicine provides detailed recommendations for 
exercise testing and prescription [20] to improve general public health by increasing 
the exercise output of ‘the masses’. The primary aim of these recommendations is 
to increase energy output with a hope to reduce conditions, such as type II diabetes 
mellitus, associated with overweight or obese individuals. Exercise is also beneficial 
to individuals recovering from illnesses, especially those with cardiovascular 
perturbations. Exercise during rehabilitation from acute episodes of conditions such 
as heart failure, can reduce recovery periods and ultimately improve prognosis for 
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the individual (see Wilson et al. for a review on the science behind the 
cardiovascular benefits of exercise [21]). The general benefit of sport is taken a 
step further and examined more specifically in sports and exercise/medicine. The 
associated underpinning science offers benefit across all sectors of society, from 
elite competitive sport to leisure and general well-being, and the vitally important 
challenges of promoting well-being and reducing exacerbations of chronic illnesses 
and hospital admissions in an aging population. 
 
1.3.2. Current uses of exhaled breath with exercise 
 
Maximal oxygen uptake 
Breath analysis is used widely within research and elite sport. It is used to measure 
an individual’s fitness level by calculating their maximal O2 uptake, referred to as 
V̇O2max: the gold standard method of assessing fitness. V̇O2max is a measure of the 
working muscles’ ability to use the O2 that is inhaled and transported by the 
circulatory system. As the body’s capability of utilising O2 increases, it allows the 
individual to work for longer, or at higher intensity, and is described as an 
improvement in the ‘fitness level’ for this person. Calculating the amount of O2 that 
is utilised during different exercise outputs is possible due to the ratios of inspired 
and expired O2 and CO2 [22]. O2 and CO2, along with N2, are the most abundant 
molecules present in exhaled breath and are the foundation of the majority of 
laboratory fitness assessments, having shaped research into exercise interventions 
over many decades. 
 The V̇O2max test measures an individual’s systemic aerobic respiration (O2 
consumption) during exercise. The test increases exercise intensity, and thus O2 
consumption, in an incremental manner with 1stepped increases every 3 or 4 min. 
This allows the participant to equilibrate with the exercise intensity and reach a 
                                                 
1 Some protocols implement a more gradual, but constant positive gradient of exercise intensity, 
often leading to shorter test times but may be argued is more amenable to individuals of a low 
fitness level, or with more fundamental health issues. 
  
5 
 
steady-state of O2 consumption, provided the exercise level is below the 
participant’s aerobic limitations.  
With stepped increments, the steady state O2 consumption will be linearly 
related to increases in exercise intensity. It is most important that the participant 
does not come to a point of volitional fatigue associated with psychological factors. 
An accurate result of O2 uptake ( V̇ O2) requires exercising until the physical 
maximum. This linear relationship of V̇O2 across the test allows for calibration of an 
individual’s V̇O2max. This provides a means to a stratified exercise training regime, 
i.e. directing an athlete to work for 30 min at 70 % of their aerobic maximum. To 
achieve maximum intensity there is an element of coercion (usually through jeers, 
praise and active encouragement) to motivate and/or persuade participants to 
continue the test for as long as is possible. By ensuring the individual exercises until 
their absolute maximum, an accurate result of V̇O2 can be achieved.  
A common method to calculate V̇O2max uses a cycle ergometer with total 
exhaled breath collected for 60 s into a pre-evacuated Douglas bag at the end of 
each incremental step. Exhaled air is analysed for O2 and CO2 content and total 
exhaled volume measured.  
Environmental sampling allows calculation of inhaled and, therefore, exhaled 
fractions of N2, 02 and CO2. To calculate V̇O2 several values must be known. A step-
by-step calculation process is described below.  
Firstly, the total exhaled air, or ventilatory equivalent, under ambient 
conditions (𝑉𝐸𝐴𝑇𝑃𝑆) is calculated and normalised to a 1 min collection (Equation 
1).  
𝑉𝐸𝐴𝑇𝑃𝑆 (𝐿) =
𝑉𝑡 (𝐿)
𝑡𝑇 (𝑠)
 𝑥 60(𝑠) Equation 1 
Where 𝑉𝑡 is total volume collected and 𝑡𝑇 is total time of collection.  
 
  
  
6 
 
To convert this value to standardised temperature and pressure (𝑉𝐸𝑆𝑇𝑃𝐷), 
𝑉𝐸𝐴𝑇𝑃𝑆 is multiplied by a conversion factor. Under these conditions one mole of 
gas occupies 22.4 L. Table 1 indicates the conversion factor value across a 
common range of laboratory temperatures and pressures. For a more 
comprehensive table see [23]. 
 
Table 1  Table to show multiplication factors for converting volume at ambient conditions to 
standard pressure, temperature and humidity values; adapted from [23]. 
 
Ambient temperature / °C 
Barometric 
pressure (mm Hg) 
19 20 21 22 23 24 25 
740 0.887 0.883 0.878 0.874 0.869 0.864 0.860 
742 0.890 0.885 0.881 0.876 0.871 0.867 0.862 
744 0.892 0.888 0.083 0.878 0.874 0.869 0.864 
746 0.895 0.890 0.886 0.884 0.876 0.872 0.867 
748 0.897 0.892 0.888 0.883 0.879 0.874 0.869 
750 0.900 0.895 0.890 0.886 0.881 0.876 0.872 
752 0.902 0.897 0.893 0.888 0.883 0.879 0.874 
754 0.904 0.900 0.895 0.891 0.886 0.881 0.876 
756 0.907 0.902 0.898 0.893 0.888 0.883 0.879 
758 0.909 0.905 0.900 0.896 0.891 0.886 0.881 
760 0.912 0.907 0.902 0.898 0.893 0.888 0.883 
762 0.914 0.910 0.905 0.900 0.896 0.891 0.886 
764 0.916 0.912 0.907 0.903 0.898 0.893 0.888 
766 0.919 0.915 0.910 0.905 0.900 0.896 0.891 
768 0.922 0.917 0.912 0.908 0.903 0.898 0.893 
770 0.924 0.919 0.915 0.910 0.905 0.901 0.896 
 
Inhaled ventilatory equivalent (VI) for 1 min must be calculated by Equation 
2. For the test performed in Chapter 5, exhaled air was collected for 60 s and 
therefore the units do not need conversion to L min-1. 
𝑉𝐼 (𝐿.𝑚𝑖𝑛−1) =  
𝐹𝐸𝑁2 (%) 𝑥 𝑉𝐸𝑆𝑇𝑃𝐷(𝐿.𝑚𝑖𝑛−1)
𝐹𝐼𝑁2 (%)
 Equation 2 
Where: 𝐹𝐼𝑁2  and 𝐹𝐸𝑁2  are the inhaled and exhaled fractional values of N2, 
respectively.  
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V̇O2 can then be calculated using Equation 3. 
?̇?𝑂2 (𝐿.𝑚𝑖𝑛−1) =  
𝑉𝐼 (𝐿.𝑚𝑖𝑛−1) 𝑥 𝐹𝐼O2 (%)
100
−  
𝑉𝐸𝑆𝑇𝑃𝐷(𝐿.𝑚𝑖𝑛−1) 𝑥 𝐹𝐸O2 (%)
100
 Equation 3 
Where FIO2 and FE02 are the fractional values of inhaled and exhaled O2, 
respectively. 
 
This provides an absolute uptake of oxygen in litres per minute. For data 
obtained from the final stage of the exercise test, this equals V̇O2max. Normalisation 
against body mass can be performed using Equation 4 to give a reading in mL(O2) 
kg-1 min-1.  
?̇?𝑂2𝑚𝑎𝑥 (𝑚𝐿.𝑘𝑔−1.𝑚𝑖𝑛−1) =  
?̇?𝑂
2 (𝐿.𝑚𝑖𝑛−1)
𝑏𝑜𝑑𝑦 𝑚𝑎𝑠𝑠(𝑘𝑔)
 x 1000 Equation 4 
 
Table 2 summarises ‘normative’ data values for V̇O2max for males and females [24]. 
 
Table 2 Normative maximal oxygen uptake ( V̇ O2max) data for males (top) and females 
(bottom) for an age range of 20 to 79 years old; adapted from [24]. 
Male, V̇O2max / mL(O2) kg-1 min-1 
Age Poor Fair Good Excellent Superior 
20 – 29 < 42 42 - 45 46 - 50 51 - 55 > 55 
30 - 39 < 41 41 - 43 44 - 47 48 - 53 > 53 
40 - 49 < 38 38 - 41 42 - 45 46 - 52 > 52 
50 - 59 < 35 35 - 37 38 - 42 43 - 49 > 49 
60 - 69 < 31 31 - 34 35 - 38 39 - 45 > 45 
70 - 79 < 28 28 - 30 31 - 35 36 - 41 > 41 
    
Female, V̇O2max / mL(O2) kg-1 min-1 
   
Age Poor Fair Good Excellent Superior 
20 - 29 < 36 36 - 39 40 - 43 44 - 49 > 49 
30 - 39 < 34 34 - 36 37 - 40 41 - 45 > 45 
40 - 49 < 32 32 - 34 35 - 38 39 - 44 > 44 
50 - 59 < 25 25 - 28 29 - 30 31 - 34 > 34 
60 - 69 < 26 26 - 28 29 - 31 32 - 35 > 35 
70 - 79 < 24 24 - 26 27 - 29 30 - 35 > 35 
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Exhaled breath condensate 
Exhaled breath condensate (EBC) is collected by cooling exhaled water vapour and 
collecting the resultant liquid. Figure 1 shows an example instrument (known 
commercially as the R Tube®) for the collection of EBC. This medium allows the 
collection of non-volatile compounds such as isoprostanes and leukotrienes. These 
molecules are considered as some of the most important intermediates in the 
inflammatory response [25]. Oxidative stress markers are thought to be present 
during airway inflammation and have shown to be significantly elevated after a 
single swimming session by competitive swimmers [26] and in asthmatic patients 
post-exercise [27]. Additionally, researchers have reported the alteration of pH in 
EBC at the onset of exercise-induced bronchoconstriction [28], which may be due to 
the release of molecules such as hydrogen peroxide [29]. The majority of the 
current work centred on EBC and exercise focuses on inflammatory responses in 
exercise-induced respiratory conditions. The current study has not located reports or 
papers on investigations into EBC analysis for exercise-based performance or 
monitoring. Because EBC collects non-volatile compounds, it was not utilised and is 
therefore outside of the scope of this research. 
 
Figure 1 A photograph of an exhaled breath condensate collection device. The participant 
exhales through the mouthpiece at the lower left and exhaled breath passes into 
the chamber above where it is cooled (cooling jacket not shown). Cooled air 
condenses and collects into a vial that is attached at the lower end. 
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Exhaled nitric oxide 
Nitric oxide (NO) forms as a free radical gas in the airways, when L-arginine is 
oxidised to L-citrulline [30], and is expired in the breath. NO is continuously 
produced in the body, and the lower airways provide the major contribution to 
increased concentrations in the breath of asthmatics [31]. Increases are likely due 
to activation of nitrogen oxide synthase 2 in airway epithelial cells [32,33]. It is 
predominately measured by the detection of photons when NO reacts with ozone in 
a chemiluminescence assay. Figure 2 shows commercially available exhaled NO 
(eNO) analysers. Investigations have reported that, in healthy participants, eNO 
levels reduce after a bout of exercise [34], with no differences in rates of reduction 
in cold [35] and high altitude [36] environments. Asthmatic individuals showed 
similar reductions in eNO to healthy controls [37] but, interestingly, chronic systolic 
heart failure patients showed an increased in eNO post-exercise [38]. These data 
suggest that an increase in post-exercise eNO due to inflammation does not occur 
when localised to the respiratory system, but is seen when systemic inflammation is 
present. 
 
 
Figure 2  Commercially available exhaled nitric oxide analysers to quantify exhaled 
concentrations. 
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Exhaled volatilome 
One area of interest within breath analysis is the exhaled volatilome [see 2 for a 
review on all aspects of the human volatilome]. This refers to the large variety of 
VOCs that are present in exhaled breath that can be collected and analysed, 
predominantly by gas chromatography-mass spectrometry (GC-MS) techniques [39]. 
It has proved a widely-used technique for the non-invasive measurement of 
potential biomarkers in health and disease [40] and samples are commonly 
analysed using highly efficient chromatographic runs. These runs can take up to 90 
min, however, they are able to separate many hundreds of VOCs present at low 
levels (less than 1 mg m-3(g)) (and therefore improving analyte identification). 
Subsequent mass spectrometric analysis provides data for multivariate analysis of 
exhaled profiles. Multivariate data analysis identifies statistically significant 
differences in VOC profiles between set groupings; for example, Turner et al. [41] 
were able to differentiate between participants when in a state of calm and after 
artificial induction of psychological stress.  
Changes in exhaled acetone and isoprene during light exercise (75 W) on a 
cycle ergometer have been previously reported [9]. Acetone and isoprene 
concentrations rose during exercise with isoprene spiking and tailing over the period 
of exertion. Acetone concentrations in a single participant rose from approximately 
750 to 1000 ng mL-1 during exercise, with near complete reversal during the 
intermediary rest period (~800 ng mL-1). Resting levels of isoprene were recorded at 
around 100 ng mL-1 and underwent a sharp 4-fold increase (~400 ng mL-1) at the 
beginning of exercise, with a gradual decrease toward resting values during the 
exercise period. Conversely, methane concentrations have been observed to reduce 
during exercise [17]. Further investigation into exhaled acetone concentrations at 
different exercise intensities showed that levels continued to rise with work output 
up to 990 kg-m min-1 (around 161 W). It should be noted that this is low-intensity 
exercise and is not representative of the work-rate of an able sportsperson [10].  
Investigation of exhaled VOCs in conjunction with exercise has provided no 
exploration into possible alterations that physical activity can produce on the overall 
exhaled volatilome signature. Overall breath ‘smellprints’ have been noted as 
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altered during exercise [16], however, there was no indication of what changes 
occurred. 
 
Metabolomics 
The human volatilome contains volatile small molecules and is an example sample 
medium suitable for metabolomics analysis. Metabolomics is the study of 
metabolites present in tissues and bio fluids that represent the end stage 
molecules of metabolic processes occurring within a living organism. Experiments 
carrying the ‘omics label may employ targeted analyses with the intention to identify 
a specific process, processes or pathway(s) that contribute to a biological function 
of interest. Conversely, non-targeted methods can be applied which prospect for 
novel (bio)markers that are indicative of a specific predefined state (e.g. differences 
between diseased and healthy individuals). The premise of metabolomics is that the 
small metabolites present within fluids and cells are indicative of physiological 
changes within an organism and can be assigned as candidate molecules to aid in 
measurement of health status or implemented for diagnostic, prognostic and 
therapeutic purposes. These identified metabolites may show causative and/or 
associative relationships with the physiological state being investigated. In 2007, 
the Human Metabolome Database (HMDB) was first published [42] and has since 
been updated, with the latest version published in 2013 [43].  The HMDB is a free-
to-access resource that details information about small molecule metabolites that 
have been identified as present within the human biological system. There are 
currently 41,993 metabolites present in the database and are represented as a 
‘metabocard’ that details chemical, clinical, biochemical and enzymatic data 
associated with the metabolite of interest and provide links to website resources for 
additional information on the molecule [44]. Examples of additional fields that 
implement this approach, and are encompassed with the ‘omics remit, include the 
study of proteins/peptides (proteomics/peptidomics), lipids (lipidomics), RNA 
(transcriptomics) and DNA (genomics). 
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Chlorine related insults to swimmers and swimming pool staff 
The association of respiratory disorders and the repeated exposure to chlorinated 
swimming pool environments has been studied [e.g. 45-48], and has led to the 
hypothesis that disinfection by-products (DBPs) are producing harmful chemicals to 
swimmers and swimming pool staff. Data show that cumulative life exposure to a 
chlorinated pool environment is associated with new onset or current asthma, with 
increased prevalence in those grouped into high cumulative exposure [47,49-51]. 
Similar findings are also seen in an outdoor chlorinated pool environment [52], 
suggesting that increased ventilation does not eliminate the association of DBPs 
with respiratory symptoms. Associated respiratory symptoms have not been 
observed when assessing children that swam in copper-silver disinfected pools [49].  
Chlorination is a common method of disinfection for swimming pool water as 
it adequately removes microbial pathogens that may be present. The mostly used 
methods mix chlorine gas (Cl2(g)) or sodium hypochlorite solution (Na+(OCl3)-) into 
the water. Chlorine reacts with aqueous organic matter to form DBPs, such as 
trihalomethanes (THMs), haloacetonitriles, haloacetic acids (HAAs) and haloamines 
[53]. The main source for the organic matter is from the bathers themselves, this 
comes in the form of bodily secretions (for example, urine and sweat which contain 
ammonia and high levels of nitrogen-containing amino acids) and externally applied 
lotions and cosmetics [54]. Swimmers are estimated to excrete 50 mL of urine and 
100 mL of sweat per swimming hour [55]. The most abundant formations of DBPs 
are THMs, with chloroform (CHCl3) generally present in the greatest concentration, 
and HAAs of which di and trichloroacetic acid (CHCl2COOH and CCl3COOH, 
respectively) are in the greatest abundance [53]. If inorganic bromine is present in 
the water, reactions occur that produce brominated by-products such as bromoform 
(CHBr3). Additionally to organic DBPs, inorganic haloamines are produced through 
reaction of chlorine/bromine and hydrolysed ammonia. Trichloramine, or nitrogen 
trichloride, (NCl3) is commonly measured in the air surrounding swimming pools 
[e.g. 45,46], has been described as a “volatile, irritant compound of penetrating 
odour” [56] and, therefore, has been identified as being responsible for the 
‘chlorine odour’ of swimming pools [57,58]. NCl3 is highly volatile and is a 
respiratory irritant in mice [59]. Pool air measurements show relationships with 
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respiratory irritation symptoms [45,60,61], see Table 3 for a list of predominant 
chemical disinfectants and their associated DBPs. Swimmers are exposed to these 
halogenated compounds via ingestion (water swallowed during swimming), dermal 
absorption (absorbed through the skin barrier) or, most importantly for respiratory 
irritation, inhalation of VOCs present on and above the surface of the water.  
Table 4 utilises data from Richardson et al. [62] to highlight the levels of a 
selection of DBPs in swimming pools in Spain, and more details can be found in 
Chapter 4 that address this subject. 
 
Table 3  A list of common swimming pool disinfection methods and their associative 
disinfection by-products; adapted from [53]. 
Disinfectant Disinfection by-products 
Chlorine/hypochlorite trihalomethanes, mainly chloroform 
 
haloacetic acids 
 
haloacetonitriles 
 
haloketones 
 
trichloroacetaldehyde 
 
trichloronitromethane 
 
cyanogen chloride 
 
chlorate 
 
chloramines 
  Ozone bromate 
 
aldehydes 
 
ketones 
 
ketoacids 
 
carboxylic acids 
 
bromoform 
 
brominated acetic acids 
  Chlorine dioxide chlorite 
 
chlorate 
  Bromine/hypochlorite trihalomethanes, mainly bromoform 
 
bromal hydrate 
 
bromate 
  bromamines 
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Table 4  Concentrations of swimming pool disinfection by-products measured from 
swimming pools in Spain; adapted from [62]. 
 
Chlorinated pool 
 
Brominated pool 
Chemical  Mean (SD) Min Max   Mean (SD) Min Max 
Free chlorine (mg L-1) 1.28 (0.43) 0.52 2.35 
 
0.50 (0.16) 0.32 0.70 
Monochloramine (mg L-1) 0.29 (0.11) 0.10 0.64 
 
0.27 (0.03) 0.24 0.30 
Dichloramine (mg L-1) 0.38 (0.14) < 0.01 0.65 
 
< 0.01 < 0.01 < 0.01 
Trichloramine (mg L-1) < 0.10 < 0.10 < 0.10 
 
< 0.10 < 0.10 < 0.10 
Chloroform (µg L-1) 15.4 (3.5) 8.4 20.8 
 
0.2 (0.1) 0.1 0.3 
Bromodichloromethane (µg L-1) 14.2 (4.2) 9.3 26.8 
 
0.4 (0.2) 0.2 0.7 
Dibromochloromethane (µg L-1) 12.8 (4.4) 6.5 22.6 
 
2.4 (0.2) 2.1 2.7 
Bromoform (µg L-1) 7.2 (3.2) 3.0 16.5   57.2 (4.4) 54.4 67.2 
Note: SD = standard deviation 
 
1.3.3 Potential uses for exhaled breath analysis in exercise science 
Exhaled VOC analysis enables a wide range of analytes and their relationships with 
underlying biological mechanisms to be studied; albeit with complications from 
environmental factors such as diesel fumes and other pollutants. This offers the 
prospect of developing breath tests that can aid athletes in their daily training by 
providing information that may only have been previously possible after completion 
of time-consuming and physically exertive tests. Breath tests may offer valuable and 
timely information for athletes, and their coaches, about stress, fatigue, onset of 
illnesses (e.g. upper respiratory tract infections) and indication of current fitness 
level. The adoption of such technologies by elite sport, regardless of their success in 
a research environment, will take many years and proven competitive benefits 
before being accepted widely and used regularly. The development of rapid, non-
invasive methods of screening for VOCs in sport and exercise are applicable to non-
laboratory based testing with high-performance sportspeople would be 
advantageous. For example, a major concern for athletes is their susceptibility to 
infections, with epidemiological evidence to suggest that although exercise provides 
a protective mechanism, this protection is lost when regular heavy training outputs 
are performed [63,64]. For top performing athletes, missing training or competition 
due to illness can cause ramifications on their current and future careers, with 
potential loss of earnings. Current monitoring often requires invasive methods such 
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as measuring immune system status through blood sampling, or time-consuming 
collection of non-invasive techniques that some individuals can find difficult to 
perform (e.g. saliva sampling). These are often accompanied by expensive analytical 
processes, e.g. enzyme-linked immunosorbent assays for measurement of 
immunoglobulin from passive drool saliva [65], and limited to targeted analysis 
without the ability for full screening. 
The experiments designed for this doctoral study represent an initial step in 
the use of exhaled breath analysis with exercise, and are intended as a pathfinder 
study for other researchers to follow to further the understanding of this under-
explored field.  
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CHAPTER TWO: PHYSIOLOGICAL AND ANALYTICAL THEORY 
 
2.1 Respiratory physiology and VOC exchange 
 
2.1.1 Structure and function of the lungs 
Respiration is the act of breathing and is achieved through a controlled set of 
muscular movements, creating a mechanical stimulus for the inhalation and 
exhalation of gases. Gases diffuse across the blood-lung barrier, transferring oxygen 
(O2) to the blood and removing by-products of metabolism, such as carbon dioxide 
(CO2), from the body. 
 
Airflow through the lung 
The human respiratory system is a series of airways that decrease in bore and 
increase in quantity as they pass deeper into the lung. The largest airway, the 
trachea, bifurcates into the left and right bronchi, which progressively split until the 
terminal bronchioles. These airways are the conducting airways, taking no part in 
gaseous exchange. Because of this, air found in this region (which equates to 
approximately 150 mL [1]) is termed ‘dead-space’. The dead-space (D) is calculated 
using Bohr’s method, as the entirety of carbon dioxide (CO2) exhaled comes from 
the alveolar gas rather than from D, Equation 5. Terminal bronchioles divide into 
respiratory bronchioles, which contain some alveoli attached to their walls, and lead 
to the alveolar ducts, containing alveolar sacks. Alveolar sacks are small hollow 
structures that have a rich capillary blood supply. They have a thin (0.2 to 2.5 µm) 
semi-permeable wall allowing gaseous molecules to pass between the air space 
and blood supply. Respiratory bronchioles and alveolar ducts are termed as the 
respiratory zone and usually have a volume of 2.5 to 3 L. 
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𝑉𝐷
𝑉𝑇
=  
𝑃𝐴(CO2) + 𝑃𝐸(CO2)
𝑃𝐴(CO2)
 Equation 5 
Where 𝑉𝐷 is the dead volume; 𝑉𝑇 is the total volume of the airways, 𝑃𝐴(𝐶𝑂2) refers to 
partial pressure of CO2 in alveolar air; and, 𝑃𝐸(𝐶𝑂2) to to partial pressure of CO2 in 
mixed-expired air. 
 
Mechanics of breathing 
Air is drawn into the lungs by reducing the thoracic cavity pressure, causing air to 
enter via the mucosal and nasal cavities to equilibrate the negative pressure. This 
occurs by contraction of the diaphragm and intercostal muscles. The diaphragm is a 
dome shaped muscle that inserts into the lower ribs and when contracted it flattens 
and increases the thoracic cavity volume, thereby decreasing its pressure. 
Intercostal muscles are situated in between ribs and contract to lift the rib cage 
upwards and outwards, further elevating the cavity volume. During exhalation, the 
diaphragm and external intercostal muscles passively relax, and the lung returns to 
the pre-inspiratory volume by elasticity, forcing excess air out of the lungs. During 
normal at-rest breathing, processes are sufficient for ventilation of required 
volumes (approximately 500 mL per inhalation). However, when forced inspiratory 
and/or expiratory actions are required (with up to several litres of air inhaled per 
breath in intense exercise) further processes are implemented. Heavy inspiration 
recruits the sternocleidomastoid and scalene muscles which lift the sternum plate 
and ribs, increasing the total inspired volume. Forced expiration is produced 
through contraction of the rectus abdominis, internal and external obliques and 
transverse abdominis. This causes an increase in intra-abdominal pressures, 
forcing the diaphragm upwards and expelling air. Furthermore, internal intercostal 
muscles may be recruited to forcefully depress the rib cage and increase the 
velocity of exhalation (see Figure 3 for a diagram of respiratory muscles [2]). 
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Inspiratory muscles   Expiratory muscles   
A Diaphragm E Internal intercostals 
B External intercostals F External oblique 
C Scalene G Rectus abdominis 
D Sternocleidomastoids H Transverse abdominis 
    I Internal oblique 
Figure 3  A diagram to show the muscles in the upper torso responsible for the mechanics of 
breathing; adapted from [2]. 
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An adult resting breath usually consists of approximately 500 mL of air 
entering and exiting the lung (known as tidal volume). However, a person can 
forcefully inhale greater volumes (around 4 to 4.5 L) and, when combined with a 
forceful and complete exhalation, is called the vital capacity (approximately 6.5 to 7 
L). Air that remains in the lungs after forceful expiration is the residual volume, and 
remains in order to maintain structure and prevent any collapse that may cause 
damage to the tissues, see Figure 4 [3]. 
 
 
Figure 4  A diagram to indicate the different partitions of the lung and their relative volumes 
compared to the total lung capacity; adapted from [3]. 
 
The blood-gas interface 
O2 and CO2 pass between the alveoli and bloodstream via diffusion from areas of 
high to low partial pressures. Fick’s Law of Diffusion (Equation 6) states that flux of 
gas across a permeable membrane is proportional to the area (A) of the membrane, 
but inversely proportional to its thickness (x). 
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𝑑𝑉
𝑑𝑡
=  
𝐴
𝑥
 ∙ 𝐷 ∙ (𝑃1 −  𝑃2) Equation 6 
Where 𝑑𝑉 is the change in volume of gas across the membrane and 𝑑𝑡 the change 
in time, A is the area of the membrane and x is its thickness. 𝐷 is the diffusion 
constant, or permeability coefficient, and 𝑃1 and 𝑃2 are the partial pressures of the 
gases on either side of the membrane. Fick’s Law was originally expressed in terms 
of concentrations but this version has been adapted for the study of partial 
pressures of gaseous molecules. 
Diffusion happens rapidly across the thin blood-alveolar barrier, which has a 
surface area of 50 to 100 m2. This large area is achieved by enclosing millions of 
sacks with capillary blood supply. Rapid exchange of O2 and CO2 occur during every 
breath, even at high ventilation rates produced during exercise or at high altitudes. 
Each red blood cell spends around 3 to 4 s in the pulmonary capillary network and 
is subject to gas exchange with 2 or 3 alveoli; this period is sufficient for almost 
complete equilibrium of the gases across the membrane [4]. VOCs are transported 
into exhaled breath following the same principle (see Figure 5). 
 
Figure 5  A simplified schematic of the gaseous exchange of volatile molecules between the 
pulmonary blood supply and the alveolar sacs of the lungs. 
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Respiratory responses to exercise 
During exercise, ventilation rates increase rapidly to supply elevated demand for O2 
delivery and CO2 removal. Resting ventilation in healthy adults is around 7.5 L min-1 
rising to 120 L min-1 during exercise [4]. This substantial increase in air ventilation 
mechanically stresses the airways and causes high levels of disturbance. 
In addition to raised ventilation, exercise causes a rise in the rate of diffusion 
of molecules across the blood-alveolar barrier. This is due to changes in both the 
diffusing capacity of the membrane, which typically increases by 3-fold or more [4], 
and the enlarged volume of blood supplied to pulmonary capillaries. Additionally to 
the distension of pulmonary capillaries, further blood vessels are recruited to 
augment diffusion. This is an important consideration for the analysis of 
metabolites in breath, particularly if exercise is performed. 
 
2.2 Exhaled VOC breath analysis 
 
2.2.1 The modern era 
Molecular breath analysis began in the early 20th century when JS Haldane and 
colleagues collected exhaled air to monitor the absorption dissociation of CO2 in 
human blood [5]. Research into breath analysis using gas chromatography research 
began in 1971, when Linus Pauling (winner of Nobel Prizes in both Chemistry 
(1954) and Peace (1962)) identified 250 compounds present in breath. He did this 
by trapping VOCs on a coiled stainless steel tube. The tube was cooled in an 
isopropyl alcohol dry ice bath [6], and VOCs were then passed through a gas 
chromatography column. Almost three decades later, Phillips et al. [7] used gas 
chromatography coupled with mass spectrometry to isolate a total of 3,481 
different VOCs from the breath of 50 participants, with only 27 VOCs that were 
observed universal to all participants (Table 5). These results define the inter-
person variability and significant challenge of using exhaled biomarkers to diagnose 
diseases and characterise health conditions. 
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Table 5  A list of 27 volatile organic compounds (VOC) found to be present in all of 50 
exhaled breath VOC collections by Phillips et al. [7]. 
VOC Mean alveolar gradient 
Isoprene 60.34 
Benzene, (1-methylethenyl)- 4.77 
Naphthalene 4.07 
2,5-Cycohexadiene-1,4-dione, 2,6-bis(1,1,-dimethyleythyl) 0.61 
Naphthalene, 1-methyl- 0.54 
Butane, 2-methyl- 0.33 
Tetradecane 0.23 
Pentodecane 0.10 
Dodecane 0.02 
Benzene -0.48 
Benzene, 1-ethyl-2-methyl- -10.09 
Benzene, ethyl -1.73 
Benzene, methyl -7.27 
Benzene, propyl -1.72 
Cyclohexane, methyl -0.75 
Decane -0.28 
Heptane -1.25 
Heptane, 2-methyl- -0.89 
Heptane, 3-methyl- -0.83 
Hexane -0.79 
Hexane, 3-methyl- -1.02 
Nonane -0.44 
Pentane, 2,3,4-trimethyl- -0.26 
Pentane, 2-methyl- -0.43 
Pentane, 3-methyl- -0.59 
Propane, 2-methoxy-2-methyl- -9.44 
Undecane -0.52 
 
2.2.2 Considerations with exhaled breath 
The major advantage for breath analysis is the non-invasive collection procedure. 
Many current methods in medical diagnostics are uncomfortable for the patient, 
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with even the basic ‘gold standard’ blood analysis via venepuncture providing levels 
of discomfort and increased risk of infection. 
A major complication of breath sampling is that expired air is not 
homogenous throughout different sections of respiratory vessels. Upper airways 
(pharynx, larynx, trachea and bronchi) contain dead space gas and do not contain 
VOCs diffused from the blood. However, inflammation and damage to these tissues 
does result in VOC release. Lower airways (bronchioles and alveolar sacks) contain 
air that has equilibrated with circulating blood. Air from this region allows a better 
representation of VOCs with blood borne origin that are present in the lungs. Due to 
physiological differences, mix-exhaled [e.g. 8], distal [e.g. 9] and rebreathed air [e.g. 
10 in rats] samples have been used to collect exhaled breath VOCs.  
Mixed-exhaled air contains gases from all lung sections. No selective 
collection is required with all exhaled gases being collected and analysed. Distal air, 
or ‘alveolar air’, is exhaled toward the end of each breath. Although gases pass 
through the dead space, it demonstrates a clearer picture of the compounds 
present in alveolar sacks, and consequently systemic circulation. When collecting 
alveolar air from a single exhalation, holding the breath before sampling produces 
increases concentration and repeatability of VOC measurements. Twenty seconds of 
breath holding can significantly increase the sampled concentrations of some 
molecules [1]. However, such breathing manoeuvres lower pH, affect the 
partitioning of many VOCs into the gas phase and may have impacts on lung 
metabolism.  
 The respiratory cycle can be divided into four different phases (Figure 6) as 
follows: 
• Phase I – exhalation of the anatomical dead space (gases in this phase 
would not typically contain any endogenous VOCs); 
• Phase II – exhaled breath contains a mixture of dead space and alveolar air; 
• Phase III – this portion of exhaled breath is a result of alveolar emptying and 
therefore most reflects the characteristics of air in the lower airways; 
• Phase IV – exhalation ceases, inhalation begins and the cycle is repeated. 
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Figure 6  Example of a typical exhaled breath profile of one complete respiratory cycle 
illustrating the increase in exhaled gas pressure amplitude (AP) and detailing the 
fractions of rebreathed, mixed-exhaled and alveolar air used in sample capture. 
Note: P# refer to different phases of the respiratory cycle; t = time 
 
Rebreathed air consists of air that has been exhaled into a collection bag, re-
inhaled and again exhaled. This allows the concentrations of VOCs in the bag to 
equilibrate with the gases in the airways. In rats, this technique produced a strong 
correlation (r=0.96) of ethanol in the breath with ethanol in arterial blood [10]. 
  
2.2.3 Current uses of exhaled breath analysis 
Exhaled ethanol is used as a measure for blood ethanol concentrations by law 
agencies across the world. Breath ethanol testers (known commonly as 
breathalysers) were introduced into the UK police force in the 1960s and have been 
used to give preliminary information on whether a person is driving under the 
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influence of alcohol. The breath alcohol limit in the UK is set at 35 µg 100ml-1(g) (35 
mg m-3(g)).  
eNO is also implemented for general use. The National Institute for Health 
and Care Excellence (NICE) recommends eNO as an option to diagnose asthma in 
those who, after initial examination, are considered to have an intermediate 
probability of the condition. It is recommended as a complementary analysis, 
therefore a negative result does not rule out asthma [11].  
Future implications for breath testing are currently in development. Phillips 
et al. [12,13] reported a breath test capable of providing information to predict the 
rejection of a heart allograft transplant. This test is currently in clinical development 
in a number of sites across the United States of America [14].  
Additionally, Helicobacter pylori (H. pylori) infection is detected by the 
presence of carbon labelled urea tests (13C), with breath tests acting as a sensitive 
and non-invasive sampling method.  
 
2.2.4 Sample collection and analysis methods 
 
Exhaled breath gases 
Exhaled breath gases are most commonly collected using Tedlar bags [e.g. 15], 
breath canisters [e.g. 8] and adsorbent tubes [e.g. 16]. Tedlar bags and breath 
canisters (BCs) collect mixed-exhaled air and require little training and/or technical 
equipment. Tedlar bags have low stability for VOC retention (< 2 hrs), require long 
desorbing time periods and are fragile, leaving them susceptible to leaks and loss 
of samples. Stainless steel BCs are more robust and have higher stability than the 
Tedlar bag, but they share also a long desorbing time and are more costly. 
Adsorbent tubes focus the gases through a metallic mesh and retain volatiles onto 
adsorbents such as Tenax (for C6 to C30 compounds) and Carbograph (for C6 to C14 
compounds). They are relatively inexpensive and can be reconditioned for repeated 
use. The stability of absorbent tubes over long storage durations is poorly 
understood. A gradual loss of some volatiles has been reported over 24 hrs [17], 
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with another report indicating that transport and storage did not affect diagnostic 
accuracy after a 14 day period in others [18]. 
 
Adaptive breath sampler for alveolar air 
Basanta et al. [9] described the use of a breath sampling unit that uses a purified 
medical air supply to produce reproducible, large volume samples of exhaled VOCs 
in human subjects. Purified air is supplied to a breathing mask through a one-way 
non-rebreathing valve, and a central control unit monitors exhaled pressure to allow 
selective sampling of expired air onto an adsorbent trap. Each exhalation is 
sampled in this manner until a suitable volume has passed through the adsorbent 
trap, typically around 2 L. This allows enrichment of VOCs present at low 
concentrations in alveolar air. A schematic drawing of the sampler can be seen in 
Figure 7. 
 
Figure 7  Schematic diagram of the main components of a breath sampling system designed 
by Basanta et al. [9]. Legend: (A) purified air supply; (B) pressure regulator; (C) 
pressure relief valve; (D) breathing mask; (E) mask air supply assembly; (F) 
adsorbent sampler assembly; (G) balanced and matched micro-control valves; (H) 
pressure transducer connected to mask; (I) electronics interface; (J) precision air 
sampling pump; and, (K) laptop with sampling software; reproduced from [9] with 
permission from the Royal Society of Chemistry. 
 
  
36 
 
Collection and analysis of VOCs using thermal desorption technologies 
Although each breath may contain high quantities of VOCs, concentrations of 
individual compounds may be below limits of detection, or masked by other, more 
prominent analytes. Use of adsorbent samplers enables thermal desorption (TD) to 
provide enriched profiles of and therefore, in theory, a wider concentration range for 
potential biomarker exploration.  
Analysis of VOCs from adsorbent traps occurs at concentrations down to 
pg.L-1 levels [19], through the use of a pre-concentration step. In TD, the adsorbent 
tube is heated at a fast rate, causing VOCs to desorb from the surface while a flow 
of inert gas passes through the tube, carrying the now volatilised compounds. VOCs 
travel through a flow-path to a second tube, known as the cold trap. This has 
identical adsorbents packed into a smaller volume and held at sub-zero centigrade, 
known as cryofocussing. Recovered VOCs are frozen and focussed into the volume 
of the cold trap, then the cold trap is flash heated under a flow of carrier gas, 
injecting VOCs into the analytical system. This process allows an enrichment up to 
5x104 (Figure 8).  
 
Solid-phase micro extraction 
Solid-phase micro extraction (SPME) uses a coated fibre that enables different 
analytes (volatile and non-volatile) to be extracted and concentrated. The extracting 
phase can be a liquid polymer, a solid sorbent or a combination of the two [21]. For 
breath investigations, the gases surround the fibre and compounds are retained to 
maintain an equilibrium. This system allows the pre-concentration and direct 
desorption to a chromatographic system, without the need for cryofocussing. Fibres 
are reusable, low cost, simple to use and portable for use outside of laboratory 
conditions. 
SPME utilises a non-quantitative tracking mechanism as it relies on creating 
an equilibrium with the sample and, therefore, cannot be used for repeated breath 
exhaled sampling. SPME is suitable for stored breath samples, such as Tedlar bags, 
canisters and syringes. These methods of collection do not provide a stable sample 
and, consequently are not suitable for non-targeted discovery studies, where 
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sample storage and degradation artefacts may mask important underlying trends. 
For these reasons SPME was not performed and therefore will not be addressed 
further. 
 
Figure 8  Schematic diagrams to show (A) the presence of collected VOCs on the adsorbent 
powder of the thermal desorption (TD) tube, (B) the TD of these VOCs from the tube 
to focus on a cooled cold trap and (C) the rapid heating of the cold trap and ejection 
of these VOCs off the cold trap and into the gas chromatograph (GC) analytical 
system; reproduced with permission from [20]. 
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2.3 Gas chromatography-mass spectrometry in exhaled breath 
analysis 
 
2.3.1 Introduction 
Chromatography originates from the early 1900’s where Russian botanist Mikhail 
Semenovich Tswett used an early form of liquid-solid chromatography to separate 
plant pigments. He termed the process chromatography from the Greek for colour 
(chroma) and to write (graphein). In 1952, James and Martin [22] were the first to 
demonstrate gas chromatography (GC) as an analytical tool, when they used it to 
separate fatty acids. 
GC is a physical separation method where a gaseous mixture of compounds 
is transported along a chromatography column by a carrier gas, and molecules are 
subject to stationary and mobile phases. The basic GC system (Figure 9) consists of 
a pressurised and regulated inert gas supply that is mixed with an injected gaseous 
sample. This mixture passes into a temperature controlled oven containing a 
column which is internally coated with the stationary phase compound. The carrier 
gas transports the molecules through the column and out to a detector that is 
connected to software to plot the peaks that elute. A comprehensive explanation of 
the theory of GC can be found in chapter 2 of Practical Gas Chromatography by 
Dettmer-Wilde and Engewald [23]. 
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Figure 9  A schematic to illustrate a basic gas chromatography system. 
 
2.3.2 Separation, elution and efficiency 
Molecules are separated based on their relative vapour pressures and partition 
coefficients with the stationary phase, causing the molecules to elute at the end of 
the column onto the detector at different time intervals, known as the retention 
time (𝑡𝑟). The 𝑡𝑟 of a molecule depends on its partition coefficient (𝐾𝐶), with lower 
𝐾𝐶 values eluting from the column first. Equation 7 defines 𝐾𝐶  in terms of the ratio 
of concentrations of a solute (𝐴) in the stationary phase (𝑠) and the mobile phase 
(𝑚) at equilibrium. 
𝐾𝐶 =
[𝐴]𝑠
[𝐴]𝑚
 Equation 7 
 
Elution development occurs as the sample moves through the column, 
consisting of series of adsorption-desorption processes where compounds are 
distributed between the two phases; this process is always thermodynamically 
driven towards equilibrium. However, as the gaseous mobile phase is in constant 
flow in a definite direction, displacement of the concentration of solute in the gas 
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mobile phase occurs along the column. As the concentration of the mobile phase 
increases further along the column, the stationary phase concentration falls and the 
analytes return to the gas phase. They are then carried further along the tube to 
create equilibrium at the next step. This process repeats throughout the 
chromatography column and determines 𝑡𝑟 (Figure 10). 
 
 
Figure 10  An illustration to show the distribution of the solute between the mobile and 
stationary phases in a chromatographic column with the influence of a uni-
directional carrier gas. EA = region in equilibrium 
 
Figure 11 illustrates samples A and B being introduced into a GC column in a 
mixed gas. They pass through the column alternating between the stationary and 
mobile phase at different rates to each other. Sample A passes through the column 
more rapidly, i.e. shorter 𝑡𝑟, eluting earlier than B, producing two distinct peaks in 
the chromatogram.  
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Figure 11  Schematic representation of the chromatographic process; adapted from [23]. 
 
Gas chromatography columns consist of two designs; packed and capillary. 
Packed columns are typically glass or stainless steel tubes that are filled with the 
stationary phase, or with a packing material that is coated in the stationary phase. 
Capillary columns are thin fused-silica tubes that have the stationary phase coated 
on the inner surface. Capillary columns are usually much longer than packed 
columns and have an internal diameter of 100 to 500 µm, as opposed to mm. 
Capillary columns produce greater separation efficiency but can be easily 
overloaded with excessive sample injection. Stationary phases used within these 
columns are most commonly a mixture of polysiloxanes with differing substituent 
groups, to change polarity of the phase. Cross-linking of the polymer coated on the 
column wall or packing material increases thermal stability, and reduces phase 
break down and bleeding from the column. 
Chromatographic column efficiency can be related to the theoretical plate 
model. The column is modelled as a large number of separate layers (theoretical 
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plates), where equilibrations of the sample between the stationary and mobile 
phase occur. The carrier gas transfers the compounds down the column from one 
plate to the next. The larger the number of theoretical plates (𝑁), the more efficient 
the column separation. Efficiency can also be stated by the Height Equivalent to a 
Theoretical Plate (HETP), with a smaller value indicated greater efficiency. The 
number of theoretical plates is calculated by examining a chromatographic peak 
after elution, using Equation 8 where w1/2 is peak width at half height, and 5.54 is 
the constant where the base of the peak is 4σ. HETP is then calculated using 
Equation 9, where L is the length of the column. 
𝑁 =
5.54 𝑡𝑅
   2
𝑤1/2
       2
 
     Equation 8 
𝐻𝐸𝑇𝑃 =
𝐿
𝑁
 Equation 9 
 
Values for 𝑁 are not fixed. Operating conditions are optimised to generate 
the highest practicable value for 𝑁 for a given set of compounds. Furthermore, 𝑁 is 
compound specific and varies between different species.  
 
2.3.3 The rate theory of chromatography 
 
The van Deemter equation 
van Deemter et al. [24] identified three effects that contribute to peak dispersion. 
As a sample travels through the column it will begin to randomly disperse and 
spread, eluting to form a Gaussian shape. The smaller the peak dispersion, the 
greater level of separation. An example of this is shown in Figure 12. 
 
  
43 
 
 
Figure 12  A representation of broad (left) and narrow (right) peaks illustrating the differing 
dispersion of chromatographic peaks and the effect on separation efficiency. 
 
van Deemter developed the rate theory which identifies three factors that 
control peak dispersion. These are: 
 
i) The A-term – eddy diffusion (or multipath dispersion): molecules travel 
through a packed column and take random paths through the stationary 
phase. Molecules on a long path take more time to travel through the 
column and fall behind those on a shorter path, causing dispersion 
(Figure 13).  Equation 10 was derived for multipath dispersion (A), where 
λ is the packing factor and Dp is the particle diameter of the packed 
column; 
 
 
Figure 13  A representation of three identical molecules (1, 2 and 3) taking different paths 
through a packed column and therefore dispersing the peak on elution; adapted 
from [25]. 
 
𝐴 = 2𝜆𝐷𝑝 Equation 10 
 
ii) The B-term – longitudinal diffusion: the concentration of analyte is less at 
the edges of the band than at its centre. The analyte diffuses out from 
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the centre toward the edges, producing band broadening. High velocity 
mobile phase reduces this effect (Figure 14). Equation 11 was derived 
for longitudinal diffusion (B), where γ is the packing factor, Dm is the 
diffusivity of the solute in the mobile phase, and ū is the average linear 
gas velocity. 
 
 
Figure 14  Representation of band broadening through longitudinal diffusion; adapted from 
[26]. 
 
𝐵 =  
2𝛾𝐷𝑚
?̅?
 Equation 11 
 
iii) The C-term – resistance to mass transfer: an analyte takes a certain time 
to equilibrate between the stationary and mobile phases. If the velocity of 
the mobile phase is high, and the analyte has a strong affinity for the 
stationary phase, the analyte in the mobile phase will move ahead of that 
in the stationary phase, broadening the band (Figure 15). Equation 12 
was derived for resistance to mass transfer (C) where f1 and f2 are 
constants, k’ is the capacity ratio of the solute, dp/f is the effective 
thickness of the mobile/stationary phase, Dm/s is the diffusivity of the 
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solute in mobile/stationary phase and ū is the average linear gas 
velocity. 
 
 
Figure 15  A schematic to illustrate a compound with high affinity to the stationary phase and 
therefore peak broadening due to the molecules in the mobile phase moving ahead 
of those in the stationary phase; adapted from [27]. 
 
𝐶 =  
𝑓1 𝑘
′𝑑𝑝
 2
𝐷𝑚
 ?̅? +  
𝑓2 𝑘
′𝑑𝑓
  2
𝐷𝑠
 ?̅? Equation 12 
 
These three factors can be integrated together to give the final van Deemter 
equation (Equation 13). 
𝐻𝐸𝑇𝑃 = 2𝜆𝑑𝑝 +
2𝛾𝐷𝑚
?̅?
 + 
𝑓1 𝑘𝑑𝑝
 2?̅?
𝐷𝑚
 +  
𝑓2 𝑘𝑑𝑓
 2?̅?
𝐷𝑠
 Equation 13 
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The Golay equation 
Capillary columns are commonly used in modern day GC. There is no A-term as the 
stationary phase is coated to the internal walls of the column. Golay [28] proposed 
a new term to satisfy the diffusion process in the gas phase of open tubular 
columns. The equation (Equation 14) has two C-terms, one for mass transfer of the 
mass in the stationary phase (CS) and one for the mobile phase (CM), where rc is the 
column radius, Dm is the diffusion coefficient of the solute in the carrier gas, and K 
is the distribution coefficient of the solute between the two phases. The simplified 
Golay equation has a B-term which accounts for molecular diffusion, along with the 
simplified CS and CM (Equation 15).  
𝐻𝐸𝑇𝑃 =  
2𝐷𝑚
?̅?
+ 
𝑓1𝑘𝑟𝑐
2?̅?
𝐾2𝐷𝑠
+ 
𝑓2𝑘𝑟𝑐
2?̅?
𝐷𝑚
 Equation 14 
𝐻𝐸𝑇𝑃 =  
𝐵
?̅?
+ (𝐶𝑆 + 𝐶𝑀)?̅? Equation 15 
 
van Deemter plots 
When the rate equation is plotted (HETP vs. ū) a non-symmetrical hyperbola shape 
is formed (Figure 16). This curve has a minimum point (Hmin), and is the optimum 
velocity for the highest efficiency and smallest plate height. 
It is possible to use this understanding of the HETP to choose a suitable 
carrier gas for a GC system. Figure 17 shows the rate equations for Nitrogen, 
Helium and Hydrogen, when carrying a C17 molecule. A higher molecular weight gas 
will generate more plates since the diffusivity (B-term) is minimised, and therefore 
will have a lower Hmin. However, if speed optimisation is required it is more efficient 
to choose a lighter gas such as helium or hydrogen. The lighter carrier gases have a 
shallower slope. This means that with an increased flow rate, the loss in column 
efficiency can be offset with the speed of analysis. If column length can be 
optimised then the lighter carrier gases would be able to provide the maximum 
number of plates per second, allowing the fastest analysis times. It is also 
advantageous to have smaller diameter columns (rc) as this minimises the CM term. 
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Figure 16  van Deemter plot showing the three factors involved in the rate theory along with a 
typical plate height curve illustrating the lowest point (Hmin) and the optimum 
velocity through the column (ūopt). 
 
Figure 17  van Deemter plots for three common carrier gases in gas chromatography. 
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Kovats retention index 
Kovats [29] defined a retention index of compounds that were relative to the use of 
a homologous series of n-alkanes. These were used based on their low polarity and 
freedom from hydrogen bonding. Kovats retention index (I) gives a value to each n-
alkane that is 100x their carbon number. A homologous series of hydrocarbons will 
have relatively constant intermolecular forces, and so separation occurs primarily 
due to differences in boiling points (i.e. vapour pressures). A logarithmic relationship 
is seen, and is linearised by plotting the log of the adjusted retention time (or 
volume) against I. I is calculated by running an analyte under the same conditions 
as the series of n-alkanes, and determined from the plotted graph. It is also 
calculated using Equation 16, where VN is the adjusted retention time or volume, 
subscript u is used for the unknown analyte and subscript x/x+1 for the number of 
carbons in the paraffin series that elutes before and after the unknown. 
𝐼 =  [
log(𝑉𝑁)𝑢 − log(𝑉𝑁)𝑥
log(𝑉𝑁)𝑥+1 − log(𝑉𝑁)𝑥
] + 100𝑥 Equation 16 
 
Resolution 
Column efficiency is also determined by the resolution of eluting peaks (RS). 
Resolution describes the degree in which adjacent peaks are separated. Equation 
17 illustrates how this is determined in chromatography using the distance between 
the two peaks (A/B) of two solutes (d), and the width at the base of the two peaks 
(wb). 
𝑅𝑆 =  
(𝑡𝑅)𝐵 − (𝑡𝑅)𝐴
(𝑤𝑏)𝐴 + (𝑤𝑏)𝐵
2
=  
2𝑑
(𝑤𝑏)𝐴 + (𝑤𝑏)𝐵
 
Equation 17 
If adjacent peaks are of equal area and so have the same peak widths; the 
equation can be simplified to Equation 18. 
𝑅𝑆 =  
𝑑
𝑤𝑏
 Equation 18 
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This formula can only be used when the peak heights of the two solutes are equal. 
Figure 18 shows an example of overlapping peaks, and the sections used to 
calculate the resolution. The higher the resolution the better the separation, a full 
baseline separation requires a resolution of ≥ 1.5. 
 
 
Figure 18  An example of two co-eluting solutes illustrating the distance between peak maxima 
(d) and the base width (wb) of the two peaks used to calculate the resolution 
number. 
 
Open tubular (capillary) columns 
Open tubular, or capillary, columns are the most commonly used in modern periods. 
They are a long, thin and open tube containing no packing material. Most capillary 
columns exist as a wall-coated open tubular column (WCOT). Tubing is made from 
glass, stainless steel or fused-silica, with the latter being the most widely used at 
present. WCOTs consist of a tube diameter from 0.10 to 0.53 mm, and a thin film of 
liquid phase coated on the inner walls of the column. Due to its open nature, very 
low flow resistances are recorded. Film thickness varies from 0.1 to 5.0 μm, with 
thinner films allowing faster analysis times and higher resolution, but with less 
overall sample capacity. Capillary columns have little loss of pressure throughout 
the length and a very high efficiency, with 3000 to 5000 theoretical plates per 
metre being common. Columns are often regularly seen up to 60 m in length, and 
long paths create very efficient separations in complex mixtures of analytes. 
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Other forms of capillary columns are: 
i) Support-coated open tubular (SCOT) – containing an absorbed layer of 
support solid coated with a liquid phase. SCOTs were originally popular 
due to their ability to hold higher levels of liquid phase, however, the 
development of cross-linking techniques has allowed stable WCOT films 
to be produced. These are now only available commercially as stainless 
steel tubes. 
 
ii) Porous layer open tubular (PLOT) – containing a porous layer of solid 
absorbent and are well suited for analysis of light fixed gases. 
 
Programmed temperature in gas chromatography 
Programming column temperature to increase through a GC run can optimise 
analytical output. Distribution constants are temperature dependent, and therefore 
retention time is inversely proportional to temperature. Gradients can improve 
separation in complex mixed samples as some compounds may not be separable 
during isothermal temperature analysis. Increasing temperatures during a GC run 
allows analytes that are still in the column to have a reduced partition coefficient 
speeding up their movement and decreasing total analysis time. Additional 
advantages are: better separation for complexes with analytes of wide boiling point 
range and improved detection limits, peak shapes and precision. Temperature can 
increase linearly, or there can be ramps of increasing temperatures at given time 
points. During this process the temperatures at the injector and detector must 
remain constant, requiring specialised equipment with three separate ovens for the 
injector, column and detector. A disadvantage of this technique is that more noise is 
commonly recorded at higher temperatures.  
If sample matrix is screened using programmed temperature gradients, 
optimum temperature of a single analyte for an isothermal GC run can be 
calculated. This is known as the significant temperature and is calculated by 
subtracting 45 from the final temperature at which the analyte eluted in the 
graduated run. 
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2.3.4 Mass spectrometry 
Mass spectrometry (MS) is a technique used to identify compounds based on their 
mass to charge ratio (m/z). MS requires multiple processes in order to obtain a 
measurement of the analyte(s) of interest. A generalised step-by-step approach is 
as follows (Figure 19):  
i) a gaseous sample is introduced to the system (known as the source). This 
step can occur by direct infusion of the sample of after separation processes 
such as liquid and gas chromatography;   
ii) analytes present in the sample undergo ionisation which can occur at 
atmospheric pressure (e.g. electrospray ionisation) or at vacuum (e.g. electron 
ionisation); 
iii) after ionisation, the analytes are transferred into a mass analyser under 
vacuum conditions. In the mass analyser, ions are manipulated by ion optics, 
and electrical and/or magnetic fields, which separate the ions dependent on 
their m/z ratio; 
iv) the ions are focussed by the mass analyser onto a detector producing an 
current for each measured ion; 
v) the detector relays a signal to a digital data system which plots the spectrum 
using specialised instrument software. 
 
 
Figure 19  A schematic of the typical processes involved in producing mass spectra. 
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Sample ionisation 
A traditional and widely employed ionisation technique used in organic MS for 
gaseous samples is electron ionisation (EI). EI is a destructive method, as typically 
fragmentation of the parent molecule occurs meaning that the molecular ion is not 
always observed. An advantage is that it leads to reproducible and characteristic 
fragment patterns in mass spectra. As fragmentation patterns are known within this 
system, it is possible to create a library of spectra for compounds, allowing 
identification of unknowns within a sample by comparison. 
EI sources consist of a heated filament, which emits electrons focussed into 
a beam using a magnet (Figure 20). Electrons are accelerated toward the anode at 
~70 eV and interact with the gaseous molecules. Radical molecular ions or 
positively charged fragments are created due to the wavelength (λ) of the free e-. At 
70 eV, λ is 1.4 Å and close to the lengths of the bonds present in the molecules, 
leading to wave disturbance. If one of the frequencies has an energy corresponding 
to a transition in the molecule, an energy transfer that leads to excitations can 
occur. If this energy is sufficient an electron can be expelled [30]. Approximately 
10eV is required to ionise most organic compounds and so excess energy provided 
by the EI source leads to the near complete fragmentation. 
  
Figure 20  Schematic representation of an electron ionisation source. 
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Atmospheric pressure chemical ionisation (APCI) is an alternative method of 
ionisation. APCI is a softer ionisation technique to EI, and usually produces a 
protonated, intact compound ion for analysis (i.e. [M+H]+). The analyte is directed 
into the ionisation source and subjected to a corona discharge, causing molecules 
to ionise and subsequently be analysed in the mass spectrometer. 
 
Mass analysers in mass spectrometry 
Mass analysers are used to separate ionised molecules into m/z values and focus 
them onto the detector. Like ionisation techniques, many different forms have been 
developed. In this section only quadrupoles and quadrupole (3D) ion traps will be 
discussed. Other examples of mass analysers include 2D ion traps, time-of-flight, 
and Orbitrap. 
Mass analysers focus ions onto a small area and limit the ions that arrive at 
the detector to a specific mass or energy. The moving ion passes across an 
electrical or magnetic field, and is deflected from its original path. A mathematical 
formula is used to calculate the radial path (𝑟) of the ion due to its mass (𝑚), charge 
(𝑧), and its interaction with the potential (𝐸) and magnetic field (𝐵) that it passes 
through (Equation 19). 
𝑟 =  (
1
𝐵
) (2𝐸
𝑚
𝑧
)
1/2
 Equation 19 
 
Detector and exit slits are in a fixed location and applied voltage is generally 
held constant. Therefore deflection of the ion is dependent on its m/z ratio, which 
produces a mass spectrum. The mass analyser operates under a vacuum system in 
the mass spectrometer through the combined use of oil and turbomolecular pumps. 
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Quadrupole mass filter 
Quadrupole mass filters operate without a magnet and separation is performed by 
using time-varying electric field effects. Four metal rods are aligned in parallel with 
diagonally positioned rods with identical potentials (direct current, DC), and each 
pair having opposite polarities. A beam of ions pass through the centre of the rods 
and a radiofrequency (RF) alternating current potential is superimposed on the 
static DC potential, inhibiting the ions from colliding with the rods (Figure 21). This 
causes the ion to follow an oscillating path along the rods, with each m/z having a 
unique path allowing detection. Only one m/z can be measured at any given time; 
due to this characteristic, quadrupoles have good sensitivity when selected ion 
monitoring (SIM) is required. SIM is where a target m/z is applied and the 
quadrupole is tuned to only allow this ion to pass through to the detector. More than 
one quadrupole can be used in series to perform MS/MS experiments. For example 
when using three quadrupoles, the first filters a single m/z value, the second is 
used as a collision cell causing fragmentation, and the third selectively monitors a 
target fragment. This method allows a very sensitive and selective analysis of a 
targeted ion and is known as selective (singular), or multiple, reaction monitoring 
(SRM/MRM). 
 
 
Figure 21  A graphical representation of the four charged rods in a quadrupole mass filter 
mass analyser and the path taken by the ions as they pass through; adapted from 
[31]. 
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Selection of masses in the quadrupole filter is achieved through altering the 
stability of ions as they pass through the ion flight path. In order to reach the 
detector the ion must be stable across both the x and y axes. As the radius of the 
quadrupole is constant due to the parallel rods, the DC potential and the RF field 
are the variables that are manipulated to allow m/z selection. The stability of an ion 
passing through a quadrupole mass analyser is dependent on the function of the 
two imposed potentials. As the product of this function increases, stable trajectories 
favour larger m/z values and an ion of a given m/z will retain a stable flight path 
until reaching its stability threshold, and therefore no longer able to maintain its 
path to the detector. Analysis that prospects a wide m/z scan window will employ a 
change in DC potential as a linear function of the RF field, allowing analysis of ions 
with successive m/z values (Figure 22). The steeper the slope of the linear function 
of DC/RF potentials gives a higher resolution, however, the resolution of a 
quadrupole mass analyser does not allow for elementary analysis and is operated 
at unit resolution – i.e. at a resolution sufficient to separate peaks one mass unit 
apart [30]. 
 
 
Figure 22  A graphical representation of the stability areas of increasing mass to charge values 
(m/z1-3). Increasing the function of the direct current (DC) and radiofrequency (RF) 
field linearly allows for successive analysis of ions with increasing m/z value. An ion 
shows instability in the system when its stability area passes above the line 
representing the function of the DC and RF potentials. 
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Quadrupole ion trap 
Quadrupole ion traps store ions with a broad range m/z by causing them to move in 
stable trajectories. They do this between a ring-shaped electrode and two end caps 
(Figure 23), accumulating ions with masses extending over several thousand m/z 
units simultaneously. Ions are subject to an oscillating field, which keeps them 
situated in the centre of the ion trap. Ions of a specific mass are ejected for 
detection by increasing the radiofrequency field in the direction of the end caps, 
causing the ions to become unstable within the electrical field. As they near the 
edge of stability, the ions are pulsed out of the trap and onto the detector. 
 
 
Figure 23  A graphical representation of a cross-sectional slice of a quadrupole ion trap mass 
analyser. The device is radially symmetrical, and zo and ro represent its size; 
adapted from [32]. 
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For a quadrupole ion trap, no DC potential is applied and therefore the 
ejection of ions occurs due to the imposed RF field. At a given RF potential, ions can 
be found to lie along a line (qz) that crosses the stability area. Lower m/z values are 
situated closer to the point of instability. As the RF field is increased, the qz for each 
ion is increased. When the qz value of an ion reaches a point >0.908 and is outside 
of the stability region (a value >1), the ion reaches its limit of stability and is ejected 
on the z axis to the detector Figure 24.  
 
 
Figure 24  A graphical representation of the stability of increasing m/z values in a quadrupole 
ion trap. As the RF field is increased the ions are shifted along qz toward an area of 
instability. Once an ion is situated outside of the stability area it is ejected out of the 
quadrupole ion trap along the z axis, causing 50 % of the ions of a single m/z to be 
directed toward the detector. 
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Ion detection 
The only detector that will be covered in this section is the electron multiplier (EM); 
the most widely used detector in MS. An EM works by having ions accelerated 
towards it at a very high velocity, colliding with a conversion dynode (held at a 
polarity opposite to that of the ions). Here there is an emission of a secondary set of 
electrons. Electrons are then multiplied through a cascade effect in the EM to 
produce a current. This cascade occurs due to electrons continually striking the 
dynode along a curved wall, producing further increased numbers of electrons as 
they accelerate toward the end of the detector (Figure 25). Finally, a metal anode 
collects the electron stream and a current is measured.  
 
 
Figure 25  A graphical representation of a charged ion colliding with the dynode of an electron 
multiplier causing a cascade of secondary electrons; adapted from [33]. 
 
  
  
59 
 
2.4  Thermal desorption-gas chromatography-mass spectrometry 
A mass spectrometer can be used as a detector for GC analysis. Coupling analytical 
instruments together allows for a very powerful analytical tool of separation and 
identification, especially when combined with a method of pre-concentration. This 
method is extremely sensitive when measuring volatile compounds from breath that 
have been desorbed onto sorbent tubes. Figure 26 shows a layout of the processes 
involved for a TD-GC-MS exhaled breath analysis. 
 
 
Figure 26  A layout of the process involved in a typical thermal desorption-gas 
chromatography-mass spectrometry analysis. 
 
2.5 Proposed experiments 
In order to explore the potential of breath analysis in sport science, three studies 
were undertaken: 
 
i) the analysis of exhaled breath of recreational swimming to track 
elimination of disinfection by-products, and to apply discovery 
metabolomic methods to test for detectable signs of inflammation; 
 
ii) the analysis of exhaled breath in conjunction with a maximal oxygen 
uptake test, to establish if metabolomic methods were able to identify 
“fitness markers”; 
 
iii) the development and preliminary testing of an interface to enable breath-
by-breath mass spectrometry of exhaled breath for use during exercise 
interventions. 
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CHAPTER THREE: GENERAL METHODS 
 
3.1 Exhaled VOC sampling 
 
3.1.1 Exhaled VOC sampling mask preparation 
Face masks were cleaned, sterilised and conditioned to remove VOC contaminants 
after each use. Masks were dismantled and all parts were soaked in disinfectant 
solution (Milton Baby Care, Newmarket, UK) following manufacturer’s instructions. 
Once disinfected, items were rinsed in clean, cold water for 5 min and air dried 
before vacuum conditioning at 40 °C and 0.7 mBar for at least 15 hrs. This final 
step removed VOC residues formed on the mask parts during sterilisation. After 
vacuum conditioning, mask parts were organised into complete sets and 
transferred to an airtight sealed plastic box for storage. The following items were 
present: 
 Main full-face mask body. 
 Silicone pillow and positioning clip. 
 Forehead support and silicone cushion. 
 Custom built T-piece with positioning clip and air inlet adapter. 
 Adjustable clip harness. 
 One-way non-rebreathing valve (single use). 
 
3.1.2 Thermal desorption tube preparation 
Adsorbent sampling tubes were supplied by Markes International (Llantrisant, UK). 
All tubes were industry standard stainless steel tubes packed with a hydrophobic 
dual-bed absorbent mixture of Tenax TA and Carbograph 1TD (Part code C2-AXXX-
5032).  
Adsorbent tubes were conditioned before use by back-flushing with purified 
nitrogen at 300 °C for a minimum of 3 hrs, followed by ‘thermal polishing’ under a 
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flow of helium at 300 °C for 20 min in a Unity thermal desorption unit (Markets Int., 
Llantrisant, UK). Once conditioned and prepared for use, adsorbent sample tubes 
were sealed with airtight caps and stored in a sealed plastic container at 4 °C. 
Clean white cotton gloves were used to handle thermal desorption (TD) tubes at all 
times. 
 
3.2  Breath sampling protocol 
 
3.2.1 Air supply to the participant. 
Exhaled breath VOCs were sampled using a portable adaptation of a previously 
described protocol [1]. Compressed ambient air was supplied by a marine 
diaphragm pump (HIBLOW linear air pump HP-200, Techno Takatsuki, Osaka, 
Japan) to a three-stage purification process, before being fed to supply the sampling 
mask. Air supply connections were push-fit silicon tubing, and were regularly 
conditioned in a vacuum oven. 
Compressed air was dehumidified by passing it through a custom made 
stainless steel vessel containing a molecular sieve (Acros Organics, Fisher 
Scientific, Loughborough, UK). Then artefact VOCs were removed by passing the air 
through a bed of granular activated charcoal 4 to 8 mesh (Sigma-Aldrich, 
Gillingham, UK), housed in a stainless steel vessel. The final stage was a respirable 
dust and particulate filter. A detailed schematic and list of components for the 
portable sample can be found in Appendix 1 (Section 3.6). 
Regular maintenance ensured the air supplied to the face mask during 
exhaled VOC sampling was safe and free from contamination. Blank samples were 
checked after each participant, and the air purification system dismantled and all 
the components conditioned when required. The large stainless steel unit 
containing the molecular sieve was connected to a purified nitrogen supply and 
back flushed for a minimum of 15 hrs at 300 C. Activated charcoal was removed 
from its holder and transferred to a clean glass beaker and placed in a vacuum 
oven. Stainless steel fittings, including the filter, were dismantled, cleaned and 
  
67 
 
placed into the vacuum oven alongside the beaker of charcoal. These components 
were then heated to 170 °C at 0.7 mBar for at least 15 hrs. Once complete and all 
items had cooled to < 40 °C, items were removed from vacuum, reassembled and 
re-attached immediately to the air supply unit. Final checks assured the air supply 
was without leaks and supplied flow to the sampling mask was sufficient. Clean 
white cotton inspection gloves were worn when handling the purified air supply 
hardware. 
 
3.2.2 Sampling procedure. 
 
Exhaled breath sampling 
Purified air was supplied to the sampling mask using silicone tubing connected to 
an inlet on a PTFE custom made T-piece. This was fitted with a disposable one-way 
non-rebreathing valve that allowed the inhalation of purified air only, and supressed 
the ingress of ambient air contamination into the breath mask. Supply flow was a 
minimum of 30 L min-1. The mask was fitted to the participant and secured by an 
adjustable clip harness. Participants were encouraged to relax and breathe in a 
natural manner. Five minutes of equilibration time was allowed for each participant 
prior to sampling. The mask was connected by silicone tubing to a pressure sensor 
located in the central control unit. A virtual instrument ([1]) analysed the pressure 
signal and displayed a recording of the breath profile, sending trigger control pulses 
to micro-valves that switched to allow the sample pump (Escort Elf, Zefon Int., 
Ocala, FL, USA) to withdraw a portion of exhaled breath. The sample programme 
was set to ensure that distal, i.e. alveolar, air was sampled.  
A custom built connection housing a silico-steel sampling capillary (Figure 
27) was connected to a luer fitting on the main body of the mask, and an absorbent 
sampling tube was connected in-line with the sampling capillary. The rear end of the 
adsorbent tube was connected by silicone tubing to the switching micro-valve 
mentioned above (see Figure 28 for an example of the sampling equipment fitted to 
a participant). 
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Figure 27  Three dimensional rendering of custom made capillary sampling connector and its 
attachment to a commercially available stainless steel thermal desorption tube; 
adapted from [1]. 
 
Exhaled air was sampled at 0.8 L min-1. Sampling time was controlled 
manually, ending once the specified sample volume had been processed. This was 
2 L for all experiments detailed in this thesis. TD tubes were removed from the 
sampling mask and capped immediately with airtight Swagelok seals, and then 
placed into an airtight sealed plastic box and stored at 4 °C until analysis (mean 
storage time equalled 51 days). After use, the breath sampling mask and its tubing 
were returned to the laboratory to be cleaned and prepared ready for reuse. 
 
Environmental sampling 
Environmental samples were collected by connecting TD tubes to the sample pump. 
A flow of 0.5 L min-1 was used for 4 min, collecting a total of 2 L of environmental 
air. These environmental blanks were collected for both ambient and filtered air 
supplies at all sampling locations, and analysed using the same methods as 
exhaled samples. 
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Figure 28  Image showing an individual participant providing an exhaled breath volatile sample 
during an experimental trial. The participant is wearing the full face mask provided 
with an inlet of purified air (A), with exhaled alveolar air being sampled through a 
thermal desorption tube controlled via an external pressure sensing device (B). The 
participant is isolated from environmental air through the use of a one-way non-
rebreathing valve (C). 
 
3.3  Exhaled VOC sample analysis 
 
3.3.1 Analytical methods 
All exhaled VOC samples collected onto adsorbent beds contained in the stainless 
steel TD tubes were analysed by thermal desorption-gas chromatography-mass 
spectrometry (TD-GC-MS). The general analysis protocol has been described in 
breath analysis publications from the Centre for Analytical Science (Loughborough 
University) [1,2]. An explanation for each step of the analysis is described and an 
overview of conditions is summarised in Table 6. 
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Pre-analysis preparation 
Prior to analysis of exhaled VOCs, sample tubes were removed from storage at 4 °C 
and allowed to warm to room temperature. Once at room temperature, the TD tube 
was attached to an injector and a 20 ng toluene-D8 (T-D8) internal standard was 
loaded onto the tube. This was performed by injecting 0.1 µL of 200 μg mL-1 T-D8 
solution in methanol into purified nitrogen flowing through the TD tube at a flow of 
100 mL min-1. The adsorbent tube remained connected to the injector for 60 s to 
ensure efficient transfer of the standard onto the adsorbent packing. 
 
Thermal desorption 
TD was performed using a Unity TD Unit (Markes Int, Llantrisant, UK). Tubes were 
fitted into the tube oven and rapidly heated to 300 °C for 5 min under a helium 
desorption flow of 45 mL min-1. Desorbed VOCs were transferred to a general 
purpose hydrophobic cold trap (Markes Int., Llantrisant, UK) held at -10 °C. Flow 
from the sampling tube to the cold trap was splitless, with all recovered VOCs 
eluting into the cold trap where they were enriched. Once the 5 min primary thermal 
desorption was complete, the cold trap was rapidly heated to 300 °C for 5 min 
whilst a helium carrier gas transferred the recovered VOCs to the GC column at 2 
mL min-1. The secondary desorption was splitless and the transfer line to the GC 
was maintained at 180 °C. 
Prior to analysing each sample batch, a retention index standard was 
analysed to assess system performance. A mixture containing a range of n-alkanes 
(C8 to C20) was used, and later utilised to allocate retention indices to VOCs isolated 
from samples. The cold trap was cleaned and conditioned between each sample 
analysis by heating to 300 °C for 5 min, with a flow of helium at 2 mL min-1. 
Desorbed residues were analysed by GC-MS and contamination levels assessed. 
This conditioning assessment was repeated until levels of contamination were 
deemed as acceptable. This usually required one or two trap cycles between each 
sample analysed. A step-by-step flow chart for an example daily analysis routine, 
and corresponding chromatographic traces indicating an example of a retention 
index standard analysis and inter-sample trap blank is shown in Figure 29. 
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Table 6  Thermal desorption, gas chromatography and mass spectrometry conditions for the 
analysis of exhaled breath volatile samples; adapted from [2]. 
Thermal desorption conditions (Markes Unity 1) 
 Tube desorption:    300 °C for 5min 
 Desorption flow:   45 mL min-1 splitless 
 Cold trap:    General purpose hydrophobic 
 Trapping temperature:   -10 C 
 Trap desorption:   300 °C for 5 min 
 Trap desorption flow:   2 mL min-1 splitless 
 Flow path temperature:   180 C 
Gas chromatograph conditions (Varian 3800) 
 Column:    Rxi-5ms 60 m x 0.25 mm i.d. x 0.25 µm. 
 Initial oven temperature:  40 C 
 Oven temperature ramp:  5 °C min-1 
 Final oven temperature:  300 C hold for 8 min 
 Carrier gas:    Helium 
 Carrier gas flow:   2 mL min-1 
Mass spectrometer conditions (Varian 4000)  
 Trap temperature:   150 C 
 Manifold temperature   50 C 
 Transfer line temperature:  300 C 
 EI scan mode:    EI auto 
 EI scan frequency:   2 Hz 
 EI scan range:    m/z 40-450 
Note: i.d.: internal diameter; EI: electron impact ionisation 
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Figure 29  An example step-by-step flow chart for a daily analysis routine (top) and an example 
chromatogram for a retention index standard analysis (bottom, lower trace) showing 
n-alkanes with a carbon number (C#) ranging from 8 to 20 and a trap blank 
chromatogram for inter-sample system conditioning (bottom, upper trace).  
Note: IR = relative intensity; tr = retention across time 
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Gas chromatography 
Gas chromatography was performed using a Varian 3800GC series instrument 
(Varian Inc. – now Agilent Technologies, Palo Alto, CA, USA) fitted with a  60 m Rxi-
5ms gas chromatography column (Catalogue # 13426; Restek, Bellefonte, PA, USA) 
(see Table 6). A carrier gas flow of helium maintained at 2 mL min-1 was used. The 
oven was set at an initial temperature of 40 C, with a linear temperature ramp of 5 
C min-1 until reaching a maximum temperature of 300 C. The oven was held at 
300 C for 8 min, producing a total analysis time of 60 min. 
  
Mass spectrometry 
The GC was coupled to a Varian 4000MS series quadrupole ion trap mass 
spectrometer (Varian Inc. – now Agilent Technologies, Palo Alto, CA, USA) by a 
transfer line maintained at 300 °C. An internal electron impact ionisation source 
(70eV) was used and the instrument operated under the conditions summarised in 
Table 6. 
 
3.3.2 Daily quality control procedures 
 
Instrument checks 
Breath and environmental VOC samples were analysed in batches of five or six per 
day. Before batch analysis, quality control and instrument checks were performed in 
the following order:  
 Air and water levels in the mass spectrometer were checked to ensure no 
leaks or excessive moisture were present. For water content, a peak at m/z 
18 would be present with a corresponding peak at m/z 19 present up to an 
acceptance of 500 counts. For air, peaks at m/z 28 and 32 were present at 
low levels above baseline and large visual deviations from baseline levels 
would indicate an air leak. An ionisation time of 3000 µs should be obtained. 
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 A mass calibration standard (perfluorotributylamine) was used to tune the 
instrument. 
 The instrument was checked for sensitivity by ensuring a suitable responses 
to m/z ions 69, 131, 264, 414 and 614 were observed. For ions with m/z 
69 and 131, the acceptable criterion was a peak at approximately 40,000 
counts. Subsequent peaks will be present at approximately 10,000 (m/z 
264), 2,500 (m/z 414) and 625 counts (m/z 614). 
 The condition of the quadrupole trap was assessed by assuring that the ion 
storage time at rest was > 20,000 µs. (If these checks indicated 
contamination, the quadrupole ion trap was heated and left overnight at 
elevated temperature to ‘bake off’ residues and contaminants. If this 
process was unsuccessful, the instrument was vented and the stainless 
steel mass analyser was removed, dismantled and cleaned using a metal 
polish followed by solvent washes in a sonic bath, before conditioning in a 
vacuum oven and reassembling.) 
 Once the mass spectrometer had passed its operational checks, a thermal 
desorption cold trap blank was performed to establish that no contamination 
was present. In the event that contamination were deemed too high, the 
process would be repeated until an acceptable threshold had been met. This 
was checked visually by assessing the height of the singular peak present in 
the chromatogram. A large peak indicated contamination within the cold 
trap. An example of an acceptable analysis is shown in Figure 29. 
 Finally, the retention index solution was analysed. Peak elution times and 
intensities were assessed across the mass/volatility range of analytes. For 
an acceptable analysis, m/z 57 was extracted from the total ion 
chromatogram and all alkanes up to C20 should be visible in the 
chromatogram. An example of an acceptable analysis is shown in Figure 29. 
Intra-batch stability was monitored throughout analytical samples by 
checking the response of the post-loaded toluene-D8 internal standard 
present in each of the experimental samples.  
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If these tests indicate a degraded instrument performance, the analytical 
process would be paused and the problem investigated. Completion of these 
tests was essential to ensure that inter-sample variation was maintained to 
acceptable levels, and analytical system artefacts minimised. 
 
3.3.3 Data processing 
 
Targeted GC-MS compounds 
All targeted data processing were performed on GC-MS output files using the Varian 
MS Workstation (v6.9.2, Varian Inc. – now Agilent Technologies, Palo Alto, CA, USA). 
Chromatograms were smoothed using a mean 3-point smooth and spikes were 
removed using a threshold factor of 5. Target analytes’ retention times and mass 
spectra were validated against commercially available standards. Data from 
standards were used to create target compound libraries that enabled analytes to 
be identified in an exhaled VOC sample. This was performed using an extracted ion 
chromatogram (EIC) for the base peak m/z ion under a clearly defined 
chromatographic peak, within a retention time window defined from the standards’ 
analyses.  
The library of targeted compounds enabled search parameters to be 
optimised to qualifier ion ratios and their peak heights and shape. Once complete, a 
search list was produced containing a list of sample files that were to be prospected 
for VOCs. The data were batch-processed and a summary report was exported to a 
comma separated value (.csv) file. 
 
Metabolomic profiling of GC-MS compounds 
Data were exported from the Varian operating system and converted from the .sms 
GC-MS output file to a .swx file suitable for import into AnalyzerPro (SpectralWorks, 
Runcorn, UK) for peak deconvolution. Peak deconvolution parameters were 
optimised via an iterative search/adjustment of parameter level against visual 
checks of the resultant data, to assess the level of over- or under-picking of peaks. 
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These parameters were applied to all breath samples and can be found in Table 7. 
Once optimised parameters had been defined, test runs with randomly selected 
sample files were performed and the resultant deconvolved data evaluated to verify 
that the deconvolution parameters were applicable across the sample set. If this 
was not the case the iterative process was repeated until satisfactory values were 
obtained.  
 
Table 7  Deconvolution search parameters to identify unique peaks in exhaled breath 
samples using AnalyzerPro software. 
Search parameter Value 
Minimum number of identified ions 2 
Height threshold 0 
Area threshold 1000 
Peak width threshold 0.04 min 
Number of scan windows 3 
Smoothing points 3 
 
Deconvolved data were exported to .csv files which were used to create a 
master file of all isolated chromatographic peaks, with corresponding quantifier and 
qualifier mass spectra ions. The master file contained information about all VOCs 
identified in breath and associated environmental samples. Every component entry 
was indexed and catalogued by: 
 Sorting into retention index order. 
 Consolidation of VOCs with similar/equivalent RI values and 
similar/equivalent mass spectra observed in different samples.  
 Allocation of consolidated groups of VOC peaks to a single labelled peak and 
inputted into a spectrum list in the MS Workstation software (as for the 
targeted analysis). This was done by selecting a GC-MS file with an RI value 
closest to the mean value for its group (approximately at the midpoint of any 
minor drift of retention time across the study period). This step improved the 
integration and reporting of the associated compound across all sample files 
(Figure 30). 
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Figure 30  A screenshot of a section of the combined picked peaks for manual sorting and 
grouping to create an identifier code for each unique peak. 
 Each peak was assigned an ID that consisted of ‘2BRI’ followed by its mean 
retention index (RI), quantification ion and qualifier ions. For example, for a 
VOC that eluted with a RI mean of 900, a base peak of 43 and qualifier ions 
(in order of magnitude) of 57, 69, 71 and 41, its ID carried forward for 
analysis would become BRI-900-43-57-69-71-41. This process allowed all 
compound IDs to contain sufficient information but yet remain unique 
(Figure 31).  
                                                 
2 BRI indicates the name is derived from an averaged retention index obtained from breath samples.  
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Figure 31 A screenshot of the truncated combined picked peak list to show one line for each 
unique peak and its respective identifier coding. 
 Integration parameters were optimised for each peak contained in the 
spectrum list. This was a process similar to the targeted method of data 
processing. 
 A search list was created detailing all of the participant and environmental 
GC-MS data files and an analysis of the files was performed. This outputted a 
VOC data summary .csv file that enabled the integrated peak areas to be 
used to build an exhaled VOC breath matrix. 
 The breath matrix designated the integration value for every VOC isolated 
against each sample (Figure 32).  
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Figure 32  A screenshot showing a section of the overall breath matrix with sample identifiers 
(column A) against each individually picked peak and their respective peak areas. 
 
 This breath matrix was then taken forward for multivariate statistical 
analyses. 
 
A schematic outline of this process can be seen in Figure 33. 
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Figure 33  Step-by-step flow chart to indicate the process for producing a comprehensive 
breath matrix file from the original GC-MS data. 
 
3.3.4 Statistical analyses 
 
Targeted analyses 
All targeted statistical analyses were performed using IBM SPSS Statistics (v 22.0, 
IBM Corp., Endicott, NY, USA). The analyses were study specific and so are 
described in the respective experimental chapters. Bonferroni adjustment was 
applied to all p values where tests for multiple comparisons were made. This 
adjustment is calculated by multiplying the unadjusted p value by the total number 
of comparisons tested. 
 
Multivariate metabolomic profiling 
A four-step multivariate statistical process was adopted for metabolomic profiling of 
the exhaled VOC data using SIMCA-P+ software (v 14, Umetrics, Umeå, Sweden).  
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Scaling  
Each variable (exhaled VOC) was transformed using Pareto scaling in accordance 
with manufacturer recommendations. Pareto scaling is most suited to MS data due 
to the up-weighting of medium peaks and down-weighting of large peaks, a process 
done without increasing baseline noise [3]. Pareto scaling has been suggested as a 
compromise between unit variance (UV) and no scaling and is performed by dividing 
each variable (after subtracting its mean, 𝑥 − ?̅?) by the square root of its standard 
deviation (SD) (Equation 20). Where Pareto scaling lead to a negative analysis, UV 
scaling was investigated.  
𝑃𝑎𝑟 =  
𝑥 − ?̅?
√𝑆𝐷
 Equation 20 
 
Preliminary principal components analysis (PCA) 
A preliminary PCA model was created to visualise the distribution of data points with 
an unsupervised separation method. PCA produces a projection of the samples in a 
multi-dimensional space according to their loadings. If a separation of groupings 
was not present a further, supervised model was used. 
 
Orthogonal partial least squares-discriminant analysis (OPLS-DA) 
This supervised method prospects the data to identify components that enable pre-
defined classes of data to be separated. The contribution of each component to the 
separation of the different classes may be evaluated by using a model contribution 
plot, known as S-plots. S-plots were analysed to identify variable components that 
showed the greatest sensitivity and selectivity in discriminating between data 
classes. These points present in the extreme ends (i.e. corners) of the S-plot. 
Identified components were then extracted from the data matrix for further analysis. 
Simca-P+ software automatically validates the OPLS-DA model by removing 1/7th of 
data and producing a model for the 6/7th of remaining data. The removed data is 
then predicted using the new model. This is an iterative process, with each 1/7th of 
the data ‘left out’ until all data have been predicted. Predicted data can then be 
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compared to the original data and the sum of squared errors calculated for the 
entire dataset. 
 
3.3.5  Analysis of target components – candidate biomarkers 
Individual sample values were extracted from the matrix for each of the target 
components and evaluated. Where time-dependent sampling occurred, the data 
were analysed in both raw (with IS normalisation) and normalised (i.e. ratio to 
maximum intra-participant reading) data formats. Any time, or group, dependent 
differences for individual variables were evaluated using the appropriate statistical 
method mentioned in the respective chapters. Multi-component contributions were 
scored by calculating the Euclidian distance for each individual at each time point 
using the Equation 21, where x refers to each participant value for the given 
variable and time point. 
√∑(𝑥𝑖
2, 𝑥𝑖𝑖
2 , … ) Equation 21 
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3.6 Appendix 1: details of portable breath sampler 
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Schematic code Description 
A Breath mask (ResMed) 
B 
Mask air supply assembly including disposable one way valve 
(Clement Clarke International Ltd, Part No. 3122061), PTFE T-
piece and silicon air supply line 
C 
Adsorbent sampling assembly including PTFE sampling valve and 
sorbent tube (Markes Int. Ltd) 
D Micro-control valves 
E Pressure transducer 
F Carbon dioxide level transducer 
G Electronic interface 
H Precision air sampling pump, Escort Elf personal pump, MSA 
I 
Dust and particulate stainless steel filter, gas filtration at 0.01 
µm, Model 97S6, dimension: L79 mm, OD32 mm, maximum 
pressure 5000 psig at 93 °C, max temp. 204 °C, weight: 0.3 kg, 
seals: viton, inlet and outlet ports: 1/4", Microfiber filter cartridge 
grade AQ (99.9999+ %) (part number: 050-50-AQ, Parker 
Balston) 
J 
VOC purification filter consisting of stainless steel vessel (L180 
mm, OD30 mm) containing granular activated charcoal 4 to 
8mesh (Sigma-Aldrich, CAS:7440-44-0, Part number: C2764-
500G)  
K 
Dehydration filter consisting of custom made stainless steel 
vessel (L260 mm, OD154 mm, ID150 mm) containing molecular 
sieve 13X, 8 to 12 mesh (Acros Organics, CAS:63231-69-6, Part 
number: 197310050) 
L 
HIBLOW linear air pump HP series, model HP-200, air flow 
volume: 200 L min-1, weight: 9 kg, voltage: AC 220~240 V, 
Dimensions: L256 mm, W200 mm, H222 mm (Techno Takatsuki 
Co. Ltd) 
M 
Laptop running pcmcia card slot and containing DAQcard-6024E, 
with Labview software (National instruments) 
N Portable metal suitcase with 3 detachable levels 
O Silicon tubing connections, RS components 
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CHAPTER FOUR: EXHALED BREATH MONITORING IN HEALTHY 
PARTICIPANTS AFTER EXERCISE IN A SWIMMING POOL 
ENVIRONMENT: A TARGETED AND METABOLOMICS 
APPROACH 
 
4.1 Introduction 
Swimming is the most popular participant sport in the United Kingdom. Statistics 
(2013) report approximately three million people participating in at least one 30 
min swimming session per week [1]. Three million bathers constitute a significant 
infection vector. Disinfection of bathing water is mostly achieved with chlorine gas 
and/or sodium hypochlorite solution as described in Chapter 1. The formation of 
volatile chlorine, and bromine, species in the swimming pool water is of growing 
concern. Even with careful pool user hygiene, introduction of biological matter into 
the swimming pool by human users induces these processes [2,3].  
The pool chlorine hypothesis proposes that the inhalation, absorption and 
ingestion of disinfection by-products (DBPs) may cause cumulative negative health 
effects. For example, the reported association between swimming pool attendance 
throughout childhood and the development of asthmatic conditions later in life [4]. 
Although arguments that health benefits of swimming outweigh the potential 
chemical hazards that are present [5], it is important that the impact on inhaled 
DBPs is not ignored. Conversely, the safety of the swimmer from other potential 
risks associated with poor disinfection are paramount.  
Uptake and elimination of DBPs has been of interest in previous years. 
Aggazzotti et al. [6] measured the elimination of chloroform (CHCl3) on four 
occasions in a competitive swimmer, after a 45 min intensive training session. 
Samples were collected immediately, 15 min post-swimming and every 30 min for 3 
hrs post-swimming, with an additional sample collected at 10 hrs post-swimming. 
The experiment showed a first order, one-compartment elimination of CHCl3 from 
exhaled breath, with an average biological half-life (t1/2) of 24 ± 4 min (mean ± 
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standard deviation). CHCl3 was measured in 3 out of 4 samples collected at 10 hrs 
post-swimming. However, 3 samples showed no detectable CHCl3 at 105 (n=1) and 
135 (n=2) min post-swimming, indicating an unexplained removal and 
reappearance. With the small number of observations in this experiment, it is not 
possible to fully understand the elimination of CHCl3 from exhaled breath after 
swimming. Lindstrom et al. [7] collected single breath samples (1 L) of respiratory 
reserve volume and mapped the levels of CHCl3 during both the exposure period (at 
points during swimming exercise) and the post-exposure elimination. In contrast to 
Aggazzotti and colleagues, elimination showed a tri-exponential model. However, 
the measurements were only taken on one male and one female and ceased at 
150 and 180 min post-exposure, respectively. Caro & Gallego [8] collected single 
breath measurements using a Bio-VOC® breath sampler (Markes Int., Llantrisant, 
UK). This device collects the final 100 mL portion of a forced exhalation and is then 
pushed through an adsorbent bed contained in a stainless-steel thermal desorption 
(TD) tube. The authors reported that exhaled concentrations of CHCl3 returned to 
pre-swimming levels at 240 min post-exposure. All of these studies collected data 
on a small population and used single breath measurements, with low volumes 
used in some cases. These sampling methods do not allow for natural breath-to-
breath fluctuation of exhaled concentrations. A sensitive, multiple-breath approach 
would be beneficial to characterise the development and elimination of DBPs. 
Furthermore, no reports in the literature describe the development of 
exhaled inflammatory biomarkers in conjunction with an elimination of disinfection 
by-products. No observational studies seeking to discover possible volatile 
biomarkers of lung damage have been reported.  
 
4.2 Study aims: 
 
4.2.1 Primary aim 
Characterise the elimination of DBPs from recreational swimmers exposed to 
chlorinated water. 
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4.2.2 Secondary aim: 
Test the hypothesis that swimming in chlorinated water produces a detectable 
change in VOC profiles following DBP exposure. 
 
4.3 Methods 
 
4.3.1 Ethical approval 
The study was approved in its entirety by the Loughborough University Ethical 
(Human Participants) Sub-Committee under the reference R13-P100. All 
participants took part voluntarily and were informed of the experimental procedures 
by issue of a participant information sheet prior to consenting. All participants gave 
written and informed consent and were free to exclude themselves and their data 
from the experiment at any time without reason. Once consented, participant 
information and samples were anonymised and assigned a unique identifier code. 
 
3.3.2 Characterisation of swimming pool environment 
All exercise testing was performed at the Loughborough Sport swimming pool 
located on Loughborough University campus. The swimming pool water was, and is, 
drawn from the local drinking water system and is disinfected using sodium 
hypochlorite (NaClO(aq)) maintained at a recommended concentration of 1 mg L-1(aq) 
with automatic electronic dosing pumps (TEKNA EVA TPG, Crius System, Pi, UK). 
NaClO (aq) has a permitted concentration range within the pool environment of 
between 0.5 mg L-1(aq) to 5 mg L-1(aq) and is deemed as non-hazardous. Ultraviolet 
light disinfection was, and is, also used. 
 Due to the basic nature of NaClO, a solution of hydrochloric acid (HCl) is 
introduced into the swimming pool water. The HCl is purchased in concentrate 
drums of 32-38% solution and diluted before being pumped into the pool water. The 
permitted concentration range for HCl in the pool water is 7.2 to 7.6 mg L-1, with a 
recommended value of 7.4 mg L-1. The pool contains approximately 2,500 m3 of 
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water and, with the pumps running at capacity, has a turnover time of approximately 
5.5 hrs. The pool water is maintained at a temperature of 27.8 ± 0.1 °C. Figure 34 
shows a detailed plan of the swimming pool building highlighting the swimming and 
sampling areas accompanied by a photograph to visualise the complex. 
 
4.3.2 Preliminary study 
The preliminary study (n=1) was conducted to provide scoping data for the design of 
the main experiment. An estimate of the time required to eliminate exogenous DBPs 
from the human body after swimming in a chlorinated swimming pool was sought.  
The participant arrived at the swimming pool at approximately 0830 hrs, 
after an overnight fast and a pre-exercise breath VOC sample was collected 
promptly. The exercise consisted of a 90 min continuous swim performed using the 
breast stroke technique. After the swim, the participant briefly showered and 
provided six 1 L breath samples, one every 5 min for 30 min. The experiment 
timeline is visualised in Figure 35. 
Participant feedback suggested that 90 min continuous swimming was 
potentially too challenging. A shorter swimming intervention would be needed in the 
subsequent research. 
All samples were analysed by thermal desorption-gas chromatography-mass 
spectrometry (TD-GC-MS) (Chapter 3) and resultant data analysed for the presence 
and intensity of CHCl3. CHCl3 levels in breath were observed to increase 190-fold 
over pre-swim levels and elimination followed an approximately exponential profile, 
with an estimated elimination time to pre-swim levels of 600 min (Figure 36). 
Therefore, a period of 600 min post-exercise monitoring was specified for the 
following experiments. 
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Figure 34  Detailed plan of the swimming pool building (top) highlighting swimming area 
(dotted oval) and room used for exhaled breath sample (dashed oval). Bottom 
picture of the swimming pool area corresponds to a view from the upper right 
section of the plan. 
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Figure 35 Schematic timeline to show sampling time points and exercise placement for an 
initial preliminary investigation into the exhalation of chlorine disinfection by-
products post-swimming. 
 
 
 
Figure 36 Elimination of chloroform as observed in exhaled breath concentrations changes in 
a single participant after a 90 min recreation swim in an indoor pool. Figure shows 
the exponential formula extrapolated for 600 min to estimate the exhaled wash out 
period. 
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4.3.2 Refinement study 
A refinement experiment (n=1) was performed to establish if DBPs were detectable 
in exhaled breath 600 min after exposure through swimming, to evaluate the 
substantial extrapolation from the data of the preliminary study. Once again, a 
participant fasted overnight and provided a resting breath sample. On this occasion 
the exercise period was reduced to 30 min. Once the 30 min exercise was 
complete, the participant briefly showered and a post-exercise breath VOC sample 
was collected. A further eight breath VOC samples were collected, see Figure 37. All 
breath samples collected were 2 L and the participant was allowed to eat and follow 
their normal daily routine throughout the sampling period.  
 
 
Figure 37 Schematic timeline to show sampling time points and exercise placement for a 
secondary preliminary investigation into the exhalation of chlorine disinfection by-
products post-swimming. 
 
Figure 38 contains example chromatographic data obtained from this preliminary 
study, showing a blank sample obtained from the filtered air via the portable 
sampler, a post-swimming exhaled breath sample and extracted ion chromatograms 
showing CHCl3, bromodichloromethane (CHBrCl2) and carbon tetrachloride (CCl4). 
Breath data were analysed for peak area intensity of CHCl3, CHBrCl2 and CCl4 at all 
time points. Figure 39 shows the elimination profile for each DBP. It was concluded 
that monitoring for 600 min post-exercise was a suitable period to provide sufficient 
data to characterise DBP elimination. CCl4 did not show a rise in exhaled intensities 
post-swimming and remained relatively constant across the sampling period. 
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Figure 38  Example chromatograms for A) a sampling air blank, B) a post-swimming exhaled breath sample and expanded regions for the extracted ion 
chromatogram (EIC) of C) m/z 83 (CHCl3 = chloroform, CHBrCl2 = bromodicholoromethane) and D) m/z 117 (CCl4 = carbon tetrachloride).  
Note: IR = relative intensity; tr = retention time 
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Figure 39 Single participant post-swimming wash out profiles for chloroform (top), 
bromodichloromethane (middle) and carbon tetrachloride (bottom) after a 30 min 
recreational swim.  
Note: IR = relative intensity; t = time 
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4.4 Main experiment 
 
4.4.1 Experimental design 
With a final sample point designated at 600 min post-exercise, a Box-Wilson central 
composite design (CCD) was used to allocate a total of five post-exercise sample 
time points [9]. The CCD depends on the number of factors in the experiment, for 
this instance a 1-factor design was produced using a 2-factor, or 2k, method. The 
CCD contains a centre (mid) point that is augmented with a group of ‘star points’ 
that allow estimation of curvature. If the distance from the centre of the design 
space to a factorial point is ± 1 unit, the distance from the centre of the design 
space to a star point is ± α with |α| > 1 (Figure 40). For this experiment, star points 
are allocated by the initial and final breath VOC samples at +5 and +600 min post-
exercise, respectively. See equations 22 to 26 for study time point calculations.  
 
Figure 40 Graphical representation of a central composite design of experiment to estimate 
curvature. The design incorporates a mid-point, two outer points (±1 units) and 2 
extreme ‘star’ points (±α) 
 
To calculate α and maintain rotatability of the design, α depends on the number of 
experimental runs in the factorial portion of the CCD; 
∝ = [𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑓𝑎𝑐𝑡𝑜𝑟𝑖𝑎𝑙 𝑟𝑢𝑛𝑠]
1
4 𝑂𝑅 ∝ = [2𝑘]
1
4 Equation 22 
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For this experiment there are two factors, therefore the factorial portion is 22; 
2
2
4  =  α =  1.414 Equation 23 
 
The mid-point is defined by the maximum and minimum factor levels; 
600(min) − 5(min)
2
= 297.5(min) Equation 24 
 
Therefore the mid-point sits at; 
5 + 297.5(min) and 600(min) − 297.5(min)  =  302.5 (min) Equation 25 
 
 If ± 297.5 is α then ± 1 unit is derived by the following calculation: 
297.5(min)
1.414
= 210.4(min) Equation 26 
 
Therefore the ± 1 unit points are at 297.5 min ± 210.4 min. This produces 
sampling points at; +5 min, +92.1 min, +302.5 min, +512.9 min and +600 min 
post-exercise. These points were simplified to; +5 (immediate), +90 (1 hr 30 min), 
+300 (5 hrs), +510 (8 hrs 30 min) and +600 min (10 hrs). 
 
4.4.2 Participant information 
Nineteen healthy males (mean ± standard deviation (SD): age 25 ± 2 yrs, height 
177 ± 7 cm, body mass 77.7 ± 11.2 kg, body mass index 24.8 ± 3.0 kg m-2) were 
recruited with a 100 % completion rate. All were capable, yet irregular, swimmers 
and free from any serious medical conditions or exercise impairing injuries. 
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4.4.3 Exercise protocol 
Participants attended the Loughborough University Swimming Pool at approximately 
0830 hrs, the morning after an overnight fast with only water permitted after 
waking. The participants completed a 30 min continuous swim at a challenging, yet 
maintainable, pace sustaining a target rating of perceived exhaustion of 15 [10]. 
Participants were allowed to choose and alternate swimming stroke throughout the 
exercise session. The exercise started at the beginning of the first length (25 m) 
performed and ceased after the completion of the length being performed in which 
the 30 min time limit expired. 
 
4.4.4 Sampling protocol 
Six exhaled breath VOC samples were collected at the times noted in Section 4.4.1. 
 
4.4.5  Sampling methods 
 
Exhaled breath VOCs 
Exhaled breath VOCs were sampled as described in Chapter 3. 
 
Environmental VOCs 
Air samples (2 L) were collected at 0.5 L min-1 onto adsorbent sample tubes 
identical to those used for exhaled breath sampling. Air samples were taken of the 
air surrounding the swimming pool and one from each sampling room (the pool 
complex and laboratory). A corresponding 2 L sample of the filtered air supplied to 
the face mask during breath sampling was also collected at 1 L min-1 for each 
location. 
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VOC sample analysis 
All VOC samples collected onto thermal desorption (TD) tubes were analysed by TD-
GC-MS; Chapter 3. Samples were analysed at the first possibility after collection. 
Due to the length of the collection period (several months), each participant was 
analysed as a sequential batch with randomised sample order. 
DBP standards were purchased from Sigma-Aldrich (Gillingham, UK) in a 
multi-component mixture (KDWR VOC Mix B, product code: 506583) of 100 µg mL-1 
of each component in methanol. A list of components included can be found in 
Table 8 and a copy of the certificate of analysis is included in Appendix 1. 
 
4.4.6 Statistical analyses 
All statistical analyses were performed using IBM SPSS Statistics (v 22.0, IBM Corp., 
Armonk, NY, USA). To assess change in post-exercise exhaled values of DBPs and 
candidate compounds, Wilcoxon signed rank tests were performed to compare each 
time point to pre-exercise values. Bonferroni correction was utilised to account for 
multiple comparisons, and p values refer to the Bonferroni adjusted value. Receiver 
operator characteristic (ROC) curves were produced and the area under the curve 
(AUC) calculated for the prediction of swimming. A paired subject approach was 
utilised to produce a ROC curve analysis using pre-swim samples as the negative 
state (control) and the 600 min post-exercise values as the target state. A 
Bonferroni adjusted p value of < 0.05 was considered statistically significant. 
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Table 8 Compounds present in the disinfection by-product standard mixture detailing 
empirical formula, estimated retention index and chemical structure. 
1,1-Dichloroethene 
C2H2Cl2 
513 
 
 
 
 
 
Trichloroethene  
C2HCl3 
687 
 
 
Dichloromethane 
CH2Cl2 
524 
 
 
 
 
 
Bromodichloromethane 
CHBrCl2 
692 
 
Trichloromethane (Chloroform) 
CHCl3 
601 
 
 
 
 
 
Dibromochloromethane 
CHBr2Cl 
768 
 
1,1,1-Trichloroethane 
C2H3Cl3 
624 
 
 
 
 
 
Tetrachloroethene 
C2Cl4 
795 
 
Carbon tetrachloride 
CCl4 
649 
 
 
 
 
Tribromomethane (Bromoform) 
CHBr3 
849 
 
4.4.7 Calibration of target DBPs 
A calibration curve was created (n=10) with on-column masses (OCM) ranging from 
39 pg to 80 ng of each analyte, with a deuterated toluene internal standard (T-D8, 
IS) (Table 9). Standards were prepared and used promptly by loading onto a thermal 
desorption tube using the same technique adopted for the T-D8 IS (Chapter 3). 
Twenty ng T-D8 was also loaded as described previously (Chapter 3). Standards were 
thermally desorbed and analysed by TD-GC-MS using the same parameters 
specified for breath and environmental samples analysis (Chapter 3).  
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All analytes were identified at each OCM value. Peak areas were determined 
and ratios were produced against the IS value. Resultant values were plotted and 
least squares regression was performed to create a linear calibration (Table 9). 
 
Table 9  Calibration profiles for disinfection by-product compound standards for a range 
from 39 pg to 80 ng on-column mass (OCM). Calibration materials were produced 
by dilution of the standard mixture and OCM values refer to those calculated from 
the stock concentration detailed on the certificate of analysis in Appendix 1. 
Disinfection by-product On column mass (ng) Ratio to IS Linear fit (R2) 
1,1-Dichloroethylene 0.07 0.001 0.9996 
 
0.15 0.002 
 
 
0.60 0.011 
 
 
2.39 0.042 
 
 
9.57 0.213 
 
 
19.14 0.420 
 
 
28.71 0.587 
 
 
47.85 0.993 
 
 
76.56 1.571 
 
    Methylene Chloride 0.04 0.084 0.9961 
 
0.07 0.052 
 
 
0.15 0.054 
 
 
0.59 0.100 
 
 
2.37 0.090 
 
 
9.49 0.235 
 
 
18.98 0.370 
 
 
28.47 0.487 
 
 
47.45 0.794 
 
 
75.92 1.331 
 
    Chloroform 0.04 0.003 0.9990 
 
0.08 0.005 
 
 
0.15 0.007 
 
 
0.61 0.036 
 
 
2.45 0.104 
 
 
9.80 0.399 
 
 
19.60 0.763 
 
 
29.40 1.190 
 
 
49.00 1.958 
 
 
78.40 3.305 
 
    1,1,1-Trichloroethane 0.08 0.002 0.9979 
 
0.15 0.004 
 
 
0.62 0.026 
 
 
2.46 0.073 
 
 
9.85 0.311 
 
 
19.70 0.597 
 
 
29.55 0.920 
 
 
49.25 1.539 
 
 
78.80 2.656 
 
    Carbon tetrachloride 0.08 0.002 0.9996 
 
0.17 0.004 
 
 
0.67 0.028 
 
 
2.68 0.076 
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10.71 0.371 
 
 
21.42 0.692 
 
 
32.13 1.065 
 
 
53.55 1.732 
 
 
85.68 2.867 
 
    Trichloroethylene 0.08 0.002 0.9999 
 
0.15 0.003 
 
 
0.61 0.018 
 
 
2.43 0.051 
 
 
9.70 0.211 
 
 
19.40 0.407 
 
 
29.10 0.644 
 
 
48.50 1.055 
 
 
77.60 1.686 
 
    Bromodichloromethane 0.08 0.002 0.9978 
 
0.16 0.004 
 
 
0.63 0.028 
 
 
2.50 0.073 
 
 
10.00 0.309 
 
 
20.00 0.581 
 
 
30.00 0.971 
 
 
50.00 1.586 
 
 
80.00 2.721 
 
    Dibromochloromethane 0.08 0.002 0.9988 
 
0.16 0.005 
 
 
0.64 0.029 
 
 
2.57 0.076 
 
 
10.29 0.319 
 
 
20.58 0.573 
 
 
30.87 0.983 
 
 
51.45 1.553 
 
 
82.32 2.587 
 
    Tetrachloroethene 0.08 0.003 0.9996 
 
0.15 0.004 
 
 
0.61 0.027 
 
 
2.44 0.073 
 
 
9.75 0.287 
 
 
19.50 0.566 
 
 
29.25 0.882 
 
 
48.75 1.463 
 
 
78.00 2.406 
 
    Bromoform 0.08 0.002 0.9974 
 
0.16 0.004 
 
 
0.63 0.029 
 
 
2.50 0.073 
 
 
10.00 0.316 
 
 
20.00 0.553 
 
 
30.00 0.974 
 
 
50.00 1.531 
   80.00 2.635   
Note: IS = internal standard 
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4.4.8 Data processing 
 
Targeted compounds 
DBPs were identified by confirmation of mass spectra and retention times using 
Varian MS Workstation (v. 6.9.2, Varian Inc. – now Agilent Technologies, Palo Alto, 
CA, USA), Chapter 3, and quantified against the calibration (Table 9).  
 
Metabolomic profiling 
Metabolomic profiling was undertaken as described in Chapter 3. 
 
4.5 Results 
 
4.5.1 Exercise performance and environmental conditions 
All participants completed the 30 min of continuous swimming without the 
development of pains/injuries or need to pause at any time. A total of 49 ± 11 
lengths (1225 ± 275 m; mean ± SD) were completed at a pace of 0.7 ± 0.2 m.s-1. 
The swimming pool environment temperatures were 24.5 C ± 0.7C, with a 
humidity of 57 ± 8 % and an ambient air pressure of 756.6 ± 7.8 mmHg across the 
19 participant sampling sessions. 
 
4.5.2 DBP standard calibrations 
All standards present in the calibration mixture could be detected at the measured 
concentrations using the analytical method described. Linear responses were 
observed in all analytes with an r2 value of ≥ 0.996 (Table 9). Figure 41 shows a 
chromatogram of the standard calibration mixture with each analyte annotated to 
their respective chromatographic feature. Measured retention times and 
corresponding mass spectra were used as criteria to confirm the presence or 
absence of each analyte in the experimental samples. An automated search 
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function was created using Varian MS Workstation and all confirmed peaks present 
in the samples were quantified by peak integration. Table 10 shows a summary of 
all the analytes in the calibration mix and their presence across the range of 
samples taken throughout the experimental period. 
 
 
Figure 41 Example chromatogram indicating peaks A-K of the disinfection by-products 
standard mixture and the post-loaded internal standard. Peaks include 1,1-
dichloroethene (A, OCM 76.56 ng), dichloromethane (B, 75.92 ng), 
trichloromethane (chloroform) (C, 78.40 ng), 1,1,1-trichloroethane (D, 78.80 ng), 
carbon tetrachloride (E, 85.68 ng), trichloroethene (F, 77.60 ng), 
bromodichloromethane (G, 80.00 ng), tolune-D8 (H, internal standard, 20.00 ng), 
dibromochloromethane (I, 82.32 ng), tetrachloroethene (J, 78.00 ng), 
tribromomethane (bromoform) (K, 80.00 ng).  
Note: IR = relative intensity; t = retention time 
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Table 10 Disinfection by-products in the standard mixture and their presence in exhaled and environmental volatile organic compound (VOC) samples. 
 
Detected in samples (%) 
Compound 
Exhaled VOC 
samples 
Pool air 
Sampling room at 
pool complex 
Filtered air at 
pool complex 
Sampling room at 
laboratory 
Filtered air at 
laboratory 
1,1-dichloroethene (A) 4 5 5 0 5 0 
Dichloromethane (B) 54 84 100 95 100 100 
Trichloromethane (C) 89 100 16 84 100 89 
1,1,1-trichloroethane (D) 6 11 37 0 53 0 
carbon tetrachloride (E) 84 100 100 100 100 100 
Trichloroethene (F) 2 16 5 5 0 0 
Bromodichloromethane (G) 58 100 58 11 53 21 
Dibromochloromethane (I) 57 100 95 16 74 37 
Tetrachloroethylene (J) 74 100 79 37 100 63 
Tribromomethane (K) 25 95 84 63 74 47 
Note: Letters A-K refer to the chromatographic peaks present in Figure 41 
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4.5.3 DBPs in exhaled VOC samples 
 
Variations in elimination profiles.  
Two classifications of elimination profile were observed. More participants (n=16) 
showed a first order elimination profile with exhaled breath concentrations reducing 
from the maximum level observed immediately after they stopped swimming. 
However, 3 participants showed alternative wash out profiles for trihalomethane 
DBPs. Two of these participants showed maximal exhaled intensities at 90 min 
post-swimming, with one participant showing elevated levels at 5 min post-exercise 
that were maintained at 90 min post-exercise. Figure 42 shows one participant with 
delayed exhalation intensities for CHCl3 with comparison to a common wash out 
profile. 
 
 
Figure 42 Comparison of one participant with delayed wash out of chloroform (circles, dotted 
line) overlaid against the wash out kinetics observed from another alternative 
participant representative of the majority of the profiles observed (triangles, dashed 
line).  
Note: I = intensity; t = time 
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Delayed elimination 
Participants showing delayed wash out profiles (16 %) were excluded from the main 
targeted analyses. However, breath data were included for non-targeted 
metabolomics analyses. It is unknown whether the delayed response is indicative of 
solely the DBPs, or indeed also of other compounds in response to swimming. 
 
First-order elimination  
All targeted DBPs were detected, with 6 DBPs observed in more than 50 % of 
exhaled VOC samples. These common DBPs were identified as dichloromethane, 
chloroform, carbon tetrachloride, bromodichloromethane, dibromochloromethane 
and tetrachloroethylene (see Table 10 for an overview of all target DBPs and their 
presence in respective samples). Three of these 6 DBPs were seen to rise post-
swimming and wash out over the 10 hr recovery period. Specifically, the 3 DBPs 
were trihalomethane species. Figure 43 shows extracted base peak ions with 
matching retention times and confirmation mass spectra for each of the 3 DBPs 
isolated from the 5 min post-exercise exhaled breath sample of one participant. All 
3 DBPs rose above pre-exercise levels in the 5 min post-exercise exhaled breath 
sample with chloroform showing the greatest increase (cohort median, 121-fold), 
followed by bromodichloromethane (4.4-fold) and dibromochloromethane (1.8-fold, 
p≤0.002). All DBPs median values rose above measured concentrations of the 
respective analyte in the sampling room environmental air, and the blank samples 
obtained from the supplied filtered air. None of the exhaled masses of DBP rose 
above the concentrations measured in the environmental air of the swimming pool 
hall. Table 11 summarises the exhaled on-column masses at all time points and the 
concentrations of environmental and blank samples for the 3 trihalomethane DBPs. 
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Figure 43 Example exhaled breath VOC sample extracted ion chromatograms (EIC) for base 
peak ions (left) and corresponding peak mass spectra (right) for trichloromethane 
(top), bromodichloromethane (middle) and dibromochloromethane (bottom).  
Note:  IR = relative intensity; m/z = mass to charge ratio; t = retention time 
 Retention times do not compare with earlier preliminary experiment due to 
installation of new chromatography column for the main experimental campaign.
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Table 11 Summary of median exhaled mass, fold change from baseline and p value of 
change for three trihalomethane disinfection by-products measured before and up 
to 600 min post-exercise in a swimming pool.  
Compound Time point / min Median exhaled mass / ng 
Fold change from 
baseline 
p Value 
 
Pre-swim 0.27 (0.00 to 1.41) 
  
trichloromethane 
(chloroform) 
+5 32.49 (5.76 to 52.01) 121.0 0.005 
+90 5.66 (2.28 to 9.96) 21.1 0.010 
+300 1.37 (0.18 to 3.35) 5.1 0.040 
+510 0.96 (0.16 to 1.62) 3.6 0.080 
+600 0.72 (0.14 to 1.55) 2.7 NS  
 
Concentration (ng L-1) 
   
Pool air 73.12 (36.68 to 223.15) 
   
Sampling room 1 0.81 (0.25 to 3.91) 
   
Air supply room 1 0.30 (0.17 to 1.41) 
   
Sampling room 2 0.47 (0.22 to 5.55) 
   
Air supply room 2 0.25 (0.19 to 3.27) 
  
     
bromodichloromethane Pre-swim 1.70 (0.00 to 2.71) 
  
+5 7.47 (2.99 to 22.74) 4.4 0.002 
+90 2.55 (1.87 to 3.67) 1.5 0.020 
+300 1.82 (1.37 to 2.39) 1.1 NS 
+510 1.73 (1.37 to 2.99) 1.0 NS 
+600 1.59 (0.00 to 3.91) 0.9 NS  
 
Concentration (ng L-1) 
   
Pool air 12.49 (2.69 to 23.51) 
   
Sampling room 1 0.48 (0.36 to 0.96) 
   
Air supply room 1 0.36 (0.00 to 0.50) 
   
Sampling room 2 0.42 (0.36 to 0.66) 
   
Air supply room 2 0.37 (0.00 to 3.35) 
  
     
dibromochloromethane Pre-swim 0.57 (0.00 to 1.09) 
  
+5 1.01 (0.59 to 1.42) 1.8 0.002 
+90 0.67 (0.58 to 0.75) 1.2 NS 
+300 0.58 (0.00 to 0.64) 1.0 NS 
+510 0.58 (0.00 to 0.65) 1.0 NS 
+600 0.56 (0.00 to 0.73) 1.0 NS  
 
Concentration (ng L-1) 
   
Pool air 1.60 (0.20 to 3.51) 
   
Sampling room 1 0.16 (0.14 to 0.37) 
   
Air supply room 1 0.14 (0.00 to 0.34) 
   
Sampling room 2 0.15 (0.00 to 0.21) 
  
  Air supply room 2 0.14 (0.00 to 2.82)     
Note: a total of 2 L of breath was sampled and thus median concentrations of 
exhaled trihalomethanes in ng L-1 correspond to the median exhaled mass divided 
by 2.  
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Median chloroform exhaled masses in breath increased 121-fold from 0.27 to 
32.49 ng OCM and remained above pre-exercise levels until at least 300 min post-
swimming (p≤0.04). Levels returned to baseline by 510 min post-swimming 
(p=0.08). Similarly, median bromodichloromethane exhaled masses increased 4.4-
fold from 1.70 to 7.47 ng OCM and remained above pre-exercise levels until at least 
90 min post-exercise (p≤0.02). Bromodichloromethane median exhaled masses 
increased from 0.57 to 1.01 ng OCM, rising above pre-exercise levels at 5 min post-
exercise (p=0.002) and returning to pre-exercise levels by 90 min. Elimination 
profiles of the 3 trihalomethane DBPs can be visualised in terms of exhaled mass 
and fold change from pre-exercise in Figure 44 and Figure 45, respectively. Figure 
46 shows an example pre-exercise exhaled breath chromatogram with overlaid and 
aligned extracted ion chromatograms for the 3 trihalomethane DBPs showing all 
post-exercise time points. 
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Figure 44 Box and whisker plots to show exhaled mass for chloroform (top), 
bromodichloromethane (middle) and dibromochloromethane (bottom) for combined 
participant exhaled breath samples. Boxes refer to median and interquartile range 
and whiskers as 10th and 90th percentiles. Compared to pre-exercise values: * 
p≤0.040 † p=0.080. 
Note: t = time 
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Figure 45 Box and whisker plots to show fold change from pre-exercise values for chloroform 
(top), bromodichloromethane (middle) and dibromochloromethane (bottom) for 
combined participant exhaled breath samples. Boxes refer to median and 
interquartile range and whiskers as 10th and 90th percentiles.  
Note: t = time 
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Figure 46 Pre-swim total ion chromatogram from a single participant (main body) with overlaid and aligned chromatograms across time sampling points for 
chloroform (extracted ion chromatogram (EIC) m/z 83, top left), bromodichloromethane (EIC m/z 83, top right) and dibromochloromethane (EIC m/z 
129, bottom) 
Note: IR= relative intensity; tr = retention time 
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4.5.4 Metabolomic profiling of exhaled VOCs 
Identified VOCs were collated to produce a search function that prospected all 
samples (Chapter 3). Six hundred and three unique VOCs were isolated, with 73 
VOCs distinctive to breath samples (present in > 20 % breath samples and < 20 % 
environment samples) with not one VOC present in > 20 % environment and < 20 % 
breath samples. Peak integration output values, normalised to internal standard, 
were organised into a matrix and imported for multivariate analysis (Chapter 3).  
In order to test the secondary aim hypothesis, breath samples obtained pre-
exercise and at the 600 min sample point were compared, see Chapter 3 Section 
3.3.4. Data models were produced with both Pareto and UV scaling methods. 
Figures and candidate biomarkers discussed herein were isolated using the UV 
method, as Pareto scaling did not allow for discernible isolation of candidate 
compounds. 
Orthogonal partial least squares-discriminant analysis (OPLS-DA) indicated 
the presence of discriminating compounds (Figure 47), and a panel of 8 candidate 
VOC were identified from the S-plot (Figure 48). Table 12 shows the average 
retention index, quantification and qualification ions for these candidates. 
Candidate compounds were modelled with principle components analysis (PCA) for 
pre- and 600 min post-exercise exhaled VOCs, yielding a near separation of time 
points (Figure 49). 
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Figure 47 Orthogonal partial least squares-discriminant analysis model 2-dimensional score 
plot for pre- (grey circles) versus 600 min post-exercise (black triangles) breath 
samples. 
 
Figure 48 S-plot for modelled variables using an orthogonal partial least squares-discriminant 
analysis model with unit variance scaling for pre- versus 600 min post-exercise 
breath samples. Candidate biomarkers are highlighted in grey ovals. 
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Table 12  List of candidate biomarkers as identified by OPLS-DA analysis on comparison of exhaled VOC samples at pre- and 600 min post-swimming. 
Experimental 
peak number 
Mean retention 
index 
Quantifier 
ion 
Qualifier 
ion 1 
Qualifier 
ion 2 
Qualifier 
ion 3 
Qualifier 
ion 4 
Up/down 
regulated 
Study ID 
98 1912 73 281 429 149 282 ↓ BRI-1912-73-281-429-149-282 
141 1098 41 71 43 57 70 ↓ BRI-1098-41-71-43-57-70 
171 961 41 43 57 95 41 ↓ BRI-961-41-43-57-95-41 
579 927 57 71 41 43 95 ↓ BRI-927-57-71-41-43-95 
68 946 285 286 269 333 287 ↑ BRI-946-285-286-269-333-287 
118 1461 43 107 93 41 69 ↑ BRI-1461-43-107-93-41-69 
383 1253 415 327 416 0 0 ↑ BRI-1253-415-327-416-0-0 
414 1337 146 145 0 0 0 ↑ BRI-1337-146-145-0-0-0 
Note: ID = identification; OPLS-DA = orthogonal partial least squares-discriminant analysis 
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Figure 49 Principal components analysis 2-dimensional score plot constructed using 
candidate exhaled VOC biomarkers for pre- (grey circles) versus 600 min post-
exercise (black triangles) breath samples. 
 
Data indicate that an observed change in the breath profile could not be 
ruled out and the study hypothesis underlying the secondary aim of this study 
should be rejected. Table 13 summarises potential identifications of BRI-946-285-
286-269-333-287 (1-Cyclohexyldimethyl silyloxypentadecane), BRI-1461-43-107-
93-41-69 ((5E)-6,10-dimethylundeca-5,9-dien-2-one), BRI-1253-415-327-416-0-0 
(Diethyl (2-ethoxyethyloxy) octadecyloxy-silane) and BRI-1337-146-145-0-0-0 (2-
benzofurancarboxaldehyde) based on spectral fit with the National Institute of 
Science and Technology Mass Spectral Library (NIST 14) and predicted retention 
index (RI) vs observed RI matches. Two upregulated compounds that were assigned 
as siloxanes may be associated with artefacts from the analytical system and were 
excluded from further study. Environmental samples were investigated for the 
presence of the remaining metabolites. BRI-1337-146-145-0-0-0 was identified in 
only 4 environmental samples. Levels of BRI-1461-43-107-93-41-69 at all time 
points versus the environmental samples can be visualised in Figure 52 of Appendix 
2 (Section 4.11). Candidate VOCs were determined to have no influence from 
environmental conditions. 
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Table 13 Four post-swimming upregulated candidate biomarkers and possible identification matches using the National Institute of Science and Technology 
mass spectral database (NIST 14). 
Candidate 
biomarker 
Most likely hit (NIST 14) 
Forward 
match 
Reverse 
match 
Probability 
(%) 
Measured / 
predicted RI 
Notes 
BRI-946-285-286-
269-333-287 
1-Cyclohexyldimethyl 
silyloxypentadecane 
517 706 8.2 946 / 2357 
Large deviation in RI - possible bleed 
from analytical column 
BRI-1461-43-107-
93-41-69 
(5E)-6,10-dimethylundec-5,9-
dien-2-one 
679 735 13.4 1461 / 1426 Good match statistics 
BRI-1253-415-327-
416-0-0 
1-Cyclohexyldimethyl 
silyloxypentadecane, Diethyl 
(2-ethoxyethyloxy) 
octadecyloxy-Silane 
450 744 4.4 1253 / 2743 
Large deviation in RI - possible bleed 
from analytical column 
BRI-1337-146-145-
0-0-0 
2-Benzofurancarboxaldehyde 555 797 Unknown 1337 / 1296 
Good match statistics - Probability 
unknown due to competing ions – 
very likely match with extra ions of 
89, 63 and 90 
Note:  NIST = National Institute of Science and Technology mass spectral database; RI = retention index 
         
O
O
H            
(5E)-6,10-dimethylundec-5,9-dien-2-one        2-Benzofurancarboxaldehyde
CH3 CH3
O CH3 CH3
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BRI-1461-43-107-93-41-69 reported an increasing trend in the hours post-
swimming. This trend was calculated to be non-significant (only once p values were 
adjusted for multiple comparisons). Power calculations for 80 % power with a p 
value of < 0.05 indicated n=38 would allow for this comparison to reach 
significance. Similarly, a ROC curve was not able to use the values for this 
compound at 600 min post-exercise as a predictor of swimming (AUC 0.614 (95 % 
CI 0.403 to 0.825, p=0.295). ROC curves were Figure 50 shows the plots of BRI-
1461-43-107-93-41-69 with values in both a raw format (normalised to IS) and 
those normalised to each participant’s maximal peak intensity across the 600 min 
time period. None of the candidates reported an individual change in values across 
the wash out period, likely due to large variations observed between participants.  
The two candidate biomarkers were used to generate a score (Euclidean 
distance, Section 3.3.5) for each time point (Figure 51). Upregulation of the 
combined ions at 510 and 600 min post-swimming was statistically significant 
p≤0.032 and the ROC curve area reported as significant for the prediction of 
swimming (AUC 0.875 (0.730 to 1.000, p<0.0005). Visual interpretation of the 
plots for BRI-1461-43-107-93-41-69 and the Euclidean distance scoring show 
similar upregulated patterns, and thus it is likely that BRI-1461-43-107-93-41-69 is 
highly influencing the calculated scores. Furthermore, investigation in to BRI-1337-
146-145-0-0-0 reported that this molecule was only characterised in 22 % of 
exhaled samples with 7 of the 19 participants influencing the pre- to 600 min post-
exercise comparisons. The research design did not incorporate a non-swimming 
group that were subjected to identical environmental exposure of the swimming 
pool environment, therefore it was not possible to assess the impact that the 
exercise had on the elevation of exhaled DBPs post-exposure. 
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Figure 50 Individual scatter plots to visualise the change in candidate biomarker BRI-1461-
43-107-93-41-69 when expressed as a response ratio to internal standard (IS) (top) 
and time point data normalised to each individual’s maximal response (bottom). 
Horizontal line refers to the median and the error bars to the interquartile range.  
Note: IR = relative intensity; t = time  
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Figure 51 Scatter plots to visualise the change in the sum of Euclidean distance scores for the 
four upregulated candidate biomarkers expressed as a mean response ratio to 
internal standard IS (top) and mean time point data normalised to each individual’s 
highest time point scoring (bottom). Horizontal line refers to the median and the 
error bars to the interquartile range. * denotes p≤0.032. 
Note: IR = relative intensity; t = time 
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4.6 Discussion 
DPBs of water treatment by chlorination were detectable in the exhaled breath of 
participants both before and after swimming, and for up to a further 510 min after a 
30 min swim. Three DPBs measured in the exhaled breath reported a pattern 
whereby a rapid increase in exhaled mass was observed immediately post-
swimming, followed by an initially rapid washout that slowed over the 600 min time 
period. Two DBPs, CHCl3 and CHBrCl2, were seen to be elevated in exhaled breath 
samples for at least 90 min after cessation of swimming exercise, with CHBr2Cl 
reducing to baseline levels within 90 min. Differing exhaled wash out behaviours 
were noted in this cohort, with 3 participants showing delayed or maintained 
maximal levels of exhaled trihalomethane DBPs. Reasons for this are unknown but 
may be attributable to alterations in exposure. For example, a delayed wash out 
may indicate ingestion of swimming pool water, residing in the stomach for a period 
of time before being released and available to diffuse into the lungs for exhalation. 
It is recommended that future investigations increase the total number of 
participants and include more sampling time points in the first 180 min post-
exercise to further understand this phenomenon. Additive information such as 
respiratory and heart rates, alongside exercise intensity measured by exhaled V̇O2, 
would provide valuable information for the comparison of participants. These tests 
were unavailable for the present investigation. 
Metabolomic profiling analyses indicated that two compounds showed an 
upregulation from baseline levels across the experimental washout period. 
Combined Euclidean distance scores reported an increase in these compounds at 
510 and 600 min post-swimming when compared to pre-swimming levels. ROC 
analysis showed that the Euclidean distance scores of the two metabolites were 
able to predict, at 600 min, that swimming had occurred. Although individual 
metabolite upregulation was not noted, one metabolite, tentatively identified as an 
unsaturated ketone ((5E)-6,10-dimethylundeca-5,9-dien-2-one), showed an 
individual trend of upregulation across the 10 hr time period when normalised to 
individual participant maximal response. The common name for this compound is 
geranylacetone (CAS: 3796-70-1) which is found in many essential oils and food 
flavourings. Geranylacetone is also characterised as an endogenous metabolite 
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[11] associated with four biological functions: cell signalling; fuel and energy 
storage; fuel or energy source; and, membrane integrity stability. Geranylacetone is 
a monoterpene that contains a chain of two isoprene units, suggestive of a 
connection to the mevalonate pathway. Geranylacetone could also be a breakdown 
product of a sesquiterpene, by oxidative cleavage of an alkene to leave the ketone. 
The metabolomic ontology of geranylacetone indicates that it is located within 
membranes and extracellular fluids. 
The role that ketones play in inflammation is not fully understood. There has 
been interest in how ketogenic diets increase the concentration of ketones in the 
biological system, known as ketosis. Ketosis has been reported to reduce pain and 
inflammation [12], with some clinical evidence to suggest that ketogenic diets can 
also reduce signs of liver inflammation (through improvements in steatosis, 
inflammatory grade and fibrosis) in obese patients with non-alcoholic fatty liver 
disease [13,14]. Other data suggest that increased ketone concentrations 
upregulate the levels of adenosine [15,16], a neuromodulator that is known to have 
anti-inflammatory effects [17,18].  
Ketogenic diets utilise a low carbohydrate and high fat intake that produces 
an upregulation of lipid oxidation which, through a cascade of reactions, produces 
ketone bodies such as acetone and β-hydroxybutyrate (β-HB) [19]. Acetone is a 
major component in an exhaled breath VOC matrix [20]. Participants in this 
experiment were asked to arrive following an overnight fast, producing a reduction 
in blood glucose levels and temporarily increasing fat oxidation. Relatively intense 
exercise was performed which is an action that has been reported to increase the 
availability of β-HB [21]. For these reasons, the rise in this unsaturated ketone may 
be attributable to the fasted exercise that was performed as part of the trial. 
However, as feeding was allowed throughout the day a continued rise throughout 
the 600 min post-exercise would not have been produced due to the elevated fat 
oxidation of a fasted state. Due to this ketone observation, acetone was 
investigated for exhaled samples across the time period and no differences were 
reported (data not shown). 
It would be premature to attribute a rise in geranylacetone concentrations in 
breath to an inflammatory response, but the upregulated trend of this compound 
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across 600 min following swimming in chlorinated water is noted. Four sources for 
this upregulated compound have been conjectured: 
 Release from damaged cellular membranes 
 Generation by oxidative breakdown of a sesquiterpene-based derivative 
 Release from ingested food 
 Generation by ketosis following fasting and exercise. 
A follow on study will be useful to establish association with inflammation using 
appropriate controls for ketosis and food constituents. A randomised cross-over 
experimental design would enable better isolation of the chlorinated pool 
environment as a potential causative factor.  
The other potentially upregulated compound was tentatively identified as 2-
benzofurancarboxaldehyde (BRI-1337-146-145-0-0-0), characterised in the Human 
Metabolome Database as a nutrient and food flavouring expected to be found at 
unquantified concentrations in cytoplasm and extracellular material [22]. It has 
been previously reported that aldehyde compounds are expressed in exhaled breath 
in response to inflammation/oxidative stress, for example malondialdehyde [23]. 
Furthermore, a recent publication reported the anti-inflammatory effects of 
benzofuran analogues [24]. As this compound was only noted throughout the 
experimental period in approximately one quarter of participants, it is not possible 
to attribute this to a post-swimming inflammatory response. However, follow on 
studies with a more targeted analysis and a larger sample size will reduce the 
sample and measurement variance enabling more reliable study statistics to inform 
the discussion.  
All participants had detectable levels of DBPs in their breath prior to 
swimming. This may be due to absorption from the swimming pool environment 
where samples were collected within the swimming pool complex, albeit in an 
adjacent room with good ventilation and no direct contact with the swimming pool 
area. However, pre-filters were used in the sampling air supply removing DBPs from 
their air during sampling. This was the first study to analyse exhaled DBPs with a 
filtered air source, and it was also the first study to measure elevated DBP 300 min 
after participants had stopped swimming. Previous experiments reported a reduced 
post-swimming time [7], elimination of chloroform after 240 min [8] or 
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inconsistencies in a single participant across 600 min post-swimming [6]. The data 
in this study reflect the changes in sensitivity afforded by the described collection 
and analysis methods, with a lower limit of quantitation likely to be below an on-
column mass of 38 pg. 
The number of participants in this study was greater (19 versus 2 to 12) than 
previous washout studies (2x washouts utilising the identical environmental 
scenario for each participant), and inter-subject variability was observed to be a 
significant confounding factor to the straightforward analysis and interpretation of 
inter-subject data. Increased participant numbers will be required for follow-on 
research. Development of exhaled breath sampling instrumentation and on-line 
analysis to allow rapid analysis of exhaled DBPs would provide a more thorough 
understanding of the washout kinetics. A portable, mass spectrometer would allow 
the further exploration of the metabolic responses reported in this experiment. 
In conclusion, this experiment characterised two distinct washout profiles of 
trihalomethane DBPs, lasting up to 510 min after swimming in a chlorinated pool.  
 
4.7 Follow on research 
To confirm or deny the rise in the candidate marker of swimming, geranlyacetone, a 
follow-on study with a targeted approach should be performed. An experiment 
mimicking the protocol used in the investigation described in this chapter would be 
utilised with a targeted analytical approach to the samples. This would increase the 
sensitivity and selectivity of the candidate molecule and allow for more definitive 
information on its evolution post-exercise in a swimming pool environment. 
Additionally, mirroring time sampling points for participants after a prolonged period 
of time away from the swimming pool environment would be beneficial. This would 
be performed in a randomised crossover design and allow for comparison of post-
swimming samples with common daily fluctuation. Furthermore, a third session 
whereby the participants perform exercise away from the swimming pool 
environment would allow for investigation as to whether the rise in exhaled levels is 
attributable to the environment itself, or is a metabolic response to exercise. A 
further session whereby participants are submerged in the pool water for an 
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identical time period but without swimming would allow for further understanding of 
the influence of exercise in the elevation and wash out of DBPs. 
If exposure to chlorinated environments in swimming pools causes healthy 
individuals to experience inflammatory responses, or increases their susceptibility 
to experience inflammatory responses, the scope of studies such as this should be 
widened to reflect factors associated with childhood development and ageing. 
Participants were healthy adult males who had some, or little, history of swimming 
during childhood. With reports associating childhood swimming with the onset of 
respiratory conditions [e.g. 25] in later life, it is of interest to establish if 
inflammatory markers are present in childrens’ breath following swimming in 
chlorinated pools. Lung development occurs throughout childhood and puberty and 
insults and injury to lung physiology may be compounded by remodelling of the 
developing lung. Could residual damage from an early age impact alveolar maturity? 
The potential of chlorination and DBPs to cause negative health outcomes for 
susceptible childhood phenotypes provides significant motivation to continue and 
develop this research. The impact of DBPs on the aging population should also be 
addressed. As aged populations increase and life expectancy is ever-rising there is a 
concomitant rise in mortality and morbidity due to lung disease [26]. Exercise has 
shown benefits to cardiorespiratory function in patients suffering from interstitial 
lung disease [27]. If inhalation of DBPs is indeed causing accelerated lung aging, 
consideration into the balance of exercise therapy (common in swimming pools due 
to the semi weight-bearing properties of water) and potential damage to the lungs 
needs to be addressed. 
  Another aspect to consider is the impact that chlorination and DBPs may 
have on an elite athlete’s respiratory system. High-performance swimmers 
experience significantly higher exercise intensities than were adopted in the current 
study. They will place larger demands on their lungs and inhale the toxic chemicals 
in significantly larger amounts. The higher intensity swimming exercises also occur 
at high frequency; many elite swimmers training or competing every day during high 
season. Similar exposure frequencies may also be a factor for those who only swim 
recreationally, but regularly. The levels observed in this study were within irregular 
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swimmers, and therefore more regular attendance to a swimming pool based 
exercise session may cause resident elevated levels of DBPs.  
Outside of exhaled breath analyses, research studies into the in vitro effects 
of DBPs on lung cell linings would be beneficial. It is important to understand 
whether DBPs are directly causing maladaptation to the epithelial cells and cell-
based investigations will provide valuable insight into the potential causal, or simply 
associative, effects of pool air inhalation and development of lung tissue damage.  
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4.10 Appendix 1: certificate of analysis for disinfection by-product 
standard mixture 
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4.11 Appendix 2: additional figure 
 
Figure 52  Box and whisker plots to show exhaled values of BRI-1461-43-107-93-41-69 and 
comparisons with environmental samples. Boxes refer to median and interquartile 
range and error bars to 10th and 90th percentiles.  
Note: IR = relative intensity; IS = internal standard 
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CHAPTER FIVE: EXHALED BREATH PROFILES AND INTENSE 
EXERCISE 
 
5.1 Introduction 
An important element in non-targeted metabolomic profiling is the selection of 
“healthy” controls. Indeed “healthy” is vague and difficult to define in absolute 
terms. Whilst a control group of participants may be recruited who are free from 
known health problems, and specifically free from symptoms and signs relating to a 
specific disease or condition under study, it is very difficult to recruit a control group 
who remain representative of the study population. “Healthy” controls are a far from 
homogenous set. A cohort of individuals with a phenotype defined strongly by a 
condition or disease that has reduced their exercise capacity will have had to adapt 
their lifestyles to using lower levels of physical activity. Individuals of potential 
control cohorts described as ‘fit”, and/or healthy, and/or asymptomatic are, in 
reality, entirely heterogeneous in their levels of physical fitness. Fit and healthy is a 
misleading descriptor full of discrepancy. Fit, in terms of health and disease, offers 
a description that an individual is free from signs and symptoms of disease. For the 
context of sport and exercise, ‘fit’ has a completely different connotation. An 
individual free from the signs and symptoms of disease, can be unfit as defined by 
their exercise capacity. Similarly, somebody who is defined as having a disease can 
possess very high exercise capacity, a notable example would be an asthmatic 
athlete.  
It is not currently understood whether a person’s level of physical capacity, 
i.e. physical fitness, is manifest in their exhaled VOC profile and this was the focus 
of this investigation. Chapter 1 describes how exhaled breath measurement is 
intrinsic to characterising exercise and physical capacity. Physical exertion 
increases respiration from cell to tissue to organ to organism and alters the exhaled 
breath profile significantly [1]. Whether it be aerobic (with oxygen present) or 
anaerobic (in absence of oxygen), alterations in exhaled oxygen and carbon dioxide 
can be measured. However, there are no data that describe what, if any, changes to 
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exhaled VOC profiles occur as a result of changes to an individual’s level of physical 
capacity. Further, there are few reported studies describing exercise factors in 
exhaled breath biomarkers. Most of such reports are concerned with exhaled breath 
condensate (Section 1.3.2) with reported increases in pulmonary pro-oxidative 
markers [2-4]. Volatile compound analyses have received less interest. King et al. 
[1] described changes in exhaled acetone and isoprene concentrations in the 
breath of participants exercising on a cycle ergometer. In general they showed that 
both compounds concentrations in breath increase with the onset of exercise. 
Acetone concentrations increased from approximately 700 to 1000 ng mL-1 in-line 
with the exercise intensity to a stable level during each exercise episode. 
Regardless of the participants’ recovery time(s) exhaled breath concentrations of 
acetone were correlated to carbon dioxide output. In contrast isoprene 
concentrations in exhaled breath increased rapidly and transiently from 
approximately 100 to 400 ng mL-1 before reducing back to baseline levels over the 
course of the exercise/recovery period. A conclusion that isoprene accumulates, 
perhaps in the working muscles, and is then rapidly eliminated with increased blood 
flow and respiration was given. Repeated bouts of exercise resulted in smaller 
increases in isoprene concentrations on beginning exercise, relative to the first 
bout, with the maximum concentration levels reducing as the recovery time 
between exercise episodes was decreased. This was also noted by Senthilimolan et 
al. [5]. However, a slight rise in exhaled isoprene in the final stages of the 30 min 
exercise protocol was observed in all participants. The implication being that 
exhaled VOC profiles may have time-dependant components within them attributed 
perhaps to changes in biochemistries and metabolism in response to exercise. 
Methane was seen to reduce in alveolar levels during a light exercise challenge and 
returned to baseline levels after cessation [6]. These VOC compounds show an 
interaction with the change in movement during exercise, and are related to 
changes in physical chemistry (ventilation) and downstream metabolites of energy 
metabolism affected during physical exertion. 
Solga et al. [7] differentiated between conditioned (i.e. trained) and non-
conditioned rowers from changes in in exhaled ammonia concentrations after a 
4000 m indoor row. Conditioned rowers exhaled ammonia increased 5-fold at 
around 120 min post-exercise and continued to rise at cessation of sampling. In 
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contrast, the non-conditioned rowers showed an increase of around 2.5-fold which 
plateaued during the recovery phase. A physically demanding test such as this 
cannot be considered as practical for monitoring fitness levels in the general 
population. Currently, the most widely recognised indication of physical fitness 
requires the participant to undergo a physical challenge at their maximal or near-
maximal levels of endurance (e.g. maximal oxygen uptake test, Cooper 12 min run). 
Such protocols cannot be tolerated by people with incapacitating conditions such as 
cardiovascular disease or respiratory complications such as chronic obstructive 
pulmonary disease. An inability to exercise at the intensity required by the test 
protocol to generate maximal data requires any sub-maximal values to be 
extrapolated. Although maximal capacity can be predicted in a healthy population 
[8], inter-person variability exists and these values may not reflect the dynamics 
seen in critically ill patients. Athletes recovering from injury may also not be able to 
complete such tests. At the extreme end of the “fitness” spectrum, a fully capable 
high performance athlete may not have the time in their training schedule to 
complete, and importantly to recover from, such tests. Consequently, they have to 
continue their intense training without the benefit that such data would give them.  
The ability to differentiate fitness levels of individuals from exhaled VOC 
profiles may be seen to be a potentially valuable source of information, and benefit 
the well and unwell alike. It would be an exciting prospect if a quick and non-
invasive breath test was able to determine the current status of an individual’s 
physical fitness. Such a test could be used in rehabilitation clinics, and athletes 
would be able to track their in-season fitness levels and manage injury recovery 
strategies in a quantitative metabolomics-based manner. 
 
This study, a starting point in this research, sought to test two hypotheses:  
i) the physical fitness of an individual is a factor in their exhaled breath 
VOC profile; 
ii) control groups of apparently ‘fit and healthy’ participants cannot be 
classified as homogenous phenotypes. 
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5.2 Methods 
 
5.2.1 Ethical clearance 
The study was approved in its entirety by the Loughborough University Ethical 
(Human Participants) Sub-Committee under the reference R12-P129. All 
participants took part voluntarily and were informed of the experimental procedures 
by issue of a participant information sheet prior to consenting. All participants gave 
written and informed consent and were free to exclude themselves and their data 
from the experiment at any time without reason. Once consented, participant 
information and samples were anonymised and assigned a unique identifier code. 
 
5.2.2 Participant information 
Thirty three healthy males (mean ± standard deviation: age 23 ± 3 yrs, height 180 ± 
6 cm, body mass 82.2 ± 10.3 kg, body mass index (BMI) 25.3 ± 2.4 kg m-2) were 
recruited and completed the research protocol. An additional participant was 
recruited, and although baseline measurements were taken, a malfunction in the 
laboratory nitrogen supply meant that the protocol could not be completed. All the 
participants reported active engagement in sporting behaviours, at either an 
individual or a team level. Although participants were deemed as ‘generally fit’ the 
cohort possessed a range of physical abilities. All participants were free from injury 
and were able to complete the prescribed exercise tests. 
 
5.2.3 Experimental design 
Participants were asked to arrive at the exercise laboratory at approximately 0830 
hrs, after an overnight fast with only water permitted after waking. On arrival, each 
participant was asked to sit quietly for 5 min before the test protocol started. The 
test protocol consisted of (Figure 53): 
 providing a reference resting sample of exhaled breath, see Chapter 3; 
 being fitted with a heart rate (HR) monitor; 
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 undertaking a maximal oxygen uptake test, (V̇O2maxtest); 
 once the V̇O2max test was complete, continuing to cycle against a low level 
resistance until breathing rate and HR returned closer to resting values 
(‘warm down’, approximately 5 min); 
 after warm down, sitting quietly and resting for 5 min; 
 after completion of the rest, providing a post-exercise exhaled breath 
sample;  
 60 min after exercise cessation, providing a final exhaled breath sample.  
After this the participant was free to consume food and drink and leave the 
laboratory. 
 
 
Figure 53  A schematic diagram to show the experimental protocol for each participant from 
arrival at the laboratory until cessation of the final exhaled breath sample. 
 
5.2.4 Exhaled VOC collection 
Exhaled breath VOCs and environmental VOCs were sampled as described 
previously (Chapter 3).  
 
5.2.5 Maximal oxygen uptake (?̇?O2max) test protocol  
Maximal oxygen uptake was determined for all participants under identical test 
conditions by performing a V̇O2max test with a cycle ergometer (Lode Excalibur Sport, 
Lode B.V., Groningen, Netherlands). An incremental, steady state exercise protocol 
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was used. Exercise intensity began with a work output of 95 W, increasing in 35 W 
steps every 3 min. No prior warm up was performed as the low intensity exercise in 
the principal 3 stages was deemed light enough to suitably prepare the lower limb 
muscles for the more intense stages. The cycle ergometer was electromagnetically 
braked so that resistance adjusted according to cadence in order to maintain a 
constant power output. Participants were allowed to determine cadence, and to 
alter this throughout the test at their own discretion. Alternative techniques where a 
constant cadence is maintained were not followed due to the potential of premature 
volitional fatigue in the lower limb skeletal muscles. Total exhaled gases were 
collected in an evacuated Douglas bag in the final minute of each 3 min stage. HR 
and rating of perceived exertion (RPE [9]) were recorded during collection. 
Participants were actively encouraged to continue the test for as long as possible, 
indicating to the investigators when they believed it was the final minute of exercise 
before exhaustion. Exhaled gases, HR and RPE were obtained regardless of exercise 
stage progression. Oxygen (O2) and carbon dioxide (CO2) content were measured 
using a gas analyser (1440 Gas Analyser, Servomex (Spectris plc), Surrey, UK) by 
sampling a flow of 2 L min-1 of the collected exhaled gas for 2 min with O2/CO2 % 
values recorded after approximately 1 min 45 s stabilisation.  
The total minute exhaled volume was measured by evacuating Douglas bags 
(after gas analysis was complete) using a vacuum pump and dry gas analyser 
(Harvard Apparatus UK, Cambridge, UK). Evacuated volume was added to the 
volume removed for gas analysis and total volume recorded. Oxygen uptake (V̇O2) 
was calculated using details in Chapter 1. 
 
5.2.6 VOC sample analysis 
All VOC samples were collected onto thermal desorption tubes and analysed by 
thermal desorption-gas chromatography-mass spectrometry (TD-GC-MS, section 
3.2.2).  
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5.2.7 Statistical analyses 
The data processing workflow described in Section 3.3.3 was followed. 
Deconvoluted and scaled data from participant samples were grouped according to 
upper and lower tertiles of fitness levels as determined by the relative, and absolute 
V̇O2 max scores (i.e. upper and lower 33% of participants split into high and low 
groupings). Sample pairings were initially analysed by principal components analysis 
(PCA) to check for unsupervised separation and subsequently investigated using the 
supervised method of orthogonal partial least squares-discriminant analysis (OPLS-
DA). S-plots were analysed for contributor variables (Chapter 3). Discriminant 
components were assessed as potential biomarkers of fitness, or exercise.  
Further data analyses were performed using IBM SPSS Statistics (v 22.0, 
IBM Corp., Endicott, NY, USA). Differences observed for high and low groupings of 
relative and absolute V̇O2max were assessed using the Mann-Whitney U Test for 
independent samples. Isolated biomarkers were individually analysed for 
differences between groupings also using the Mann Whitney U Test. Predictors of 
relative and absolute V̇O2max were analysed using a general linear regression model 
with stepwise entry. Distribution of exhaled VOC values observed across time were 
assessed using the Kruskal-Wallis H test for related samples. An alpha value (p) of 
< 0.05 was deemed as statistically significant and, where appropriate, is reported 
as its Bonferroni adjusted value. 
Heat maps and cluster analysis were performed using GENE-E (Broad 
Institute, Cambridge, MA, USA) on data scaled to a log2 base. 
 
5.3 Results 
 
5.3.1 Exercise testing 
All participants completed the exercise test to their self-reported maximum. 
Common protocol for the successful attainment of V̇O2max include a measurement 
of HR within 10 beats min-1 of predicted maximum (𝐻𝑅(max) = 220 − 𝑎𝑔𝑒 𝑖𝑛 𝑦𝑒𝑎𝑟𝑠) 
and a respiratory exchange ratio (𝑅𝐸𝑅) of ≥ 1.1 [10]. Completion of these criteria 
was as follows:  
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 15 / 33 participants satisfied both criteria. 
 4 / 33 participants achieved a 𝑅𝐸𝑅 of ≥ 1.1 but HR data were unavailable. 
 10 / 33 participants achieved a 𝑅𝐸𝑅 of ≥ 1.1 and HR within 10 % of 𝐻𝑅(max). 
 2 / 33 participants did not achieve a 𝑅𝐸𝑅 of ≥ 1.1 but did achieve a HR 
within 10 beats min-1 of 𝐻𝑅(max). 
 2 / 33 participants achieved one of; a) 𝑅𝐸𝑅 of ≥ 1.1, b) HR within 10 beats 
min-1 of 𝐻𝑅(max), or c) HR within 10 % of 𝐻𝑅(max). 
 No participant was able to maintain a cadence of ≥ 60 in their final minute.  
 Across all participants, 77 % reported a final minute RPE of ≥ 19, with 10% 
and 13 % reporting RPE = 18 and RPE = 17, respectively.  
 Two participants were subsequently excluded from the data analysis when 
their pre-exercise exhaled breath samples were discovered to contain levels 
of solvent molecules high enough disrupt the chromatography. See Figure 54 
for example chromatograms from an environmental blank (filtered air from 
sampler), an ‘acceptable’ breath sample and an ejected breath sample from 
a single participant. 
 An average V̇O2max score of 46.5 mL(O2) kg-1 min-1 was obtained with a range 
of 35.3 – 58.9 mL(O2) kg-1 min-1.  
Group differences stratified by upper and lower tertiles (n=10) of relative and 
absolute V̇O2max are displayed in Table 14. The high relative V̇O2max group had 
decreased mass, height and BMI (≤0.023). The high absolute group had 
increased mass and BMI and performed less self-reported minutes of walking 
per week (p≤0.005). No differences were seen for laboratory exercise 
conditions.   
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Figure 54  Example chromatograms to show i) an ejected breath sample due to excess solvent at 2.8 min (bottom) and a zoomed chromatogram for post-
solvent peak responses (bottom inset) with a region of disrupted chromatography highlighted (dashed oval), ii) an acceptable exhaled breath sample 
from the same participant (middle), and iii) an environment blank sample taken from the filtered air supplied to the sampling mask (top).  
Note: IR = relative intensity; tr = retention time 
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Table 14  Baseline and exercise characteristics of participants and environmental conditions grouped by highest and lowest 33 % values for relative and 
absolute maximal oxygen uptake (?̇?O2max). 
  
Relative ?̇?O2max 
 
Absolute ?̇?O2max 
    High Low p Value   High Low p Value 
 
Age / yrs 23 (3) 22 (3) 0.247 
 
24 (4) 22 (2) 0.796 
 
Mass / kg 72.6 (6.2) 89.3 (9.1) < 0.0005 
 
90.2 (9.6) 75.7 (9.2) 0.005 
 
Height / cm 176 ( 7) 183 (5) 0.023 
 
184 (6) 177 (7) 0.075 
 
BMI / kg m-2 23.5 (1.4) 26.6 (2.4) 0.004 
 
26.7 (2.0) 24 (1.5) 0.004 
W
e
e
k
ly
 
a
c
ti
v
it
y Vigorous /min 325 (196) 230 (113) 0.353 
 
374 (173) 228 (152) 0.052 
Moderate / min 89 (112) 144 (103) 0.143 
 
174 (155) 168 (325) 0.218 
Walking /min 225 (99) 292 (179) 0.280 
 
133 (84) 331 (145) 0.002 
 
Relative V̇O2max / mL(O2) kg-1 min-1 51.9 (2.6) 40.9 (2.8) < 0.0005 
 
47.3 (5.9) 45.0 (5.6) 0.481 
 
Absolute V̇O2max / L(O2) min-1 3.8 (0.4) 3.6 (0.4) 0.481 
 
4.2 (0.2) 3.4 (0.1) < 0.0005 
 
Final stage heart rate / beats min-1 191 (7) 186 (9) 0.277 
 
185 (10) 192 (5) 0.063 
 
Room temperature / °C 21.1 (1.0) 21.4 (0.8) 0.247 
 
21.1 (0.9) 21.2 (1.1) 0.796 
 
Room pressure / mmHg 764 (7) 760 (6) 0.218 
 
762 (14) 764 (6) 0.353 
 
𝐹𝐼O2 (%) 21.0 (0.1) 20.9 (0.1) 0.165  
21.0 (0.1) 21.0 (0.1) 0.631 
  𝐹𝐼CO2 (%) 0.05 (0.01) 0.04 (0.01) 0.739   0.04 (0.01) 0.04 (0.01) 0.971 
Note:  BMI = body mass index; CO2 = carbon dioxide; O2 = oxygen; Fi = Fractional inhaled. All data expressed as mean 
(standard deviation); n=10 for both groups. 
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5.3.2 Metabolomic profiling analyses 
After data processing, exhaled and environmental VOC features were identified and 
allocated a study reference as defined in Chapter 3; i.e. identified by retention index 
(RI) and mass spectrum. These information were used to produce a search function 
that prospected all samples. A total of 373 peaks were isolated, integrated and 
normalised to the internal standard, and imported into a multivariate analysis work-
flow as described in Chapter 3. 
 
High vs low relative V̇O2max groups  
Separation in PCA was not observed (Figure 55). OPLS-DA analysis was performed 
on the high vs low relative V̇O2max groups and showed near separation of groupings 
(Figure 56). However, further investigation into the corresponding S-plot yielded no 
suitable candidate VOCs (data not shown). 
 
Figure 55 Principal components analysis 2-dimensional score plot constructed for breath 
samples for those falling into low (black triangles) and high (grey circles) relative 
maximal oxygen uptake groups. 
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Figure 56 Orthogonal partial least squares-discriminative analysis 2-dimensional score plot 
constructed for breath samples for those falling into low (black triangles) and high 
(grey circles) relative maximal oxygen uptake groups. 
 
High vs low absolute V̇O2max groups 
Separation in PCA was not observed (Figure 57). OPLS-DA analysis was performed 
on the high vs low absolute V̇O2max groups and complete separation was achieved in 
the score plot (Figure 58). The S-plot was analysed and three upregulated and two 
down regulated compounds were selected for further investigation, see Figure 59 
and Table 15. 
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Figure 57 Principal components analysis 2-dimensional score plot constructed for breath 
samples for those falling into low (black triangles) and high (grey circles) absolute 
maximal oxygen uptake groups. 
 
Figure 58  Orthogonal partial least squares-discriminative analysis 2-dimensional score plot 
constructed for breath samples for those falling into low (black triangles) and high 
(grey circles) absolute maximal oxygen uptake groups. 
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Figure 59 S-plot for modelled variables using an orthogonal partial least squares-discriminant 
analysis model for pre-exercise breath samples of low vs high absolute maximal 
oxygen uptake grouping. Candidate biomarkers are highlighted in grey ovals, no 
further compounds were considered as candidates. 
Table 15 List of candidate biomarkers as identified by discriminant analysis on comparison of 
high vs low absolute maximal oxygen uptake groupings. 
Ex. # 𝑅𝐼̅̅ ̅ Q QI1 QI2 QI3 QI4 Study ID 
26 1141 355 269 267 73 356 BRI-1141-355-269-267-73-356 
82 1295 429 325 73 341 430 BRI-1295-429-325-73-341-430 
89 659 43 59 0 0 0 BRI-659-43-59-0-0-0 
110 658 67 53 93 68 91 BRI-658-67-53-93-68-91 
201 655 59 43 0 0 0 BRI-655-59-43-0-0-0 
Note:  Ex. # = experimental peak number; ( 𝑅𝐼̅̅ ̅ ) = mean retention index; Q = 
quantifier ion m/z; QI1 to 4 = qualifier ions 1 to 4 m/z; ID = identification; OPLS-DA 
= orthogonal partial least squares-discriminant analysis. 
 
Candidate biomarker analysis 
The five compounds in Table 15 were evaluated against the V̇O2max scores for the 
two stratified groups. Outliers were excluded and BRI-659-43-59-0-0-0 and BRI-
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655-59-43-0-0-0 were examined closely and ascertained as the same compound 
that had had altered ion statistics across the study. This information was used to 
combine these features. Figure 60 compares exhaled values of the two upregulated 
candidate biomarkers across groups. RI and NIST searches indicated that they were 
propan-2-one (acetone, BRI-659-43-59-0-0-0) and 2-methyl-1,3-butadiene 
(isoprene, BRI-658-67-53-93-68-91), two exhaled breath metabolites that have 
been studied in relation to exercise previously [1]. Further whole cohort analysis of 
correlation with these ions with absolute V̇O2max scores showed no correlation (p ≥ 
0.081). However, a strong positive relationship was observed between candidates 
(Spearman’s rho (rs) = 0.693, p < 0.0005, Figure 61). 
 
5.3.3 Predictors of fitness 
In order to assess whether any, or a combination of any exhaled VOCs were 
predictive of the measured values for absolute V̇O2max, a general linear regression 
model with a stepwise variable entry method was performed. Three VOCs were 
identified in the analysis and reported an adjusted r2 = 0.459 and a p value of < 
0.0005. This reported that 45.9 % of the variance seen in absolute V̇O2max could be 
explained by the 3 VOCs.  
When analysed for Spearman’s correlations, two VOCs showed significant 
negative correlations with absolute V̇O2max, BRI-818-43-85-41-57-70 and BRI-1460-
41-56-55-0-0 (rs=-0.492 and -0.397, p=0.007 and 0.033, respectively). BRI-732-
41-69-99-100-0 did not show any correlation (rs=0.109, p=0.592). Further 
investigation in to the data highlighted one extreme point for BRI-818-43-85-41-57-
70, and when removed the VOC retained correlation (rs=-0.442, p=0.019). However, 
BRI-1460-41-56-55-0-0 lost correlation once all zero results (n=5) were removed 
from the analysis (rs=-0.124, p=0.565), suggesting a skew of data from these 
results. Visualisation of the scatter plot for the correlation of BRI-818-43-85-41-57-
70 with absolute V̇O2max shows a negative trend with V̇O2max but with large variation 
(Figure 62). Therefore, it is not possible to yet identify a model that successfully 
links maximal oxygen uptake with exhaled VOCs in this cohort. 
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Figure 60 Plot to show the distribution of acetone (top) and isoprene (bottom) in low and high 
absolute ?̇?O2max groups in a pre-exercise exhaled breath sample. Horizontal line is 
shown at the median with errors bars indicating the interquartile range.  
Note: some individuals’ values are missing in acetone due to chromatographic peak 
splitting. IR = relative intensity; IS = internal standard 
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Figure 61 Scatter plot to show the relationship of acetone and isoprene values in pre-exercise 
exhaled samples showing a positive intra-person relationship between both 
compounds. Spearman’s rho (rs) and corresponding p value are reported.  
Note: IR = relative intensity; IS = internal standard 
 
 
Figure 62  Scatter plot to show the relationship of absolute maximal oxygen uptake (VO2) and 
BRI-818-43-85-41-57-70 values in pre-exercise exhaled samples.  
Note: IR = relative intensity; IS = internal standard 
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5.3.4 Changes in exhaled VOCs after exercise 
To assess changes in VOCs caused by the maximal exercise protocol, multivariate 
analysis was performed across the three exercise stages. Data were visually 
analysed through a heat map for all measured variables across all time points prior 
to modelling. No signs of time point patterning were observed and cluster analysis 
indicated more impact was present for inter-person variability, opposed to variability 
across time points (data not shown due to visibility in print). 
Initial analysis performed by OPLS-DA showed no separation in a 2-
dimensional score plot. However, a leftward shift at 10 min followed by return 
toward pre-exercise sample points is present (Figure 63). When the S-plot was 
analysed it showed that only one VOC was providing a strong influence on the model 
(Figure 64). This VOC was BRI-658-67-53-93-68-91, 2-methyl-1,3-butadiene or 
isoprene, as identified in the previous analysis.  
Further post-exercise VOC analyses were completed on the previously 
reported groupings of high and low relative V̇ O2max scores. These analyses 
prospected for whether individuals with lower fitness levels showed alternative 
responses to the maximal exercise. Both at +10 and +60 min post-exercise no 
separation could be identified between these groups and therefore suggests that 
the differing fitness in the individuals did not account for a fluctuation in VOC 
profiling in response to the exercise-induced stress (data not shown). 
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Figure 63 Orthogonal partial least squares-discriminant analysis 2-dimensional score plot 
showing all three breath sampling time points. Markers correspond to pre- (grey 
circles), +10 min post- (white boxes) and +60 min post- exercise (black triangles). 
 
 
Figure 64  S-plot for modelled variables using an orthogonal partial least squares-discriminant 
analysis model for pre-exercise and post-exercise breath samples of low vs high 
absolute maximal oxygen uptake grouping. Candidate biomarker is highlighted in 
grey oval. 
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5.3.5 Isoprene across exercise stages 
Isoprene was investigated and a non-automated integration was completed for all 
samples. Kruskal-Wallis H test indicated that there was not an equal distribution of 
ranks across the three time points and pairwise comparisons indicated an increase 
in exhaled isoprene between the 10 and 60 min post-exercise time points 
(p=0.041). A reduced trend was observed for isoprene at 10 min post-exercise 
when compared to baseline levels, but no statistical significance was reached. 
Similarly, no differences were observed between baseline values and 60 min post-
exercise (p≥0.269, Figure 65). 
 
Figure 65  Box and whisker plots to display exhaled isoprene levels for all participants at pre- 
and post-exercise time-points. * denotes p = 0.041.  
Note: IR = relative intensity; IS = internal standard 
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5.4 Discussion 
Non-targeted metabolomics-wide analysis of exhaled breath in physically fit 
individuals prior to an exercise capacity test was able to provide some indication 
into the direction of the recorded fitness test value. Common breath metabolites 
acetone and isoprene showed an observed reduction for individuals with elevated 
absolute maximal oxygen uptake. However, a small sample size did not allow for 
significant differences to be observed once extraordinary values were removed from 
analysis, nor when manual integration of candidates was performed.  
Partial separation was observed between groups when a relative V̇O2max 
score was utilised, but no suitable candidate VOCs could be isolated from the 
corresponding S-plot. The process of creating a test value relative to body mass may 
have led to the normalisation of levels for acetone and isoprene. Further correlation 
analyses were completed and showed no associations of acetone or isoprene with 
mass, height, BMI or age (p>0.05, data not shown). However, near significance was 
recorded for isoprene and height (rs=-0.442, p=0.051).  
Breaths analysed prior to and in stages for up to one hour post-exercise 
testing showed one compound fluctuating, again isoprene. A reducing trend post-
exercise was observed and returned to baseline values by one hour. These data 
conform to the on-line analysis performed by King et al. [1] which showed a rise of 
exhaled isoprene at the onset of exercise and then a reduction across the exercise, 
perhaps due to the removal of an ‘isoprene store’ in the working muscles. 
Interestingly, subsequent tests showed blunted increases at exercise onset without 
adequate recovery, and therefore supported the idea that these ‘pools’ were not 
replenished. The data presented in this chapter support this theory as we see 
reduced levels after a bout of intense physical activity, which returns to baseline 
levels with sufficient rest time of one hour. 
Breath analysis is a growing research field. Many laboratories wish to create 
diagnostic breath tests to capture information on developing illnesses long before 
they are detectable by current measures. It is important to consider the use of a 
control group when these experiments are conducted. Interestingly, 33 fit, young, 
healthy and male participants would be considered an ideal group to provide control 
samples for a disease versus no disease research design. However, these data 
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show that within this relatively homogenous group of individuals, suggestions of 
differences in exhaled profiles due to physical fitness are observed. This study only 
highlights one aspect of variation within a homogenous group, their physical fitness 
level, and it is not unlikely that exhaled breath profiles will differ for other aspects of 
natural variation. Examples of these may be height, mass, ethnicity and age, 
amongst many others. This raises an important question of when is a control group 
really a control group? Further works into the variation of normal individuals is 
needed to support future diagnostic research of exhaled breath VOCs. 
Results reported here suggest that exhaled breath VOCs may have a 
potential role in fitness testing. A larger cohort size with a wider range of fitness 
abilities is required in further studies to develop the results from this pilot 
experiment. Trends seen in reduced acetone and isoprene levels, measured at rest 
prior to exercise, with increased oxygen uptake offer the potential to be explored 
further. If real associations are seen in a larger sample set, the use of on-line 
targeted exhaled VOC analysis for these compounds could be implemented to 
provide a rapid ‘snapshot’ of an athletes current fitness ability, without the need for 
exhaustive exercise testing protocols. This would afford the athlete and coach to 
monitor fitness levels during competition periods, or when recovering from injury 
and physically unable to complete a high intensity protocol. This advantage can also 
be translated to a public health scenario, where individuals recovering from surgery 
or other debilitating illnesses/procedures are undertaking light fitness training but 
would not be able to push to high intensities to truly measure oxygen uptake 
capacity. 
This experiment may be viewed as an exploratory attempt in implementing 
these technologies to provide answers for a non-exercising fitness test. It is 
important to understand that these data do not show significant associations but 
report trends that may be able to report differences with further exploration. Power 
calculations show that in order to achieve a statistical difference between the two 
groups, with an alpha value of 0.05 and a power of 80%, group sizes of 36 and 41 
would be required for acetone and isoprene, respectively. 
In conclusion, the small group of participants with a relatively narrow range 
of fitness values were able to report trends that showed acetone and isoprene to be 
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reduced in those who utilised increased volumes of inhaled oxygen, without 
normalisation to take into account body mass. The data does not show significant 
differences and further experiments with an increased sample size and wider range 
of maximal oxygen uptake values must be performed. Time point analyses of 
exhaled breath profiles reported that isoprene showed altering exhaled levels, with 
a trend for isoprene reduction seen post-exercise, and return to baseline within the 
one hour recovery period. These data reinforce the validity of the experimental 
conditions as they follow previously seen trends in the literature [1]. 
Improved and novel experiments in sport and exercise science and exhaled 
breath analysis ought to be completed to allow the progression of these non-
invasive technologies into a sporting context. 
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CHAPTER SIX: DEVELOPMENT OF AN ATMOSPHERIC 
PRESSURE IONISATION INTERFACE FOR ON-LINE, 
QUADRUPOLE MASS SPECTROMETRIC EXHALED BREATH 
ANALYSIS 
 
6.1 Introduction 
Mass spectrometry (MS) has the potential to obtain high resolution data and 
enables identification of a compound by its mass to charge ratio (m/z). Gas 
chromatography-mass spectrometry (GC-MS) is the gold standard technique for 
exhaled breath analysis [1]. However, such precision is time consuming and 
requires large equipment with extensive infrastructure. It is not a practicable 
proposition to place such instruments in the field for on-line analysis. GC-MS can 
offer high chromatographic resolution and is readily coupled to pre-concentration 
techniques such as thermal desorption (TD) [2] or needle trap devices [3], enabling 
trace level VOCs in breath to be concentrated up to detectable levels prior to 
analysis. Trapping on adsorbent tubes or storing samples in Tedlar bags enables 
samples to be taken at a remote location and then returned to the laboratory for 
analysis, and the use of GC compound libraries aids in the identification of VOCs in 
breath samples. However, due to the inherent complexity of breath samples the 
chromatographic separation often requires long run times (upwards of 30 min) 
making the technique ill-suited to high-throughput screening of large numbers of 
individuals. In addition, subtle chemical changes may occur during transport and/or 
storage time [4] and some information may be lost. Perhaps most importantly, the 
equipment required for this tends to be large, bulky, laboratory-based instruments 
that are operated by specialist users. When considering both medical and sporting 
situations, any potential use of exhaled breath VOC analysis would likely require 
virtually instantaneous results to present the clinician/coach with information that 
can answer the question in mind, and therefore impact on decisions that are 
subsequently made (e.g. treatment modalities or alteration of training intensities). 
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Furthermore, the notion of sampling and analysing at different sites creates the 
potential factor of maintenance of sample integrity through travel and storage. 
Limitations of off-line GC-MS led to the development of real-time time 
analysis techniques such as proton transfer reaction mass-spectrometry (PTR-MS) 
[5,6] and selected ion flow tube mass spectrometry (SIFT-MS) [6] for breath 
analysis. These approaches are capable of monitoring highly volatile species in 
breath in real-time, providing instantaneous diagnostic data. Both techniques 
enable direct analysis of breath and, with sub-µg L-1 levels of sensitivity, do not 
require any pre-concentration which greatly decreases the lead time to results. Both 
of these technologies make use of a chemical ionisation mechanism, have been 
successfully miniaturised (e.g. PTR-QMS 300, Ionicon, Innsbruck, Austria; and Voice 
200 (SIFT-MS), Syft Technologies, Christchurch, New Zealand) and have great 
potential for monitoring highly volatile species. However, there is a requirement that 
samples are introduced in gaseous form and these technologies are therefore not 
well-suited to analysing some of the larger, semi-volatile, species present in breath. 
Furthermore, their ion chemistry limits the types of compounds that can be 
analysed and, although sensitive, GC-MS is capable of analysing lower exhaled 
concentrations. A combination of high sensitivity MS measurement in a miniaturised 
format is required. 
The interfacing of breath sampling to MS using ambient ionisation 
techniques such as extractive electrospray ionisation (EESI-MS) [7-11], atmospheric 
pressure chemical ionisation (APCI-MS) [12] and glow discharge [13] has also been 
accomplished. These approaches can be used to interface volatile analysis to any 
mass spectrometer with an atmospheric pressure ionisation source. EESI-MS has 
been used off-line to analyse pre-concentrated breath samples collected on TD 
tubes enabling identification of breath metabolites [8], and has the potential to 
include a fast GC separation to give additional selectivity and remove background 
interferences [9]. This approach coupled to a high-resolution mass spectrometer 
has been shown to give increased throughput over GC-MS at the cost of 
chromatographic resolution. On-line extractive electrospray has been demonstrated 
to be capable of determining non-volatile compounds such as urea [10] and 
nicotine [11] in breath with µg L-1 levels of sensitivity. APCI-MS has proven effective 
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in determining volatile species, notably being used to detect aroma compounds 
released from food whilst eating [12,13]. This work led to the development of the 
MS-nose interface where a coaxial Venturi interface was used to produce a 
commercial volatile analysis source for Waters mass spectrometers. Outside of food 
analysis, on-line breath analysis using APCI-MS has been shown to be a sensitive 
method for determining narcotics in breath [14]. However, a limitation of most 
equipment used in these studies is that they are large, expensive and require 
climate controlled laboratories and expert users. Therefore, they are not suitable for 
either patient point-of-care or in community sports-medicine applications. 
Recently smaller, transportable, mass spectrometers have been developed 
that exploit enhanced electronics to produce smaller footprint and lower cost 
systems while maintaining most of their functionality. Examples of such 
developments include the Advion Expression Compact Mass Spectrometer (CMS) 
and the Waters QDa detector and Microsaic 4000 MID, and have been 
demonstrated for a number of different applications including on-line flow chemistry 
[15] and phytochemical screening [16].  
 
6.2 Experimental objectives 
The objective of this experiment was to develop an interface for a commercially 
available, compact and transportable mass spectrometer to enable it to be used for 
exhaled breath VOC sampling. In this instance an Advion Expression CMS was to be 
interfaced to a Venturi jet pump placed into the source nitrogen supply to enable 
breath samples to be drawn rapidly into the ionisation source.   
The approach was tested by simulating a disease/intervention marker (i.e. a 
pseudo-biomarker) by inducing a controlled change in an exhaled breath profile 
through the use of an ingested, commercially available, peppermint oil capsule. 
Experiments aimed to monitor subsequent appearance and elimination of the oils 
components and/or metabolites over time, and enabled the evaluation of the 
performance of this new breath analyser in a real breath matrix. 
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6.3 Methods 
 
6.3.1 Ethical clearance 
This study was approved by the Loughborough University Ethical Advisory 
Committee using an exhaled breath generic protocol with reference G09-P5. All 
participants took part voluntarily and were provided with a description of the 
experimental procedures before giving their written consent. All participants were 
free to exclude themselves and their data from the experiment at any time without 
reason. Once consented, participant information and data were anonymised and 
assigned a unique identifier code. 
 
6.3.2  Capsule details and mass spectral behaviour 
For all experiments a commercially available 200 mg peppermint oil capsule was 
ingested (Boots, Nottingham, UK). The exact makeup of the capsule was unknown. 
Menthol and menthone are major components of peppermint oil [17] comprising 
40.7 % and 23.4 % of the mixture, respectively (Figure 66). Initial trial runs showed 
that the largest response after dosing was seen relating to the menthone 
metabolite of the capsule (data not shown). Analysis of a 1:100 dilution of a 
menthone standard in water by APCI-MS demonstrated that the m/z 81, 137 and 
155 ion are the main peaks in the mass spectrum (Figure 67). For this experiment 
an emphasis was placed on the monitoring of the ions with m/z 137 and 155. The 
m/z 155 is understood to be protonated menthone, the structure for the m/z 137 
species is unknown but corresponds to the loss of H2O from the molecule and is 
likely to be in the form of a protonated terpinene (Figure 66). The ion with m/z 81 
relates to a [C6H8+H]+ ion, known to be common ion from monoterpene 
fragmentation [18]. 
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Figure 66  Chemical structures for menthol, menthone and a possible structure for the 
diagnostic m/z 137 ion. 
 
 
Figure 67  Atmospheric pressure chemical ionisation mass spectrum of the volatile headspace 
from a 1.0 % menthone solution in HPLC grade water.  
Note: I = intensity; m/z = mass to charge ratio 
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6.3.3 Instrumentation 
The same model of respiratory facemask used for collecting adaptive breath 
samples, Chapter 3, was interfaced into the APCI source of an Advion Expression 
(CMS) using a Venturi jet pump built in-house (Figure 68) that was heated to 100 C 
with a thermostatically controlled rope heater (Omega, Manchester, UK). Air was 
supplied to the mask at 20 L min-1 and the APCI gas was set at 4 L min-1, generating 
a suction sample flow from the mask of 260 mL min-1. Exhaled breath profiles were 
monitored with the pressure transducer system used to control sample acquisition 
for adsorbent bed sampling [19]. The CMS ion source parameters were optimised 
using a menthol vapour source, see Table 16, and the mass spectrometer 
instrument was operated in the positive ion mode for all these proof-of-concept 
experiments. 
 
Figure 68  Schematic drawing to show the modification to the atmospheric pressure chemical 
ionisation (APCI) gas line to incorporate a heated Venturi pump and full face 
breathing mask to allow analysis of exhaled gases via APCI on a compact mass 
spectrometer (MS). 
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Table 16 A table showing the source and acquisition conditions for exhaled breath volatile 
analysis using atmospheric pressure chemical ionisation on a compact mass 
spectrometer. 
Source Conditions  Level 
Capillary temperature / C 250 
Capillary voltage / V 42 
Source voltage / V 15 
APCI gas temperature / C 40 
Corona discharge voltage / kV 5 
 
Acquisition Conditions   
Ionisation mode Positive 
m/z range 30 - 300 
Scan time / ms 300 
 
6.3.4 Preliminary GC-MS characterisation  
A pilot experiment was conducted in order to estimate the potential levels of 
menthone in exhaled breath using the method detailed in Chapter 3. Exhaled VOCs 
were collected from 2 L of breath prior to and at 73, 174, 415 and 600 min post-
ingestion of the peppermint oil capsule. Samples were collected on a dual-bed TD 
tube and analysed using thermal desorption (Unity 2, Markes Int., UK)-gas 
chromatography (Agilent 7890, Wokingham, UK)-mass spectrometry (Agilent 5977A 
quadrupole mass spectrometer, Wokingham, UK) (TD-GC-MS). Sample 
chromatograms were processed for the presence and intensity of m/z 112 (base 
peak of menthone for electron ionisation) and an elimination curve was created. 
Levels of menthone and the period of wash out for these from the human biological 
system were assessed. Standard calibration analyses for menthone (Sigma-Aldrich, 
Gillingham, UK) were performed and quantitative values were obtained for each 
sample time point. 
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6.3.5 Menthone elimination experiment with CMS 
Sixteen healthy volunteers consented and completed the experimental period (7 
male and 9 female over an age range from 22 to 53 years). 
Participants wore a non-vented full face mask fitted with silicone pillow 
(ResMed, Abingdon, UK) containing a one-way non-breathing valve and were 
supplied with filtered air from a laboratory compressed air source as detailed in 
3.2.2. The mask contained two outlets, one connected to the previously described 
mask pressure monitoring device [19] and the other via silicone tubing to the 
Venturi pump interfaced to the CMS. All participants were issued their personal 
mask for their repeated measurements over a period of 6 to 10 hrs. Masks were 
not shared to ensure no transfer of infection material or VOC carryover 
contamination was presented.  
Participants were encouraged to breathe in a relaxed manner with their 
mask on for 2 min to equilibrate with the filtered air supply. After 2 min, the data 
acquisition was started whilst the participants continued to breathe normally for a 
further 3 min. Mass spectra and breath mask pressure profiles were recorded for 
the full 3 min period.  
To begin, continuous real-time monitoring was conducted with a single 
participant. The individual exhaled at a normal depth and rate into the mask for 20 
min post-ingestion of a peppermint oil capsule and data was continuously acquired 
and the ion with m/z 137 was monitored as the most intensely released metabolite. 
The main experiment was conducted where each participant gave a baseline 
exhaled VOC sample (0 min) before ingesting the capsule. Subsequent breath 
samples were acquired at 60, 120, 240 and 360 min post-ingestion for each 
participant. Monitoring of the intensity of menthone in the exhaled breath provided 
an assessment of the capability of the instrumental setup to detect changes in 
exhaled VOCs. Additionally, four participants repeated the experiment with sampling 
time points of 0 (pre-ingestion), 180, 240, 360, 480 and 600 min in order to further 
extend the experiment to lower concentrations (see Figure 69 for schematic). One 
female and three male participants form the original study with ages ranging 
between 26 and 36 years were recruited to complete the extended protocol. 
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Figure 69  Schematic timeline for exhaled breath experiments for up to 360 (experiment 1) 
and 600 (experiment) minutes post-ingestion of a commercially available 
peppermint oil capsule  
Note: t = time 
 
6.3.6  Statistical analyses 
Statistical analyses were performed using IBM SPSS Statistics (v 22.0, IBM Corp., 
Armonk, NY, USA). Wilcoxon signed rank tests were performed to assess the 
changes in intensity of the exhaled ion m/z 137 and 155 over time in comparison 
to baseline (0 min) measurements. All p values described in this manuscript refer to 
their Bonferroni adjusted values for multiple comparisons. An alpha (p) value of < 
0.05 was deemed as statistically significant. 
 
6.4  Results 
 
6.4.1 GC-MS analysis of exhaled peppermint oil VOCs 
A linear calibration was performed on menthone spiked onto TD tubes over a range 
from 0 to 8 ng on column mass (OCM) and a linear response was obtained (Figure 
70). For the washout experiment performed on a single participant, Figure 71 
shows that menthone was observed in the exhaled breath at all sampling time 
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points, including the baseline sample prior to ingestion of the capsule. The pre-
ingestion sample displayed an OCM of 0.112 ng (corresponding to 56 pg L-1 exhaled 
breath) and increased 7-fold to 0.771 ng OCM at 74 min (corresponding to 386 
pg.L-1 exhaled breath). This concentration then dropped over time and reduced to 
near baseline levels of 0.166 and 0.131 ng OCM at 415 and 600 min, respectively. 
An overlay of the extracted ion responses for the menthone fragment ion at m/z 
112 is shown in Figure 72 to enable visual comparison of the peak area response 
obtained for menthone at each time point. 
 
 
Figure 70  Calibration curve for menthone using thermal desorption-gas chromatography-
electron ionisation mass spectrometry with linear fit (solid line) and 95% confidence 
intervals (dashed lines) plotted.  
Note: I = intensity; OCM = on-column mass 
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Figure 71  Figure to show the intensity of m/z 112 ion (menthone fragment) obtained by 
thermal desorption-gas chromatography-mass spectrometry against time over a 
600 minute period post-ingestion of a peppermint oil capsule.  
Note: I = intensity; t = time 
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Figure 72  Overlaid extracted ion chromatograms for m/z 112 (menthone fragment) for each 
of the 5 sampling time points. Data obtained by analysis of exhaled breath by 
thermal desorption-gas chromatography-electron ionisation mass spectrometry.  
Note: I = intensity; tr = retention time 
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6.4.2  CMS analysis of exhaled peppermint oil VOCs 
 
Comparison of breathing profiles using APCI-MS and breath mask pressure 
Breathing profiles could be clearly observed in the total ion trace (Figure 73), where 
each peak demonstrated an increase in ion counts at the onset of exhalation, a 
plateau during steady-state exhalation and a reduced ion count at the cessation of 
exhalation and beginning of inhalation. This breathing profile followed an identical 
pattern to that seen in the pressure trace measured from the breathing mask 
(Figure 74). 
 
 
Figure 73 Example total ion trace for one participant over a 3 minute sampling period 
(bottom) with expanded view of four breaths (top) to show the total ion response 
corresponding to (i) the increased exhalation at the beginning of the breath, (ii) 
steady-state exhalation during the middle portion of breath and (iii) the cessation of 
exhalation and onset of inhalation toward the final stage of the breath. 
Note: IR = relative intensity; t = time 
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Figure 74 Example pressure trace of the full face breathing mask (top – dashed line) and the 
time-matched total ion response from the compact mass spectrometer (bottom – 
solid line). Each peak corresponds to one breath and shows a matching response of 
breathing profile from both sampling modalities. 
Note: IR = relative intensity; t = time 
 
VOC profiles 
Acetone in exhaled breath has been observed at concentrations ranging between 
200 to 600 µg L-1 in healthy individuals [20]. Exhaled breath VOC samples taken 
from participants before the peppermint oil was ingested all contained the acetone 
[M+H]+ ion at m/z 59 as the base peak. Further, a proton bound dimer was also 
observed at m/z 117 (Figure 75). 
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Figure 75 Averaged atmospheric pressure chemical ionisation mass spectrum for one 
participant prior to ingestion of a peppermint oil capsule.  
Note: IR = relative intensity; m/z = mass to charge ratio 
 
Menthone emergence and elimination 
 
Continuous real-time monitoring 
Continuous real-time measurement of peppermint oil metabolite evolution in breath 
showed an increase in m/z 137 response after approximately 10-13 minutes post-
ingestion. This increase can be attributed to the release of menthone from the 
ingested tablet as previous reported a reduction in exhaled menthone after 5 min of 
breathing synthetic air, remaining at the reduced levels for up to 30 min [21]. This 
continued to increase toward the end of the sampling period (Figure 76). The large 
intensity peak at 7 min corresponds to involuntary eructation producing a large 
response of the ion. This occurs due to the breakdown of the capsule in the 
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stomach, followed by an uncontrolled reflux of stomach gases containing high levels 
of peppermint oil components. Based on the data obtained from the 6 hr (360 min) 
experiments, the intensity of the m/z 137 is expected to further increase before 
reaching its peak intensity. This observation highlights the suitability of this method 
for the application of real-time breath analysis and shows the potential for on-line 
analysis of the metabolism of components released after digestion. 
 
 
Figure 76  Extracted ion trace for m/z 137 in one participant for 20 min immediately post-
ingestion of the peppermint oil capsule. Large peak intensity seen at 7 min 
corresponds to involuntary eructation. The inset shows the steady increase in m/z 
137 observed between 10 to 20 min. A manually drawn trend line superimposed 
over the inset demonstrates the gradual increase in exhaled intensity over time. 
Note: I = intensity; t = time 
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Extended protocol 
The first sample time point after ingestion of the peppermint oil capsule was 60 
min, see Figure 77. The three additional peaks reported from the APCI-MS 
menthone standard analysis were detected in the exhaled breath samples (m/z 81, 
137 and 155). The most intense of the peaks resulting from peppermint oil dosing 
was at m/z 137.  
 
 
Figure 77 Averaged atmospheric pressure chemical ionisation mass spectrum for one 
participant at 60 minutes post-ingestion of a peppermint oil capsule.  
Note: IR = relative intensity; m/z= mass to charge ratio 
 
The elimination of menthone was monitored by tracking the m/z 137 and 
155 ion for all participants. Two distinct wash out profiles were observed. Twelve 
participants saw a rise in the intensity of the exhaled peppermint oil components at 
60 min post-ingestion, before decreasing in an exponential manner over the 
sampling time period. Alternatively, delayed peak intensity was observed in 4 
participants showing a maximal ion response at 120 min, reducing to similar levels 
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as the main group by 240 to 360 min (Figure 78 for m/z 137). For participants not 
showing a delayed maximal intensity, ion intensities for m/z 137 were increased at 
60 min (p=0.008) and remained above baseline (0 min) levels for the entirety of the 
sampling period (p≤0.009), with ion intensities of the m/z 155 increased at 60 and 
120 min (p≤0.020) and returning to baseline levels by 240 min (p>0.05). No 
statistical increases were reported in the delayed ion response group, due to 
underpowered analyses with n=4. Power calculations to report a significant 
difference at 60 min compared to baseline for a power of 80 % and a p value of < 
0.05 indicate a sample group of n=13 would be required. When the two groups 
were combined, exhaled levels of m/z 137 remained above baseline values past 
360 min post-ingestion (p≤0.004) and remained above baseline values for m/z 155 
until 120 min post-ingestion (p’s=0.004) returning to baseline by 240 min post-
ingestion (p>0.05).  
 
 
Figure 78 Extracted ion response for all participants stratified by common (solid line, n=12) 
and delayed (dashed lined, n=4) maximal intensities of m/z 137 from prior to and 
up to 360 min post ingestion of the peppermint oil capsule. Plotted points refer to 
the median value and error bars to the interquartile range. # p≤0.009.  
Note: I = intensity; t = time 
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Samples collected for up to 10 hrs (600 min) after ingestion of the 
peppermint oil capsule showed further decrease of m/z 137 over time, with median 
values remaining above baseline throughout (data not shown). Statistically different 
levels were not observed in this cohort, again due to underpowered analyses with 
n=4. Final elimination of the peppermint oil compounds and a return to baseline 
values was predicted at approximately 10.5 to 11 hrs post-ingestion.  
 
6.5 Discussion 
The previously validated breath monitoring and sampling system interfaced to an 
APCI-CMS was shown to provide sensitive analysis of exhaled VOCs. Data obtained 
were ready for processing and evaluation directly from instrument without any 
further requirement for pre-processing preparation. Single breath measurements 
were demonstrated for metabolites, such as acetone, commonly measured in 
concentrations in the µg L-1 down to ng L-1 levels. The introduction of a controlled 
and artificial change in breath profile was demonstrated by dosing with a 
peppermint oil capsule, indicating the potential use of the instrument to monitor 
real-time changes in metabolism (e.g. drug metabolism, responses to exercise etc.). 
The full 3 min of data were averaged to give the spectra, and acetone and its 
dimer were detectable from a single breath in all participants without any prior pre-
concentration, highlighting the sensitivity of this approach for the analysis of low 
molecular weight VOCs. The performance of the CMS in full scan mode compares 
favourably for this application with a quadrupole time-of-flight instrument which 
required pre-concentration of 2.5 L of breath on thermal desorption tubes to 
achieve a roughly comparable level of sensitivity, albeit with accurate mass 
measurement [9]. 
With refinement of the engineering, the CMS instrument is capable of in-situ 
breath analysis such as on a clinical ward or at pitch-side during a sporting event. 
The analysis time is compatible with embedding the procedure into training 
protocols for use by athletes and coaches. Further research is required to identify 
exhaled VOCs that are altered through events such as heavy training, injury or 
illness. Here is an opportunity to provide elite sports with a tool to assess the 
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athlete’s health status. The identification of VOCs that are increased/decreased 
with the onset of an upper respiratory tract infection, or other common illnesses 
such as gastrointestinal disturbances may be seen as a priority research goal. 
Training or competing during the development of an illness increases the stress on 
the individual, and the probability of injury accompanied by a reduction in their 
performance. The impacts are a loss of training and competition time with follow-on 
consequences that last significantly longer than the episode of ill-health. 
Psychological impacts should not be discounted either, and for the top performers 
financial impacts may be substantial. Success here would allow coaches to protect 
the athlete from exacerbation of the health impacts from training and/or 
competition when it was medically inappropriate to do so. The longer term benefit is 
intended to be reduced recovery times and an overall increase in the opportunities 
for effective training/competition.  
Additionally, with the development of breath-by-breath measurements it 
could be possible to monitor exercise-induced stress markers that enable 
personalised and stratified optimisation of training sessions, reducing over-training 
and realising the full potential of a training session. 
The ability to transport the device for rapid analysis of exhaled VOCs in 
community settings for individuals for whom travel to a clinic is problematical, and 
frail or vulnerable patients in long term care, is attractive. In hospital, preliminary 
applications may be the monitoring of metabolism responses to drug therapy and 
research into such exhaled biomarkers is logical continuation of the research 
described here.  
Comparison with the obtained calibration indicated that the concentration of 
menthone in the breath at the 360 min time point was approximately 21 ng L-1. This 
cannot be compared directly with the APCI-MS system since there is no separation 
occurring before ions are detected on the APCI-MS system Other peppermint oil 
species, such as α- and β-pinene and isomenthone, or metabolite species may 
possibly be contributing to the m/z 137 response. As menthone is one of the major 
components of peppermint oil (23.4 %, [17]), this suggests that the mass 
spectrometer is capable of detecting species in the sub-µg L-1 levels. This 
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observation highlights that the CMS with direct APCI analysis has potential as an in-
clinic breath analyser 
In conclusion, it has been shown here that a CMS is capable of being 
interfaced with an exhaled breath sampling device for a rapid, non-invasive on-line 
measurement of exhaled VOCs. Further development is required to achieve full 
mobilisation of the instrument and its true value to future sporting or medical 
situations will only be fully appreciated as exhaled VOC biomarkers are discovered 
through further research. 
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CHAPTER SEVEN: GENERAL DISCUSSION 
 
This thesis proposes that exhaled breath analyses have a potential role in 
enhancing competitive sport and general exercise, and as such there is a basis for 
further research. Breath as a sampled medium in exercise, most notably sports 
training and competition, has yet to be properly explored. The ability to make rapid 
and non-invasive measurements that provide previously unobtainable information 
on the athletes’ metabolism and condition would be advantageous. The ability to 
enhance training and competition would be of great interest to athletes, coaches 
and non-professional sports players. This research sought to prospect the use of 
exhaled breath analysis in exercise-as-medicine and sports performance contexts. 
 
7.1 Review of swimming impacts on breath profiles 
 
7.1.1  Summary of findings 
In Chapter 4, exhaled breath monitoring was used to assess potential lung health 
impacts associated with swimming in a chlorinated pool environment. Known 
disinfection by-products (DBPs) were monitored in exhaled breath both before and 
for several hours after a 30 min recreational swim. Rapid rises in the exhaled 
breath concentrations of 3 trihalomethane DBPs were observed, with peak 
concentrations reported immediately post-swimming. The largest rise was observed 
with chloroform (median = 121-fold increase across 19 male participants), followed 
by bromodichloromethane (4.4-fold) and dibromochloromethane (1.8-fold). Three 
participants showed a delay in the build-up of peak exhaled intensity, with highest 
concentrations noted at 90 min post-swimming. Previous reports have not observed 
this modified wash out profile. Although reasons for delayed kinetics are unknown, 
ingested pool water may have provided DBPs that were released only after further 
processing in the digestive tract. General wash out kinetics, i.e. rapid increase with 
a decline slowing over an extended period, are in-line with previous studies [1-4]. 
  
181 
 
This research was able to define wash out characteristics in a larger cohort than 
previous reports, allowing for the identification of delayed responders. Although this 
better defines the nature of wash out kinetics, further investigation is required to 
support these observations. 
A novel approach used to assess chlorine-based swimming pool insults was 
the metabolomic treatment of the data. Analyses isolated exhaled compounds that 
reported an increased trend in exhaled concentration over 10 hrs post-swimming. 
These were BRI-1461-43-107-93-41-69 (geranylacetone, CAS: 3796-70-1) and BRI-
1337-146-145-0-0-0 (2-benzofurancarboxaldehyde, CAS: 4265-16-1). This is the 
first report to identify these molecules in response to exercise. Geranylacetone is 
associated with cell signalling, fuel storage and membrane integrity stability [5]; 
therefore its presence provides a plausible link to an inflammatory response. It is 
neither possible to attribute, nor rule out, this as a response to chlorine-induced 
inflammation. The identification of a ketone body suggests possible emergence of a 
marker to reflect biological stress, whether it be oxidative or inflammatory. Further 
work is required to either eliminate or support this finding. The study involved young 
(mean 25 (95 % confidence intervals (CI) 24 to 26) yrs) but fully matured males. An 
important aspect for future study would be to investigate the impact to chlorinated 
swimming pool exposure in the adolescent lung. The complexity of the human lung 
increases during maturation, and exposure to these chemicals could cause 
transient problems during developments stages. The effect of potential early 
residual damage should be investigated more thoroughly. 
This is the first report of non-targeted metabolomics for exhaled breath 
volatiles using a wide-range mass to charge (m/z) scan performed in conjunction 
with any mode of exercise.  
 
7.1.2 Recommendations for follow on studies 
 
Relocate on-site sampling station 
Two samples, pre- and 5 min post-swimming, were collected within the swimming 
pool complex. Although not directly connected to the swimming pool and adequately 
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ventilated, contamination with DBPs was still present and environmental artefacts 
may have been present during breath sampling. However, blank samples of the 
filtered air supply were shown to contain levels lower than those measured in the 
breath (Table 11, Section 4.5.3). Experimental design would be improved if all 
samples were taken off-site, with an adjacent building or a mobile laboratory 
providing suitable alternatives.  
 
Management of exercise intensity 
Participants exercised for 30 min at a pace to push their own limits, but not so that 
they were unable to complete the full exercise duration. As with any exercise, 
swimming requires a combination of physical fitness and technical ability. Although 
none of the participants were regular swimmers, a range of swimming ability meant 
that certain individuals were able to swim further distances. Heart rate and 
respiration levels were not possible during the exercise meaning accurate levels of 
respiratory exposure were not monitored. Nevertheless, variability was addressed 
through selection of phenotypically matched participants (19 healthy males; mean 
body mass index (BMI) 24.8 (95 % CI 23.3 to 26.2) kg m-2, age 25 (24 to 26) yrs). 
Inclusion of pool-capable on-line measurements of expired oxygen, heart rate and 
breathing rate would be beneficial for future investigations. The removal of the need 
to swim is a potential design modification. More specifically, alternative exercise 
modalities could be performed in the swimming pool, such as aqua jogging. This 
would remove the requirement for technical swimming ability whilst maintaining a 
pool-based protocol. Nonetheless, the nature of variability in VOC profiles between 
matched phenotypes was observed throughout the samples collected in this 
research, regardless of exercise ability. 
 In addition, inclusion of control conditions would benefit the experimental 
conclusions and provide more robust comparisons. Each participant would serve as 
their own control, using a 4-way randomised crossover research design. The 3 
protocols would consist of:  
i) exercise in a swimming pool environment; 
ii) exposure to a swimming pool environment without exercise; 
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iii) matched exercising intensity performed in an alternative location; 
iv) a time-matched period without exercise. 
 
7.2 Review of fitness prediction breath test 
 
7.2.1 The prospect of rapid assessment of physical fitness 
Data obtained in Chapter 5 indicate the potential to categorise individuals into 
levels of absolute maximal oxygen uptake (V̇O2max) using exhaled concentrations of 
acetone and isoprene (median ratios to internal standard (interquartile range (IQR)) 
for low versus high absolute V̇O2max group; acetone 8.93 (4.38 to 10.53) versus 
5.71 (3.98 to 7.19); isoprene 7.60 (3.72 to 11.08) versus 4.83 (2.86 to 7.44). 
Furthermore, a general linear model with stepwise entry isolated exhaled 
compounds that were significantly related to the measure of absolute V̇ O2max 
values. This technique takes the inputted independent variables and adds one 
variable per iteration in a stepwise manner, until a model is produced that contains 
all of the dependent variables independent predictors. One molecule (BRI-818-43-
85-41-57-70) displayed a significant negative correlation (rs = -0.442, p=0.019) 
with absolute V̇O2max. However, variability observed across participants highlighted 
the requirement for a larger sample power to confidently assign an association. The 
prospect of acetone and isoprene monitoring as a targeted measurement for the 
rapid assessment of physical fitness is attractive. These are ubiquitous breath 
analytes, related to metabolism, that are at concentrations high enough to be 
analysed with relative ease [6]. The scope for this application is wide, from the 
monitoring of incapacitated persons to the support of an elite athlete. In sporting 
contexts, this test offers condition monitoring without added physical exertion. 
Participants were young (mean age 23 (95 % CI 22 to 24) yrs), healthy (BMI 
25.3 (24.5 to 26.2) kg m-2, V̇O2max 46.5 (44.6 to 48.4) mL(O2) kg-1 min-1, self-
reported vigorous exercise 307 (245 to 370) min.wk-1) and disease-free, and would 
be suitable a control set in diagnostic investigations. Nevertheless, data suggest 
that, even within this set of ‘control’ participants, exhaled VOC differences are 
present. Multivariate discriminant analyses were able to separate participants 
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categorised as high (median 4.3 (IQR 4.0 to 4.4) L(O2) min-1) and low (3.4 (3.3 to 
3.4) LO2 min-1) absolute V̇O2max. Further investigation reported that acetone and 
isoprene were 2 of the major discriminants. Statistical significance was not met for 
these molecules, however clear trends for reduced levels in higher absolute V̇O2max 
levels were observed. This raises an interesting question; what would the defining 
characteristics of a control cohort be? For example, acetone and isoprene have 
been related to disease states (e.g. in critically ill patients and diabetes [7]). All 
participants were informed to arrive at the laboratory in a fasted state, normalising 
the effect of rises in acetone during starvation [8]. Under the assumption that 
protocol was followed, any differences cannot be attributed to the fasted state. 
Acetone levels showed a decrease with increased oxygen capacity, and suggest that 
previously reported disease associations may be related the measurement of 
inactive individuals. 
 
7.2.2 Recommendations for future studies 
 
Incorporate a longitudinal research design 
A major limitation in this study was the relatively narrow range of physical fitness 
within participants. A longitudinal study tracking changes in exhaled VOCs 
throughout an exercise training intervention would contribute further understanding 
to the field. This fitness contrast could be assessed and VOCs mapped against rises 
in maximal oxygen uptake. 
 
Baseline repository 
The fasted, resting breath samples from a cohort of young and healthy male 
participants that were captured in this study forms a valuable resource. This cohort 
of participants forms the basis of a well-defined and phenotypically matched group 
of ‘control’ participants with corresponding exercise capacity data. This information 
is envisaged to be beneficial to the wider research community. Future plans to 
release this cohort as freely accessible will allow for researchers to compare like-for-
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like data against these participants, and adjust for physical fitness where 
appropriate. 
 
VOC profiles from a maximally exercised metabolism. 
It was anticipated that maximal levels of physical exertion would induce changes in 
metabolism and be reflected in the exhaled breath profiles. This was not observed. 
Isoprene was identified to change in exhaled concentration across the three 
sampling time points. An expected reduction in concentration post-exercise was 
observed. This confirmed a previous report where it was proposed that a ‘store’ of 
isoprene, perhaps in the working muscles, was being released during exercise [6]. 
Isoprene concentrations returned to baseline levels after one hour. The 
methodology was not able to record the rate of return or concentration dynamics.  
 
The need for on-line measurements 
The measurement procedure was limited by the total number of samples that were 
accessible. On-line measurements were needed and not available. Transient short-
lived changes could not be monitored during or immediately after exercise, nor 
could rates of change in concentration. This limitation could be overcome with 
further development of on-line breath analyses using a compact mass 
spectrometer, as described in Chapter 6.  
The experimental design was not able to monitor breath profiles over an 
extended period. Changes in metabolism and associated VOC markers may take 
several hours to manifest themselves, and future experiments would benefit from a 
longer follow-up period. 
 
7.3 Increased cohort size 
Difficulties encountered from the observed variability in exhaled VOCs would be 
reduced with increased sample sets. Chapter 5 utilised only male participants who 
were all sport-active and within a narrow age range (18 to 30 yrs). Future 
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investigations would benefit by repeating the experimental design, with the addition 
of (an) older age group(s) (e.g. 30 to 50 and 50 and over). This would allow for 
greater understanding of whether observed changes translate to another age group 
and cohort. Importantly, critically ill patients who cannot perform physical exercise 
tests are often older individuals, and comparing exhaled data to those from young 
adults may not be appropriate. The addition of female participants would allow 
investigation of gender-specific reactions. Female metabolism may be partly 
regulated by the menstrual cycle, therefore the timing of sampling must be taken 
into consideration during future investigations. 
 Studies would also benefit from an extended platform of analytical tests. For 
example, the introduction of ion mobility spectrometry may allow further delineation 
of exhaled VOCs. A multiplex approach would allow for a more comprehensive 
analysis of obtained data. 
Stratification of participants by high/low V̇O2max values, inevitably produced a 
reduced cohort size for comparison, and therefore reduced statistical power for 
tests of difference. Power calculations for a power of 80% and a p value < 0.05 
reported that group samples sets of 36 and 41 would be required to record 
statistical differences in acetone and isoprene, respectively. Therefore, for future 
investigations it is advised that a minimum cohort of 80 individuals is used for each 
grouping to be investigated; i.e. 80 young males, 80 young females, 80 older males 
etc. The larger group size would allow for adequate stratification at the median, and 
produce more robust correlation analyses. 
 
7.4 An on-line breath analyser for breath-by-breath monitoring 
A sampling interface was developed to allow the adaptation of a compact mass 
spectrometer, in order to enable on-line measurement of exhaled volatiles. This 
modification enabled the provision of instant readings, a requisite feature for the 
elite sporting community. The concept was tested using an ingested peppermint oil 
capsule enabling breath-by-breath concentrations of exhaled menthone to be 
tracked for up to 10 hrs. In addition to the on-line breath-by-breath approach, data 
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can be collected on ion accumulation over a short (3 min) period, and analysed 
instantly.  
Important operational aspects that have yet to be resolved satisfactorily are 
the provision of portable air and nitrogen supplies. This requires the construction of 
a custom built trolley with these items incorporated. More significantly, if breath 
analyses are to be performed with participants during or immediately after exercise, 
then the breath sampling system needs to be redesigned. Participants require 
sufficient air to breathe at ventilatory rates of up to 200 L min-1 (data not shown 
from V̇O2max exercise test collections). This is significantly higher than the 30 L min-1 
supplied to the current system. Future studies, including those that are outlined in 
this thesis, would benefit greatly from the development and application of this 
system for use in exercise research. 
 
7.5 Concluding remarks 
The research presented in this doctoral thesis describes initial investigations into 
the integration of exhaled breath VOC analyses into a performance-based sports 
monitoring context. This is the principle report to show exhaled metabolites as a 
potentially functional analysis for reporting physical capability. The findings are of 
interest, but with the requirement for future developments and validation. This 
thesis has investigated the use of exhaled breath in two domains: 
i) health based monitoring, whether it be within athletes/exercising individuals 
or those suffering or recovering from health complications; 
ii) performance based monitoring for athletes. 
The research describes the analysis of potentially harmful chlorinated DBPs 
and their delayed removal from the biological system. Tentative identifications of 
metabolites that show an up-regulated trend, and that may be attributable to a post-
contamination inflammatory response, were proposed. Furthermore, it describes an 
initial use of exhaled breath volatiles as a potential non-invasive analytical test to 
monitor physical fitness and exercise capacity. Finally it described preliminary 
advances in allowing analyses using a portable mass spectrometer to be done in 
real-time. 
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The advancement of this research would progress the field, by offering the 
possibility of a wider scope of health and fitness monitoring. Our understanding of 
the possibility of lung injuries, and accumulative damage of repeat exposure to 
swimming pool environments, remains poor. Swimming is a form of exercise 
promoted as beneficial to those with respiratory complaints such as asthma. 
However, an unequivocal rebuttal to swimming-exacerbated respiratory problems is 
not possible, nor is it supported by the findings from this research. Swimming is the 
most recreationally popular activity in the United Kingdom [9] and promoted heavily 
within primary schools. It is important to assess possible health impacts that may 
occur in the developing lung and ascertain whether chlorine exposure and inhaled 
DBPs are causing detrimental effects. The answers to such questions will require 
the implementation of highly sensitive exhaled breath assays within scaled and 
properly stratified cohorts.  
The capability to monitor physical performance through exhaled breath 
analysis would benefit athletes and health professionals alike. The impact of an 
assay that could adequately monitor the fitness of individuals prescribed exercise 
rehabilitation would be substantial. Cardiovascular rehabilitation, after events such 
as stroke, myocardial infarction and heart failure, would enjoy notable benefit from 
advances in this field. It would also allow physicians to develop a better 
understanding of if, and how, an exercise regime is benefitting an individual. 
Furthermore, these innovations would advance the movement toward personalised 
precision medicine. In the context of sport, the ability to monitor, or acutely assess, 
fitness capabilities would enable athletes to reduce their exhaustive testing burden, 
allowing them to focus on their applied training in their respective sports. In 
addition, this aspect of monitoring would likely be of interest to the military services, 
allowing for the regular monitoring of fitness levels in serving personnel. These 
advances are not without their difficulties, but the preliminary data described in this 
thesis show initial steps toward these difficult but rewarding goals. 
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7.6 Conclusion 
In conclusion, the research described in this thesis has demonstrated, for the first 
time, the possibility of exhaled breath monitoring in an exercising and sporting 
context. It has also yielded insights into potential health impacts and personalised 
and/or stratified training. The experiments are not without flaws and their 
shortcomings stimulated the development of a new, on-line, at-track/pool/clinic 
instrument. This has since been developed further and is due to be released as a 
commercial product in Q2 2016 by Advion. These first studies engender a hope that 
they could be repeated and developed, so that the techniques they employed 
become common practice in the future. 
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